Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AARS1	"AARS, AlaRS, CMT2N"	ENSG00000090861	"Alanyl-tRNA synthetase 1"	P49588	16	70251983-70289707	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 25.1;Cytotrophoblasts: 63.0;Extravillous trophoblasts: 29.9;Hofbauer cells: 27.1;Syncytiotrophoblasts: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034261, HPA040870, HPA044223"	Supported		Supported	Cytosol		NA	NA		620000	"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB034261: AB_1562673, HPA040870: AB_10794995, HPA044223: AB_2678862"	"unprognostic (1.98e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.02e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.83e-3)"	43.7	54.7	60.1	33.4	64.3	7.9	41.4	73.3	88.6	42.1	49.2	48.9	26.0	49.8	49.6	29.5	40.4	22.3	47.9	62.8	71.7	43.6	72.0	45.3	30.0	78.6	68.6	37.3	75.8	74.9	50.1	35.6	84.9	40.0	26.2	59.3	53.3	47.2	62.4	28.8	32.7	47.8	66.3	38.3	51.8	23.8	74.8	36.4	66.6	39.7	35.5	45.9	32.8	83.9	123.7	192.8	52.9	205.7	127.3	115.0	125.7	97.7	135.3	119.7	151.8	162.5	163.2	140.4	127.2	99.3	90.8	137.2	160.5	133.1	170.7	63.2	54.7	135.6	78.0	152.2	348.0	74.4	77.2	133.9	193.8	228.1	508.4	91.4	120.3	209.3	176.0	173.4	91.3	282.0	89.4	85.0	104.3	160.0	108.5	170.4	36.1	317.0	84.7	60.3	67.9	57.3	269.5	62.3	246.1	75.8	197.7	181.3	75.2	85.2	82.9	84.9	78.8	233.8	174.2	258.2	155.4	124.9	175.9	6.5	7.8	2.7	11.9	13.2	13.0	12.8	9.7	11.7	11.9	9.1	11.2	12.2	0.1	22.7	14.1	7.0	8.0	12.6	60.1	64.3	73.3	88.6	62.8	71.7	78.6	68.6	84.9	66.3	74.8	83.9	6.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	63.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	29.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	52.0	0.2	0.0	0.0	0.0
ABAT	"GABA-T, GABAT"	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674596-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 137.9;kidney: 133.3;liver: 345.6;pancreas: 138.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 268.2;Inhibitory neurons: 95.0;Oligodendrocyte precursor cells: 76.9;Proximal tubular cells: 94.9"	"Cancer enhanced"	"Detected in all"		"glioma: 27.3;liver cancer: 26.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 127.5;MCF7: 81.9;RH-30: 67.4;T-47d: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		No	No		2100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.36e-5)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	3.3	27.7	94.6	4.7	105.4	2.2	5.1	85.2	103.4	3.8	70.7	7.6	43.6	3.8	9.6	7.7	6.2	4.4	14.1	90.2	120.7	133.3	345.6	4.5	5.0	90.8	107.4	10.5	138.3	8.2	55.8	3.4	137.6	21.7	7.8	29.6	6.5	3.5	1.6	2.7	20.1	2.7	88.1	4.1	7.4	13.4	137.9	4.2	29.3	1.4	5.9	9.9	4.1	70.9	0.7	0.2	32.1	18.7	5.0	1.7	2.0	4.2	2.2	1.8	0.7	12.7	0.9	4.0	1.4	2.3	1.2	8.3	2.1	7.7	2.4	2.3	2.1	5.5	0.1	127.5	8.1	1.3	8.3	6.5	3.4	3.2	1.4	0.9	0.6	10.7	1.1	2.6	0.6	81.9	2.1	0.6	2.8	23.2	0.3	9.7	67.4	1.8	1.2	20.9	5.1	15.7	1.9	1.0	0.2	6.2	42.6	3.4	0.6	0.8	5.7	2.7	0.1	3.0	0.3	0.8	0.8	5.7	4.2	0.7	1.9	2.7	1.5	2.2	0.7	0.6	1.0	1.1	1.2	1.2	0.7	1.1	6.1	1.2	4.2	0.2	1.1	1.2	94.6	105.4	85.2	103.4	90.2	120.7	90.8	107.4	137.6	88.1	137.9	70.9	1.7	0.0	6.9	39.5	6.1	1.5	4.0	3.3	2.2	27.3	9.1	5.0	10.8	20.0	5.8	1.8	4.2	1.4	5.3	8.9	23.5	1.6	13.0	12.9	6.2	2.4	15.6	13.9	41.8	6.2	1.5	3.2	5.6	12.9	1.3	59.5	7.1	268.2	5.2	35.3	95.0	3.9	2.0	15.7	7.4	8.7	3.7	8.2	1.8	19.7	6.5	48.6	9.2	76.9	17.7	6.8	6.1	4.5	1.0	7.4	15.7	94.9	3.6	5.8	0.0	4.3	3.8	3.7	0.9	9.5	0.6	1.4	6.3	2.3	6.9	5.0
ABHD12	"ABHD12A, BEM46L2, C20orf22, dJ965G21.2, DKFZP434P106"	ENSG00000100997	"Abhydrolase domain containing 12, lysophospholipase"	Q8N2K0	20	25294742-25390835	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Cataract, Deafness, Disease variant, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 315.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026866	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA026866: AB_1844446"	"prognostic unfavorable (3.81e-5)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.32e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.67e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (8.51e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.08e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.11e-3)"	29.5	33.0	55.7	27.4	67.3	26.5	26.9	70.0	64.7	32.1	35.9	37.0	47.0	25.3	133.1	50.0	24.8	33.4	30.5	77.3	58.2	45.5	29.8	32.6	30.8	70.9	64.6	30.6	117.8	55.3	42.1	29.6	73.3	35.5	36.4	30.8	36.9	39.9	13.3	52.4	52.8	23.6	66.0	22.0	55.0	19.2	71.8	23.4	80.8	14.8	41.5	37.2	35.1	96.9	67.2	148.3	41.6	50.9	79.6	47.1	93.3	97.0	84.5	73.7	84.6	90.1	93.0	21.8	53.3	77.0	155.1	116.5	44.4	56.8	62.8	22.7	41.9	33.3	46.8	128.4	59.3	33.3	71.6	58.7	42.0	85.4	44.1	95.7	33.2	37.8	25.8	315.3	72.8	142.5	51.8	31.0	29.4	77.8	96.8	39.2	95.3	195.0	43.4	145.7	46.6	39.7	75.4	198.9	133.8	72.3	67.4	47.6	44.6	98.3	63.0	57.1	54.0	38.8	36.1	33.4	61.8	38.7	57.3	15.8	18.8	17.3	9.9	17.0	7.5	3.8	10.2	13.7	17.9	5.1	8.9	8.9	3.6	15.4	17.7	17.0	10.4	8.6	55.7	67.3	70.0	64.7	77.3	58.2	70.9	64.6	73.3	66.0	71.8	96.9	20.7	6.4	6.5	19.2	13.8	17.7	32.0	9.8	19.4	34.5	19.6	19.7	16.6	30.0	13.7	27.6	10.4	91.6	22.2	97.0	27.4	33.7	53.0	24.9	18.1	17.5	34.0	14.5	37.7	34.3	95.2	22.9	35.2	28.3	10.2	26.9	15.0	19.5	114.1	42.1	46.0	28.9	20.3	37.8	43.8	107.1	16.1	62.4	33.8	42.2	58.7	44.1	23.7	50.8	67.5	22.9	77.7	20.7	39.3	31.6	126.7	24.6	13.1	23.3	26.3	13.8	19.5	19.9	37.7	27.2	18.3	130.8	18.0	19.6	33.3	35.2
AC091167.6		ENSG00000275674	"Novel protein"		15	90266317-90314499	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 1.2;pancreas: 1.1"	"Cell type enriched"	"Detected in single"	5	"Alveolar cells type 2: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;CACO-2: 1.0;U-266/84: 1.1"															NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"				"unprognostic (1.02e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.70e-2)"			"unprognostic (2.50e-2)"		"unprognostic (6.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.18e-2)"	"unprognostic (4.73e-2)"		"unprognostic (1.52e-1)"	"unprognostic (3.05e-2)"	0.0	0.0	0.8	0.0	0.5	0.0	0.1	0.2	0.7	0.1	0.0	0.2	1.2	0.1	0.1	0.0	0.2	0.0	0.0	0.5	0.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.1	0.3	0.2	0.0	0.1	0.1	0.0	0.3	0.5	0.2	0.1	0.0	0.7	0.2	0.1	0.0	0.4	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.3	0.2	0.0	0.0	1.9	0.1	0.0	0.1	0.1	1.0	0.3	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.5	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.3	0.2	0.1	0.1	0.4	1.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.5	0.2	0.7	0.5	0.8	0.1	0.1	0.1	0.1	0.4	0.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACSS1	"ACAS2L, AceCS2L, dJ568C11.3, MGC33843"	ENSG00000154930	"Acyl-CoA synthetase short chain family member 1"	Q9NUB1	20	25006230-25058980	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 300.4;Cytotrophoblasts: 329.7;Syncytiotrophoblasts: 419.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 50.3;JURKAT: 51.2;MOLT-4: 49.6;OE19: 64.6;RPMI-8226: 75.1;U-937: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041014, HPA043228"	Enhanced					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA041014: AB_2677251, HPA043228: AB_2678372"	"unprognostic (6.87e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.20e-3)"	"prognostic favorable (8.33e-5)"	"unprognostic (2.44e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.58e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.60e-1)"	12.8	9.5	65.0	15.5	70.2	33.4	14.1	55.8	66.9	16.1	124.7	28.1	49.3	16.1	19.7	14.3	18.8	15.0	91.3	64.5	55.7	49.9	13.9	20.2	25.5	57.9	65.0	22.6	57.4	34.0	11.3	118.4	53.8	29.1	20.6	4.0	39.8	12.0	44.6	18.0	46.8	13.1	53.4	33.6	62.9	38.6	67.7	30.9	29.8	41.4	21.3	15.7	14.5	60.8	0.1	11.8	3.4	0.0	10.6	4.0	0.2	1.3	5.1	5.0	3.3	12.0	1.6	21.0	2.0	4.8	21.5	5.9	17.1	2.6	1.0	0.0	1.6	36.0	0.2	50.3	11.1	8.5	0.4	7.0	8.6	0.5	0.0	0.0	10.9	51.2	1.9	39.0	0.4	1.3	49.6	14.6	0.2	64.6	18.9	38.2	1.1	75.1	7.3	9.4	8.3	0.2	2.3	4.6	33.5	0.2	22.5	19.1	1.7	0.1	0.1	0.1	0.6	26.7	1.9	0.0	0.5	51.5	13.0	5.6	2.8	7.2	4.2	5.1	3.3	4.0	2.7	3.6	3.5	5.1	2.3	3.5	0.5	10.2	3.4	2.1	2.7	2.3	65.0	70.2	55.8	66.9	64.5	55.7	57.9	65.0	53.8	53.4	67.7	60.8	10.8	12.8	15.1	300.4	29.8	5.2	6.7	3.1	5.2	2.2	15.1	8.0	73.0	45.8	7.7	11.0	0.0	329.7	26.4	27.2	76.3	6.5	87.7	14.3	5.0	9.7	0.0	42.9	0.9	7.7	10.9	14.0	26.5	7.2	5.7	20.4	9.3	6.2	53.2	0.0	1.8	28.5	10.2	11.2	8.8	16.2	34.5	12.0	7.2	41.2	12.3	14.8	25.7	32.2	31.4	1.9	15.8	32.4	42.2	14.0	90.6	16.7	13.8	1.0	19.7	8.8	12.0	1.1	2.0	9.5	4.3	419.5	22.6	60.2	23.4	4.1
ADGRF3	"GPR113, hGPCR37, PGR23"	ENSG00000173567	"Adhesion G protein-coupled receptor F3"	Q8IZF5	2	26308173-26346817	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 11.4;Early spermatids: 12.0;Late spermatids: 28.0;Microglial cells: 5.6;Oligodendrocytes: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.4;U-937: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA044500	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"	Cytosol	"HPA044500: AB_10794290"	"unprognostic (9.58e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.68e-4)"	"unprognostic (8.98e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.66e-4)"	"unprognostic (2.29e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.70e-5)"	0.1	0.1	0.5	0.4	0.3	0.4	0.0	1.0	0.6	0.0	0.5	0.1	0.5	0.1	0.0	0.2	0.1	0.1	0.0	0.4	0.4	0.8	0.1	0.1	0.5	0.6	0.3	0.2	0.8	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.2	0.5	0.4	0.4	0.2	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.5	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.2	0.0	1.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.3	0.7	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.0	1.4	0.4	0.9	0.0	0.0	0.8	0.7	0.3	0.0	1.1	0.8	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.7	0.7	1.2	0.0	1.4	0.1	0.0	0.0	0.4	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.3	1.0	0.6	0.4	0.4	0.6	0.3	0.4	0.3	0.4	0.4	0.4	0.0	0.0	11.4	1.3	0.0	0.3	0.0	0.0	0.9	0.3	0.4	0.7	0.0	0.0	0.0	2.1	0.1	0.8	0.0	0.0	0.1	12.0	0.9	1.1	0.2	0.0	0.0	3.4	0.0	0.1	0.2	0.5	0.8	0.0	0.2	0.0	0.2	0.1	1.7	4.1	0.1	0.0	0.0	0.0	28.0	0.0	0.5	0.0	5.6	0.3	0.2	0.0	3.0	6.3	0.1	0.0	0.0	2.7	0.1	0.4	0.1	0.0	1.2	0.0	0.2	0.3	1.5	0.4	0.1	0.0	0.1	0.9	0.2	0.2	0.1
AKAP7	"AKAP15, AKAP18"	ENSG00000118507	"A-kinase anchoring protein 7"	"O43687, Q9P0M2"	6	131135467-131283535	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 56.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 88.8;Cholangiocytes: 177.3;Oligodendrocyte precursor cells: 123.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 27.2;RPTEC TERT1: 23.5;RT4: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027172, HPA027200, HPA028327"	Approved		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles		"HPA027172: AB_1844689, HPA027200: , HPA028327: AB_10601353"	"unprognostic (2.83e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.03e-3)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.56e-4)"	9.0	56.6	15.8	6.4	16.3	10.9	6.7	17.7	20.7	8.1	11.5	19.1	29.8	6.4	5.7	4.2	6.8	9.9	6.7	16.0	16.7	8.1	24.4	6.6	11.2	15.3	16.2	9.8	42.0	4.0	4.3	4.0	15.3	14.0	18.9	7.6	4.6	6.4	15.9	2.8	16.5	5.9	16.7	9.6	5.3	8.8	17.0	11.9	5.9	14.4	7.6	8.7	5.6	15.8	1.2	2.1	7.8	3.8	4.4	9.0	5.4	3.3	5.3	5.5	7.3	2.8	2.2	0.1	6.1	5.7	4.1	0.1	2.3	3.6	4.0	0.0	3.3	8.0	2.7	12.2	6.1	0.4	2.5	7.8	2.4	3.6	4.6	5.1	5.8	4.6	1.4	11.7	5.3	2.1	3.6	2.1	27.2	0.8	2.9	7.3	5.1	0.1	23.5	27.2	0.1	2.7	4.5	0.4	11.1	4.5	1.8	17.1	2.1	2.5	3.5	7.5	8.3	10.5	0.1	2.0	6.3	8.1	5.9	15.2	1.9	0.3	8.1	3.8	12.8	3.7	11.1	11.0	2.4	5.5	17.6	11.0	0.5	4.4	4.7	0.1	4.3	6.0	15.8	16.3	17.7	20.7	16.0	16.7	15.3	16.2	15.3	16.7	17.0	15.8	11.7	19.2	9.1	88.8	16.4	6.2	6.5	0.8	6.8	22.3	10.1	13.2	10.4	177.3	1.6	5.5	16.7	8.2	18.0	22.1	19.6	35.7	8.2	31.6	13.4	6.5	1.2	63.8	44.7	4.2	10.2	7.4	6.1	35.6	10.8	22.9	9.7	39.9	8.6	8.4	79.1	14.8	10.2	20.8	9.9	2.7	8.4	12.9	1.8	68.4	9.8	38.2	25.7	123.6	62.7	2.2	33.2	5.7	3.4	8.2	13.6	26.5	1.4	13.2	0.0	12.6	6.9	4.6	10.0	7.0	4.1	4.7	23.9	26.0	22.0	4.9
AL132780.3		ENSG00000259132	"Novel protein"		14	22946270-22982258	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	32	"Alveolar cells type 1: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 38.9;MCF7: 23.7"									HPA029803	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 11: Alveolar cells - Smell perception"			"HPA029803: AB_10601428"																		3.0	4.8	9.5	2.8	9.6	4.7	2.5	9.1	13.9	4.0	9.0	5.6	3.9	2.6	6.8	4.2	4.7	4.2	8.1	9.6	9.4	7.7	6.9	4.0	6.4	10.1	9.4	6.9	12.8	2.3	3.1	2.8	9.9	4.7	4.0	2.0	3.7	2.1	5.8	6.1	4.2	1.8	9.5	10.2	5.4	3.4	9.8	4.7	3.4	1.5	2.6	3.5	3.0	10.2	4.0	13.0	4.4	0.8	7.1	7.1	6.1	0.0	5.6	3.7	4.1	2.9	0.0	0.0	1.9	9.4	1.3	0.6	2.9	3.9	2.1	0.0	1.6	0.0	7.7	38.9	4.1	4.2	0.1	4.3	8.1	3.5	8.3	8.5	6.9	12.7	0.0	5.6	3.4	23.7	6.2	16.8	2.2	6.4	5.1	5.7	3.9	4.4	14.1	10.8	4.4	1.9	0.0	2.8	1.4	4.7	4.6	7.9	0.1	5.4	2.6	0.6	4.4	4.7	9.4	7.1	0.4	1.7	3.1	0.3	2.8	1.2	1.7	2.5	0.6	1.6	1.0	1.0	2.8	2.3	1.8	1.0	5.8	0.5	1.6	1.4	2.4	1.5	9.5	9.6	9.1	13.9	9.6	9.4	10.1	9.4	9.9	9.5	9.8	10.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL512785.2		ENSG00000254706	"Novel protein"		1	162365407-162383531	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 7.6;HEL: 12.0"	"Low region specificity"	"Detected in all"							"HPA052251, HPA074060"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"		Nucleoplasm		"HPA052251: AB_2681775, HPA074060: "	"unprognostic (1.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.50e-1)"		"unprognostic (9.12e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.57e-1)"		"unprognostic (3.42e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.61e-3)"	"unprognostic (6.07e-2)"		"unprognostic (1.19e-2)"	"unprognostic (6.10e-2)"	1.1	0.6	0.5	0.3	1.2	1.2	1.8	2.3	0.6	1.9	3.5	2.1	2.1	0.9	0.0	1.0	1.2	2.4	0.7	0.6	1.4	1.2	2.7	1.0	0.2	3.8	1.6	0.3	3.2	1.0	0.4	0.7	2.5	1.1	0.5	0.0	5.0	3.9	0.2	1.1	1.4	0.7	2.6	0.1	2.1	1.5	1.4	0.2	0.1	0.2	0.1	0.7	0.3	4.1	7.6	0.0	4.0	4.4	0.2	0.0	0.0	0.8	0.5	0.4	0.0	1.7	2.6	0.0	5.8	0.0	1.5	3.0	0.4	0.5	0.0	0.1	3.9	12.0	0.0	2.8	0.1	0.2	0.0	0.8	0.2	0.0	0.5	0.7	1.5	0.9	1.2	0.2	0.2	2.7	0.4	0.0	3.5	2.1	3.0	0.3	0.1	0.0	1.4	2.7	1.7	1.9	2.6	0.4	1.9	0.5	4.3	0.0	2.1	0.1	1.0	0.1	1.8	5.8	0.0	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	2.3	0.6	0.6	1.4	3.8	1.6	2.5	2.6	1.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANGEL1	"Ccr4e, KIAA0759"	ENSG00000013523	"Angel homolog 1"	Q9UNK9	14	76786009-76826246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.3;Late spermatids: 75.1;Oligodendrocyte precursor cells: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000948	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA000948: AB_2227189"	"unprognostic (4.81e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.43e-4)"	"unprognostic (9.24e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (5.46e-4)"	"unprognostic (3.03e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.32e-2)"	11.3	18.5	18.3	11.8	19.7	6.8	12.7	16.7	21.2	12.8	15.6	10.0	9.2	14.8	23.8	7.0	12.2	11.4	15.7	19.2	21.1	11.6	19.3	14.0	12.2	22.5	19.6	19.3	50.8	17.2	21.1	10.4	21.5	9.3	10.9	26.4	15.8	8.4	12.2	6.4	10.3	12.3	18.1	29.3	15.8	52.4	20.1	8.1	13.7	9.8	10.9	9.5	8.5	23.8	13.1	14.0	15.2	13.6	12.2	11.1	14.1	7.7	11.0	7.8	9.9	13.5	18.2	23.8	11.1	6.7	10.6	16.2	14.6	13.7	13.1	10.1	13.1	14.8	9.7	10.3	7.9	7.8	8.7	11.8	16.8	7.3	14.5	11.3	20.0	24.8	14.5	6.2	8.2	25.3	14.0	11.6	17.5	20.7	18.4	17.0	10.4	14.1	11.8	18.4	21.5	9.6	11.6	15.8	7.1	13.8	31.1	8.4	9.6	9.1	8.0	6.9	6.4	15.9	12.9	14.7	7.7	13.7	11.8	0.8	4.8	1.6	5.9	5.5	7.2	6.8	5.3	5.6	7.5	5.5	7.5	5.6	1.4	5.5	7.1	4.9	4.5	5.9	18.3	19.7	16.7	21.2	19.2	21.1	22.5	19.6	21.5	18.1	20.1	23.8	7.4	6.4	10.5	17.6	4.7	1.1	1.8	1.5	2.2	2.4	5.7	5.0	6.7	5.7	2.2	3.7	10.4	1.5	1.5	2.1	0.0	3.3	64.3	3.7	3.9	10.0	4.2	4.2	18.3	3.2	2.8	4.3	1.5	3.3	1.3	15.9	7.1	9.5	7.2	0.0	19.7	4.4	4.1	5.7	2.0	75.1	2.1	5.5	1.8	23.4	1.4	4.9	1.0	64.8	30.2	2.5	1.0	4.9	8.9	3.4	1.7	1.3	1.4	8.9	6.6	5.1	2.4	15.9	4.9	2.8	0.4	1.2	3.0	12.9	4.6	1.5
ANKEF1	"ANKRD5, dJ839B4.6, FLJ21669"	ENSG00000132623	"Ankyrin repeat and EF-hand domain containing 1"	Q9NU02	20	9986126-10058303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 14.0;testis: 14.6"	"Group enriched"	"Detected in many"	21	"Early spermatids: 323.1;Late spermatids: 383.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/84: 14.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041151	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli fibrillar center, Plasma membrane, Cytosol"		"HPA041151: AB_10796569"	"unprognostic (4.72e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.38e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.73e-2)"	"prognostic favorable (4.44e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (3.11e-1)"	2.4	1.4	1.1	1.5	1.1	0.6	3.1	2.7	1.4	2.2	2.8	2.5	2.5	1.0	1.0	2.5	4.0	2.2	1.0	0.9	1.7	2.5	4.0	1.7	1.2	1.4	1.3	2.2	14.0	4.3	2.2	0.7	1.4	1.9	2.3	5.3	2.6	2.1	0.6	2.8	2.4	0.7	0.9	1.2	3.7	14.6	1.6	1.7	5.7	0.6	1.8	1.6	1.3	0.9	9.0	8.7	0.9	2.1	2.2	1.5	5.9	1.3	0.1	1.6	0.8	5.1	7.2	0.1	2.4	0.3	9.7	7.1	2.3	9.0	1.9	0.0	1.4	1.1	2.2	5.3	1.0	0.9	0.2	3.9	9.8	1.5	1.4	4.0	1.4	3.2	3.4	6.1	0.4	2.4	1.4	0.0	4.4	11.2	2.4	0.0	0.1	5.6	5.3	5.5	6.5	3.1	3.8	8.7	0.0	3.2	7.2	0.8	0.9	1.1	1.4	0.1	1.4	7.0	14.2	1.3	2.4	0.4	1.2	0.0	0.0	0.0	0.7	0.0	1.1	0.5	0.7	0.5	0.0	0.4	1.0	0.6	0.1	0.5	0.0	0.5	0.7	0.2	1.1	1.1	2.7	1.4	0.9	1.7	1.4	1.3	1.4	0.9	1.6	0.9	0.5	3.2	6.7	1.3	2.0	0.3	2.3	1.6	3.4	1.7	3.4	1.8	1.8	2.8	2.0	7.3	0.0	2.2	1.2	2.7	1.9	4.5	323.1	6.7	1.0	1.8	5.3	0.4	1.1	6.3	2.0	0.9	10.7	2.8	1.3	0.7	0.7	9.1	1.3	3.3	2.8	3.8	2.0	0.3	0.6	383.0	3.4	1.4	0.0	1.0	0.0	0.8	3.1	0.5	0.4	5.3	4.2	4.1	4.8	1.9	3.3	2.8	16.2	4.9	0.0	0.7	0.3	5.1	3.4	8.6	0.3	1.5	2.6	1.1	3.7	1.5
ANKRD62	DKFZp779B1634	ENSG00000181626	"Ankyrin repeat domain 62"	A6NC57	18	12093843-12129764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"brain: 1.1;pancreas: 1.0;testis: 1.6"	"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 92.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059835	Enhanced		Uncertain	"Nucleoplasm,Nuclear bodies,Actin filaments"		NA	NA				"Cluster 22: Non-specific - Unknown function"		"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Actin filaments"	"HPA059835: AB_2684136"	"unprognostic (2.45e-2)"	"unprognostic (1.18e-1)"		"unprognostic (2.37e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.01e-1)"		"unprognostic (1.98e-1)"		"unprognostic (6.61e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.55e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-3)"	"unprognostic (8.70e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.4	0.0	0.6	0.0	0.7	0.0	0.0	0.4	0.1	0.0	1.3	0.3	0.1	0.4	0.3	0.0	0.0	1.7	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	2.2	0.1	0.2	0.5	0.0	0.0	16.5	1.7	0.6	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.6	0.8	2.6	0.6	0.2	0.0	1.0	0.0	0.1	1.0	1.0	0.2	0.5	1.1	0.4	0.0	0.8	0.2	0.0	0.0	0.9	0.0	1.3	0.3	92.8	15.8	0.5	1.1	0.0	0.2	0.1	0.2	0.5
ARFGEF3	"BIG3, C6orf92, dJ171N11.1, KIAA1244, PPP1R33"	ENSG00000112379	"ARFGEF family member 3"	Q5TH69	6	138161939-138344663	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4;salivary gland: 18.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 114.6;Excitatory neurons: 200.9;Inhibitory neurons: 207.8;Oligodendrocyte precursor cells: 173.9;Oligodendrocytes: 378.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 14.8;RH-30: 13.4;RT4: 19.4;SK-BR-3: 22.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036350	Uncertain					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA036350: AB_10672084"	"prognostic unfavorable (8.20e-4)"	"unprognostic (4.31e-2)"	"unprognostic (9.91e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.69e-2)"	1.2	3.8	13.4	0.7	16.4	0.4	7.9	20.1	17.7	5.0	0.0	4.2	2.2	0.7	0.9	0.4	2.2	1.7	1.0	16.7	13.0	2.1	0.1	6.4	0.2	11.1	17.7	0.1	8.7	15.8	7.0	1.4	14.4	12.0	4.8	2.8	18.0	1.0	0.2	1.2	1.9	0.7	7.5	0.4	10.0	0.6	15.2	0.1	1.9	0.7	0.2	3.4	0.4	28.4	8.0	3.1	0.0	0.6	0.0	0.0	4.7	0.3	0.2	0.2	0.0	0.1	0.4	0.0	3.1	0.3	2.7	2.6	3.8	2.0	0.0	0.0	4.9	0.0	1.5	0.9	0.0	3.0	0.0	0.0	0.9	0.0	0.9	3.5	4.1	2.7	0.0	4.9	0.0	14.8	0.0	0.0	2.7	8.5	3.4	0.6	13.4	2.6	2.6	19.4	6.9	0.0	7.8	22.2	0.9	0.3	4.4	0.0	0.4	0.2	2.2	0.0	7.9	1.7	6.7	0.0	3.2	1.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	16.4	20.1	17.7	16.7	13.0	11.1	17.7	14.4	7.5	15.2	28.4	9.4	16.0	114.6	34.3	0.5	0.0	18.8	0.0	6.2	19.0	39.9	12.6	6.4	14.3	44.6	3.7	0.0	16.5	0.8	2.5	3.9	11.4	83.0	8.6	1.4	11.9	66.7	2.7	200.9	24.7	2.4	4.1	41.3	17.7	2.5	0.1	8.2	0.3	1.4	11.8	207.8	44.2	0.0	0.0	0.0	22.0	0.0	0.5	0.0	36.5	2.0	0.9	0.0	173.9	378.1	14.2	8.4	0.0	0.9	67.6	2.5	0.3	37.2	3.3	0.0	3.5	0.9	4.1	1.1	3.0	0.0	6.2	0.8	0.1	13.2	42.7
ASCL5	bHLHa47	ENSG00000232237	"Achaete-scute family bHLH transcription factor 5"	Q7RTU5	1	201113953-201127184	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"pancreas: 2.1"	"Cell type enhanced"	"Detected in single"		"Oligodendrocyte precursor cells: 1.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 2.8;cerebral cortex: 2.1;hippocampal formation: 1.6"	"Not detected"	"Not detected"									NA	NA				"Cluster 22: Non-specific - Unknown function"		"Cluster 1: Pancreatic cells - Digestion"				"unprognostic (9.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.43e-2)"	"unprognostic (8.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.84e-2)"	"unprognostic (9.50e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.25e-7)"	"unprognostic (2.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.48e-2)"	0.0	0.1	0.5	0.0	0.4	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.8	0.8	0.0	0.0	0.1	0.1	0.2	0.1	0.3	2.1	0.0	0.2	0.0	0.1	0.2	0.0	0.3	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.5	0.8	0.8	0.2	0.1	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1
ASNS		ENSG00000070669	"Asparagine synthetase (glutamine-hydrolyzing)"	P08243	7	97851677-97872542	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"	Ligase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 121.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 233.9;Late spermatids: 217.0;Smooth muscle cells: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 8.9;T-cells: 14.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004924, HPA029318, HPA064737"	Approved		Enhanced	Cytosol		No	No		47000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341"	"unprognostic (3.93e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.79e-5)"	"prognostic unfavorable (9.42e-6)"	"unprognostic (2.28e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (5.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.33e-1)"	17.3	18.0	49.9	19.5	52.3	13.7	17.8	52.7	66.3	19.9	28.2	24.5	9.7	19.0	31.5	27.0	20.1	11.2	19.4	55.3	51.0	28.9	9.3	25.6	28.8	58.7	43.5	20.8	121.4	26.3	44.1	4.6	59.4	21.5	19.9	35.3	41.6	14.5	8.0	22.9	22.6	18.0	43.6	30.3	46.0	33.3	49.7	13.3	27.5	8.6	25.7	21.7	18.6	63.8	124.6	46.6	51.6	415.9	35.3	57.9	109.1	85.7	62.5	41.6	134.8	64.2	49.3	101.7	45.3	189.8	92.3	57.4	118.2	151.2	102.2	122.4	85.3	31.0	24.6	50.8	347.8	207.1	89.9	106.2	508.8	55.8	361.2	23.5	41.4	94.4	177.1	365.2	76.3	286.5	6.4	54.4	68.1	308.4	125.4	14.0	10.0	282.7	28.4	22.3	218.1	156.7	23.2	136.7	499.0	60.6	57.1	139.1	7.6	21.6	138.5	56.7	40.7	412.6	239.7	401.1	288.7	90.3	220.8	1.9	0.3	0.4	3.6	1.1	4.3	8.9	7.2	3.4	1.5	6.0	10.1	5.5	1.8	2.0	1.0	0.2	14.2	3.3	49.9	52.3	52.7	66.3	55.3	51.0	58.7	43.5	59.4	43.6	49.7	63.8	5.8	9.6	7.2	11.1	14.4	12.4	26.1	20.9	6.2	20.3	9.7	11.2	7.6	7.2	12.3	9.2	25.0	3.1	6.7	10.5	7.9	30.9	233.9	2.9	8.6	6.7	24.4	46.1	51.8	61.6	7.8	8.9	14.3	4.5	8.2	8.8	2.9	1.3	1.1	25.2	48.6	19.6	32.6	1.3	3.2	217.0	9.6	2.1	8.8	5.6	7.3	9.2	5.2	16.1	16.9	36.6	14.7	9.4	19.9	26.1	1.1	3.9	4.5	24.9	6.6	10.2	112.3	3.4	20.2	5.5	10.9	5.6	11.2	6.0	9.9	14.9
ATAD3C	FLJ34599	ENSG00000215915	"ATPase family AAA domain containing 3C"	Q5T2N8	1	1449689-1470163	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 19.8;Collecting duct cells: 20.2;Distal tubular cells: 45.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 13.1"									HPA065305			Approved	Mitochondria		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA065305: AB_2685459"	"unprognostic (9.23e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.79e-2)"	"prognostic favorable (5.15e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.12e-3)"	1.1	0.2	5.3	0.9	6.3	0.5	1.6	5.2	6.4	2.0	4.3	2.3	0.6	1.7	1.2	1.1	2.0	0.7	0.9	5.5	6.2	4.3	5.2	1.5	0.4	6.7	6.0	1.1	4.6	0.1	1.8	0.3	6.4	4.0	0.3	1.2	2.6	2.0	0.2	0.8	0.8	0.7	5.5	0.4	0.7	1.2	6.1	0.4	4.0	0.0	0.5	2.9	1.4	10.1	0.2	0.0	0.2	0.3	0.3	0.0	0.2	0.1	0.0	0.2	0.0	1.2	2.5	0.2	0.3	0.1	0.1	0.3	1.0	0.4	0.1	0.1	1.0	0.2	0.9	1.6	0.2	0.2	0.2	0.0	0.1	0.1	0.7	0.0	0.0	0.3	0.2	3.0	0.1	0.7	0.3	0.8	0.5	0.1	0.2	0.3	0.1	13.1	0.8	0.2	2.0	0.7	0.0	0.5	0.1	2.1	2.6	0.2	0.2	0.1	0.2	0.3	0.1	1.4	2.1	0.4	0.1	0.3	0.0	0.8	0.1	0.3	0.3	0.1	1.2	0.5	0.4	0.3	0.0	0.3	0.5	0.4	0.5	0.5	0.1	0.1	0.6	0.2	5.3	6.3	5.2	6.4	5.5	6.2	6.7	6.0	6.4	5.5	6.1	10.1	2.5	6.4	19.8	0.7	4.2	3.4	3.5	1.3	4.6	5.0	17.4	14.4	4.6	0.0	2.7	20.2	16.7	0.7	2.0	2.0	45.0	5.3	0.4	3.6	3.8	4.2	4.2	0.0	1.0	9.2	0.3	1.8	0.0	6.1	3.8	0.6	1.8	6.8	1.8	6.7	0.6	1.9	0.0	2.9	2.5	1.4	1.2	0.7	3.6	2.8	0.5	2.8	4.1	1.0	10.8	4.4	0.3	4.9	8.4	3.0	1.3	16.2	1.3	9.1	0.0	7.3	1.6	0.5	1.5	1.5	5.7	0.8	3.6	4.2	1.3	3.1
ATP13A2	"CLN12, HSA9947, PARK9"	ENSG00000159363	"ATPase cation transporting 13A2"	Q9NQ11	1	16985958-17011928	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuronal ceroid lipofuscinosis, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 112.4"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 20.6"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 20.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037038, CAB037111, HPA050910, HPA054717"	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB037038: AB_1840715, CAB037111: AB_1840714, HPA050910: AB_2681269, HPA054717: AB_2682583"	"unprognostic (3.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.33e-7)"	"unprognostic (1.04e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.84e-3)"	15.3	18.6	49.7	20.2	45.8	11.6	14.3	30.3	81.2	10.6	3.3	15.9	12.7	12.1	6.6	23.6	9.5	9.3	11.6	46.7	66.0	16.6	6.2	17.9	17.7	112.4	60.8	8.7	55.7	12.9	57.0	12.6	110.8	14.3	9.8	22.8	27.4	7.9	17.2	16.5	16.7	8.6	32.0	26.0	19.3	10.3	64.1	9.5	16.7	5.3	10.3	12.9	12.1	44.3	28.3	27.4	14.7	60.8	13.8	12.2	40.8	15.8	15.4	17.1	16.6	48.9	31.4	12.5	65.9	26.9	14.6	43.1	32.1	59.5	6.2	17.2	58.5	43.7	28.0	27.2	17.5	15.6	19.6	10.0	31.6	47.1	36.6	55.0	32.3	32.2	28.2	22.6	70.2	22.2	18.4	8.8	23.2	66.3	20.0	20.0	60.1	50.7	19.0	42.8	40.9	27.4	73.8	87.7	60.2	18.8	29.9	19.6	34.4	18.0	34.5	30.8	33.1	4.8	6.1	14.0	34.6	85.2	30.3	0.0	1.6	0.3	2.6	3.7	2.9	1.3	2.1	2.2	0.4	3.1	1.0	1.5	0.5	2.7	3.6	20.6	1.8	1.4	49.7	45.8	30.3	81.2	46.7	66.0	112.4	60.8	110.8	32.0	64.1	44.3	18.9	0.0	2.2	14.4	8.3	6.5	6.9	5.7	6.2	35.9	16.9	11.3	3.6	7.2	6.8	7.3	35.5	5.8	33.4	44.6	5.9	15.1	1.4	6.7	3.8	14.4	7.7	4.2	53.1	25.1	33.6	6.0	18.8	19.0	8.9	20.5	6.1	3.7	10.4	47.1	61.8	15.0	0.0	17.3	2.8	1.7	5.3	10.1	5.4	11.2	6.1	34.0	8.2	20.1	18.1	57.0	49.0	6.4	5.4	12.3	18.2	5.3	4.3	38.4	0.0	4.6	5.7	13.6	16.4	11.6	5.3	9.3	11.1	4.8	21.7	12.8
AUP1		ENSG00000115307	"AUP1 lipid droplet regulating VLDL assembly factor"	Q9Y679	2	74526645-74529760	"Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007674	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Vesicles"		"HPA007674: AB_1078251"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (2.97e-9)"	"unprognostic (9.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.96e-2)"	48.0	42.2	68.0	44.4	69.0	78.8	52.6	71.0	85.8	56.0	72.1	76.9	70.6	38.7	78.6	49.9	45.3	46.0	38.4	67.6	71.0	48.8	106.9	48.7	41.3	73.0	69.6	38.1	127.3	77.6	2.1	60.6	69.7	38.9	81.0	32.4	89.1	46.3	57.7	42.3	68.5	55.8	70.5	39.5	56.7	24.5	70.1	42.5	50.9	66.6	51.5	69.6	20.7	72.1	114.2	133.4	55.3	87.5	183.1	107.7	124.9	89.1	152.6	122.3	77.3	196.9	130.6	126.4	61.9	126.5	210.3	143.4	140.4	115.1	98.5	100.1	128.7	153.6	71.2	180.7	181.5	97.8	127.9	128.5	256.7	174.4	198.6	101.1	117.3	105.1	202.2	164.5	134.0	124.6	79.0	200.6	111.4	298.3	111.9	95.3	150.0	270.3	139.3	90.9	80.7	79.6	65.2	200.4	162.2	70.8	90.2	156.7	59.3	162.9	97.2	50.6	146.8	87.9	88.1	120.4	129.6	155.9	184.9	113.8	132.9	108.9	81.9	169.3	89.6	90.6	81.0	82.0	124.6	113.9	72.9	75.8	68.8	85.3	144.7	118.3	107.9	132.2	68.0	69.0	71.0	85.8	67.6	71.0	73.0	69.6	69.7	70.5	70.1	72.1	64.8	67.3	44.6	22.5	97.3	73.2	120.7	161.1	80.8	31.7	71.4	59.6	34.9	74.4	108.1	68.0	14.6	140.0	86.6	150.4	23.5	125.2	24.3	36.2	50.1	74.9	73.8	72.4	17.7	208.7	217.3	73.0	121.8	58.7	89.9	57.3	50.0	114.3	161.8	37.0	16.1	127.7	136.3	83.5	95.5	29.7	44.4	95.2	97.8	17.8	67.2	74.5	72.1	14.6	23.4	153.1	141.3	38.0	229.9	141.1	196.0	59.6	46.6	43.2	59.2	60.0	104.2	85.9	64.6	95.7	78.7	223.8	77.6	68.4	134.2	143.9
AUTS2	"FBRSL2, KIAA0442"	ENSG00000158321	"Activator of transcription and developmental regulator AUTS2"	Q8WXX7	7	69598296-70793506	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Autism, Autism spectrum disorder, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 598.7;Excitatory neurons: 871.5;Inhibitory neurons: 1405.7;Microglial cells: 583.7;Oligodendrocytes: 1231.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 8.1;naive B-cell: 9.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 82.8;REH: 84.1;SCLC-21H: 112.5;T-47d: 80.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000390	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA000390: AB_1845218"	"unprognostic (8.73e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.62e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (7.33e-2)"	8.7	5.2	50.4	9.1	41.1	8.5	17.2	10.6	19.0	7.9	0.0	11.3	6.8	7.4	6.2	11.5	7.0	13.3	5.5	21.8	32.0	13.9	20.2	10.8	4.8	40.6	25.9	14.6	5.7	11.3	9.7	4.1	23.0	11.3	10.0	11.0	48.2	5.7	15.2	20.5	15.6	7.5	14.0	6.5	10.5	7.9	37.3	10.7	5.8	5.2	6.3	10.5	10.5	8.7	0.3	7.5	82.8	4.3	5.4	3.2	0.9	5.2	0.0	0.4	0.5	29.1	0.3	13.0	1.9	5.0	0.5	27.1	10.0	11.5	2.3	60.5	22.4	6.2	7.8	0.3	2.4	0.1	0.4	8.6	15.2	12.5	3.1	3.0	0.0	13.5	0.6	6.5	7.2	4.8	1.2	2.4	59.0	18.9	0.1	84.1	40.0	39.8	0.0	12.5	112.5	61.3	5.3	9.2	0.2	35.4	80.0	0.1	0.0	0.3	27.1	8.8	52.6	0.2	0.2	43.1	0.1	0.2	0.2	1.0	0.2	0.1	1.4	0.1	1.9	8.1	0.9	1.4	0.6	9.4	0.1	0.8	0.4	1.5	0.1	2.8	0.2	0.6	50.4	41.1	10.6	19.0	21.8	32.0	40.6	25.9	23.0	14.0	37.3	8.7	13.7	19.2	38.2	598.7	19.9	28.6	21.1	25.0	34.7	37.2	72.9	41.5	20.8	11.5	22.2	9.2	16.7	1.2	103.2	23.5	5.9	13.1	31.8	11.5	36.0	15.9	28.9	5.2	871.5	1.3	0.1	19.3	4.1	11.0	0.0	44.4	12.1	28.8	0.8	63.9	1405.7	23.4	38.7	2.6	17.1	27.7	15.8	5.5	17.8	583.7	0.8	11.2	25.7	292.0	1231.2	3.9	15.3	14.7	37.7	32.6	15.3	12.4	20.3	20.7	26.3	13.7	17.2	10.1	16.9	20.3	16.1	1.4	35.5	10.4	25.3	26.6
BACE1	BACE	ENSG00000186318	"Beta-secretase 1"	P56817	11	117285207-117316259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 119.1;pancreas: 271.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 118.9;Early spermatids: 99.9;Late spermatids: 343.0;Oligodendrocytes: 99.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 88.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016358	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"CAB016358: AB_626716"	"unprognostic (7.96e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.94e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.76e-4)"	15.4	16.0	34.3	8.0	68.5	3.3	11.7	68.7	44.0	18.3	11.9	13.7	6.1	19.7	8.8	13.5	15.9	19.1	11.4	34.3	44.5	14.8	25.6	14.4	5.1	89.7	67.0	20.5	271.5	18.5	10.7	13.8	76.6	13.4	7.6	44.7	11.0	18.3	12.5	11.4	7.7	21.3	61.6	12.4	9.8	11.2	59.9	3.8	12.2	9.1	5.0	12.4	14.3	119.1	11.5	10.7	22.9	37.3	80.9	82.3	1.0	62.9	44.4	24.4	19.0	4.5	16.4	1.4	14.6	88.3	18.4	17.9	24.3	12.1	20.5	3.1	12.1	6.0	17.3	5.1	36.5	2.5	1.7	68.1	20.2	29.7	31.8	68.0	21.4	3.8	2.7	1.1	46.5	33.4	2.5	2.1	15.5	10.6	25.9	6.4	11.6	1.6	12.2	5.9	31.7	36.7	22.5	2.6	5.9	23.5	26.2	7.6	31.4	45.2	5.0	48.2	19.4	0.7	1.0	1.1	23.8	2.0	34.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	34.3	68.5	68.7	44.0	34.3	44.5	89.7	67.0	76.6	61.6	59.9	119.1	12.1	19.2	10.1	16.3	0.3	4.7	4.1	3.4	9.1	53.7	8.7	9.0	8.7	18.6	13.3	5.5	118.9	1.0	0.1	2.0	5.9	7.4	99.9	5.1	32.1	8.3	21.7	1.7	24.9	20.0	1.3	19.5	3.1	8.9	2.5	15.8	6.8	38.6	9.4	57.2	32.0	5.1	2.0	17.2	7.7	343.0	19.3	7.9	3.6	14.0	4.0	17.9	0.0	22.1	99.8	4.3	6.3	22.2	0.1	2.4	1.7	6.3	3.4	55.2	6.6	18.1	14.2	3.4	1.7	10.6	3.4	0.8	1.2	68.0	4.5	3.4
BANF2	"BAF-L, BAF2, BAFL, C20orf179, dJ803K15.1"	ENSG00000125888	"BANF family member 2"	Q9H503	20	17693672-17735871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 110.2"	"Group enriched"	"Detected in some"	163	"Early spermatids: 899.1;Late spermatids: 2850.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042635	Approved					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA042635: AB_10795707"					"unprognostic (2.08e-1)"		"unprognostic (9.15e-2)"			"unprognostic (6.42e-3)"	"unprognostic (1.13e-1)"		"unprognostic (1.63e-2)"	"unprognostic (3.42e-1)"		"unprognostic (3.18e-1)"		0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.4	0.1	0.9	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	20.5	0.0	0.1	0.0	0.3	0.1	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	110.2	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	899.1	0.0	0.0	0.4	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2850.2	11.5	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	6.8	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	10.9	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
BCAP31	"6C6-Ag, BAP31, CDM, DXS1357E"	ENSG00000185825	"B cell receptor associated protein 31"	P51572	X	153700492-153724565	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport"		"Deafness, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003906, CAB015350, CAB015424"	Supported	Approved	Enhanced	"Endoplasmic reticulum"		NA	NA		170000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270"	"unprognostic (1.02e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (9.87e-4)"	"unprognostic (3.25e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	294.1	213.9	171.5	100.9	175.5	151.3	210.9	171.8	213.9	139.5	202.5	157.7	133.3	127.4	228.9	214.0	151.0	118.0	123.5	183.0	192.1	160.7	185.5	144.5	111.8	190.8	187.5	130.9	266.4	193.7	123.5	143.3	195.3	154.6	166.5	63.9	179.7	177.7	81.9	187.3	143.8	155.0	183.4	138.5	129.3	117.3	186.9	99.7	161.4	75.5	134.6	177.9	145.8	185.0	505.5	482.4	128.0	650.6	593.8	179.1	295.3	269.9	287.5	291.6	371.6	386.8	361.9	315.9	1068.1	412.2	373.9	506.8	337.3	518.6	221.0	152.8	436.9	198.4	350.4	323.3	276.4	335.1	373.2	233.8	454.2	282.3	330.1	298.4	372.6	172.0	268.0	528.3	332.7	535.3	187.3	402.5	145.8	704.6	431.7	207.5	152.8	693.2	459.3	546.8	173.3	241.8	111.8	520.6	350.0	200.3	196.2	320.2	380.0	248.9	234.7	338.9	495.1	518.0	1120.1	397.3	460.9	402.6	223.7	630.5	484.2	489.1	507.5	535.7	454.7	436.1	504.5	507.4	420.7	463.6	439.1	474.7	624.5	449.8	632.3	666.9	457.1	1110.8	171.5	175.5	171.8	213.9	183.0	192.1	190.8	187.5	195.3	183.4	186.9	185.0	184.9	112.2	114.1	14.7	97.5	141.9	232.2	374.0	172.4	53.0	127.3	165.7	60.3	134.4	222.8	128.8	45.9	467.5	113.5	194.1	37.2	252.4	7.8	99.7	70.1	165.5	103.2	59.3	16.9	210.0	444.8	103.6	78.5	103.9	95.6	68.5	199.6	216.0	356.2	32.0	12.8	155.1	244.1	148.4	125.6	20.6	105.3	166.2	160.1	17.8	137.5	138.2	111.2	11.6	12.9	247.1	187.4	98.9	120.8	191.8	242.8	170.9	172.6	51.8	157.8	42.9	106.5	310.3	231.3	174.0	130.4	538.1	114.6	120.4	187.0	260.4
BCAT1	BCT1	ENSG00000060982	"Branched chain amino acid transaminase 1"	P54687	12	24810024-24949101	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 58.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 203.2;Early spermatids: 161.4;Exocrine glandular cells: 139.9;Langerhans cells: 265.8;Late spermatids: 370.3"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 19.0;glioma: 10.7;lung cancer: 7.2;ovarian cancer: 24.0;testis cancer: 27.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 17.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 5.8;monocytes: 17.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 261.3;NTERA-2: 287.4;RH-30: 310.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048592	Uncertain					NA	NA		97000	"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 34: Spermatids - Unknown function"			"HPA048592: AB_2680454"	"unprognostic (1.90e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (3.05e-5)"	"unprognostic (9.49e-3)"	"unprognostic (4.22e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.97e-3)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.38e-4)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (7.55e-2)"	"prognostic unfavorable (8.54e-4)"	6.7	5.9	4.1	7.1	5.7	2.4	2.1	11.1	10.6	3.6	0.0	3.0	0.8	8.6	1.0	2.0	7.2	4.4	1.8	3.0	19.6	1.2	1.3	9.6	6.4	19.4	19.8	7.2	58.2	0.4	6.6	15.2	22.7	0.9	2.6	14.5	1.7	0.8	0.7	0.6	3.6	5.7	6.4	2.0	1.8	7.1	14.0	5.2	1.2	2.0	5.3	4.1	1.3	7.9	30.3	12.1	106.8	0.2	30.5	59.0	54.9	60.9	40.6	33.4	55.2	67.1	83.1	114.0	0.3	100.7	6.5	12.0	77.2	0.5	88.2	261.3	15.4	91.1	2.0	37.3	112.3	105.9	31.6	77.4	2.0	85.1	17.8	73.0	114.3	56.9	88.5	1.1	28.7	0.6	65.2	30.1	287.4	0.0	8.1	0.1	310.3	1.4	0.1	10.4	0.1	60.1	0.1	0.2	0.5	114.8	0.2	45.2	150.8	19.7	72.9	80.4	58.1	13.2	13.9	152.7	69.9	62.4	0.3	0.0	2.3	0.0	0.0	3.6	0.1	1.1	0.0	0.1	5.8	0.0	0.0	0.0	1.0	0.1	17.1	3.4	0.2	1.0	4.1	5.7	11.1	10.6	3.0	19.6	19.4	19.8	22.7	6.4	14.0	7.9	1.7	16.0	26.0	1.6	1.3	8.7	0.1	2.5	0.0	203.2	0.3	0.3	1.6	1.5	2.2	0.0	2.1	61.2	4.3	0.0	1.9	1.8	161.4	41.5	92.6	16.8	0.0	20.8	39.6	139.9	23.2	27.6	0.0	89.1	11.4	117.4	7.9	0.3	72.3	42.1	81.8	0.0	14.2	87.1	265.8	370.3	7.2	59.9	7.2	38.4	22.3	7.1	0.0	84.4	57.4	49.6	0.0	4.1	0.7	0.2	0.0	0.1	3.3	12.2	6.6	14.9	17.4	1.9	1.6	0.5	7.2	22.4	2.8	41.3	0.1	0.1
BEND3	KIAA1553	ENSG00000178409	"BEN domain containing 3"	Q5T5X7	6	107065182-107115515	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 6.2;Late spermatids: 6.9"	"Cancer enriched"	"Detected in all"	4	"testis cancer: 12.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA017891, HPA062067"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA017891: AB_2064595, HPA062067: AB_2684675"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.37e-8)"	"unprognostic (1.59e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-1)"	0.8	0.7	1.0	0.9	0.8	0.9	0.7	2.1	0.9	0.7	0.4	1.5	1.2	0.8	1.0	0.9	0.9	0.6	1.0	0.7	0.7	1.2	0.7	0.9	0.8	0.7	0.7	0.7	1.5	0.6	0.8	0.5	0.7	1.0	1.5	0.8	1.5	0.4	1.2	0.6	1.1	0.7	0.8	0.6	2.0	1.8	1.0	1.0	0.8	0.6	0.8	0.7	0.5	0.9	2.9	4.0	11.3	6.4	1.3	0.9	9.3	1.1	1.4	1.4	1.6	4.7	2.1	8.6	2.8	3.0	2.6	2.8	12.2	6.3	2.3	3.4	6.1	2.2	3.1	5.2	1.0	6.1	2.9	2.4	2.6	2.2	3.1	1.0	1.9	4.0	6.7	3.4	1.9	5.8	5.3	4.7	15.9	7.4	2.5	7.3	3.2	5.7	2.4	8.6	11.3	5.5	3.6	6.0	2.2	5.7	3.6	4.9	2.2	4.1	3.7	1.8	5.5	2.3	3.4	8.7	1.3	4.7	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	2.1	0.9	0.7	0.7	0.7	0.7	0.7	0.8	1.0	0.9	1.3	3.2	2.7	1.3	0.7	2.9	1.1	0.8	1.8	1.0	1.3	0.8	3.0	4.3	1.8	0.0	6.2	1.1	0.8	0.6	0.0	1.0	5.8	1.3	1.8	1.2	1.2	0.8	1.2	1.8	1.2	1.2	2.6	1.5	0.0	1.9	0.0	0.5	0.6	0.0	2.1	2.4	0.0	1.0	1.2	6.9	0.9	1.0	0.0	1.0	0.1	0.5	0.0	3.0	1.6	1.4	0.8	0.0	1.6	1.6	0.5	0.9	1.1	1.5	0.0	2.1	2.5	0.7	2.5	1.8	3.0	0.8	1.1	0.5	3.3	0.9
BMP8B	"BMP8, OP-2"	ENSG00000116985	"Bone morphogenetic protein 8b"	P34820	1	39757182-39788865	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 72.1;Late spermatids: 106.5;Plasma cells: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"THP-1: 120.5;U-266/70: 33.7;U-266/84: 52.5;WM-115: 56.7"									HPA047254			Approved	Vesicles	"Secreted to blood"	NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA047254: "	"unprognostic (1.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.64e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.72e-4)"	"unprognostic (1.79e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.67e-2)"	"unprognostic (8.68e-3)"	"unprognostic (4.82e-1)"	1.7	5.6	2.1	1.5	2.0	0.8	0.9	1.1	5.3	2.1	0.1	3.8	5.4	1.5	3.3	1.0	1.3	0.8	1.0	2.8	1.8	0.9	0.6	1.3	0.7	13.4	3.5	0.8	7.0	1.8	2.7	1.5	3.3	2.4	2.7	0.5	1.7	2.5	0.6	2.0	4.1	0.7	2.8	1.5	1.8	2.2	2.6	0.4	4.7	1.6	0.7	1.6	2.1	4.7	2.7	4.5	0.3	3.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	5.4	0.1	1.8	0.0	0.7	0.4	4.2	0.0	0.0	1.0	5.8	4.9	3.6	0.3	0.1	0.6	0.9	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.6	18.1	0.2	3.7	0.1	2.5	0.3	2.8	1.8	2.7	15.9	5.7	4.0	2.7	13.0	3.4	4.3	0.3	13.4	0.9	3.1	120.5	0.0	0.1	0.3	1.1	0.2	33.7	52.5	2.0	0.0	3.7	56.7	0.2	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	2.1	2.0	1.1	5.3	2.8	1.8	13.4	3.5	3.3	2.8	2.6	4.7	0.0	0.0	1.8	0.0	3.5	0.4	0.6	0.2	0.0	0.5	1.1	0.8	1.2	0.0	0.8	0.0	0.0	0.0	0.9	13.5	0.0	1.0	72.1	1.1	0.6	0.4	1.2	0.0	0.4	3.4	0.0	1.7	1.1	2.3	0.0	0.3	0.4	0.0	0.4	0.0	0.3	2.0	0.0	0.0	2.7	106.5	1.2	0.8	5.4	0.0	0.7	0.1	0.0	8.0	1.8	2.2	2.2	0.7	38.9	0.4	5.0	0.0	0.4	0.5	0.0	1.8	3.4	0.8	0.4	0.4	0.0	0.0	0.7	0.1	1.2	0.8
BRSK2	"C11orf7, PEN11B, STK29"	ENSG00000174672	"BR serine/threonine kinase 2"	Q8IWQ3	11	1389899-1462689	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, Exocytosis, Mitosis, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 37.8;pancreas: 104.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 22.9;Bipolar cells: 87.9;Cone photoreceptor cells: 35.5;Excitatory neurons: 35.5;Horizontal cells: 69.0;Inhibitory neurons: 23.5;Rod photoreceptor cells: 28.6"	"Cancer enhanced"	"Detected in many"		"glioma: 3.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 15.8;AN3-CA: 17.3;CACO-2: 14.4;HAP1: 13.3;NTERA-2: 27.2;SCLC-21H: 62.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073690			Approved	"Golgi apparatus"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"		"HPA073690: "	"unprognostic (5.47e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.63e-1)"	"unprognostic (6.42e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.17e-7)"	"unprognostic (3.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.86e-1)"	1.1	2.4	11.5	0.2	16.0	0.1	0.7	29.2	37.8	2.1	0.0	2.8	0.5	1.0	0.0	0.8	2.0	0.7	1.0	20.5	2.1	0.5	0.2	0.4	0.1	7.9	3.6	0.9	104.2	2.2	15.6	0.6	8.6	1.4	0.1	17.4	0.4	0.2	0.4	0.3	1.5	0.1	0.5	0.6	1.9	9.0	5.0	0.1	1.0	0.2	0.0	0.8	1.1	17.6	0.1	7.2	15.8	17.3	0.3	0.5	0.0	0.2	0.2	1.3	0.5	14.4	0.9	0.0	2.4	0.2	0.2	0.0	13.3	0.1	1.0	1.7	6.2	0.0	0.0	0.2	0.7	0.0	0.6	0.2	0.0	0.0	1.6	0.3	0.0	0.5	0.2	0.1	0.3	1.7	0.0	0.0	27.2	5.1	2.2	0.0	0.0	0.0	0.2	0.2	62.0	9.0	3.3	0.2	4.7	0.3	0.3	0.8	0.3	1.4	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	16.0	29.2	37.8	20.5	2.1	7.9	3.6	8.6	0.5	5.0	17.6	0.4	0.0	0.0	22.9	0.1	0.3	0.1	0.0	0.0	87.9	0.1	0.1	2.1	0.0	0.0	0.0	35.5	0.0	0.2	0.1	0.0	0.1	0.5	0.2	0.4	0.6	0.0	0.0	35.5	1.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.2	69.0	23.5	0.2	0.0	0.0	0.0	0.7	0.9	0.1	0.0	6.5	0.0	20.7	0.0	20.1	20.6	0.3	0.0	1.2	0.0	0.2	0.0	0.1	0.0	28.6	6.6	0.9	6.0	0.9	1.7	0.1	0.0	0.0	0.6	0.1	0.1	0.0
C12orf45	MGC40397	ENSG00000151131	"Chromosome 12 open reading frame 45"	Q8N5I9	12	104986316-105074197	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 462.1"	"Lineage enriched"	"Detected in all"	13	"dendritic cells: 462.1"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038722	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear membrane"	"HPA038722: AB_10673118"	"unprognostic (1.27e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.58e-10)"	"unprognostic (1.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.19e-2)"	11.9	8.5	11.8	10.5	12.0	12.2	10.5	15.8	21.0	12.0	6.9	9.7	10.1	8.3	5.9	10.3	7.4	4.3	9.5	10.8	9.1	9.0	14.6	7.2	11.1	7.0	6.7	8.9	24.7	2.4	7.8	4.4	8.4	9.7	7.5	4.5	14.7	4.2	7.5	10.5	7.8	6.4	4.4	11.4	15.1	6.4	10.9	9.2	11.0	2.1	11.0	9.5	10.3	13.3	23.3	32.4	15.3	39.2	12.7	13.0	70.9	20.6	5.2	12.2	6.8	32.8	11.4	44.2	20.1	9.3	30.5	15.2	12.9	31.1	13.5	12.6	22.9	29.5	14.9	45.4	18.4	44.4	22.1	19.1	12.9	18.5	19.7	20.4	20.0	36.4	24.7	11.1	12.0	38.5	29.2	75.3	29.9	34.6	46.2	39.0	18.6	99.9	16.9	29.9	19.5	14.2	20.0	41.9	32.7	27.8	34.8	17.8	9.9	30.2	20.1	26.3	31.6	23.2	28.5	47.5	14.1	30.7	29.2	8.3	34.0	0.6	13.6	30.7	17.1	34.6	18.1	17.3	106.0	25.4	18.6	17.9	3.3	27.8	17.2	462.1	32.9	21.0	11.8	12.0	15.8	21.0	10.8	9.1	7.0	6.7	8.4	4.4	10.9	13.3	15.7	6.4	33.4	1.3	30.4	39.0	44.2	52.8	23.3	11.5	23.4	31.8	37.9	20.0	39.9	33.1	25.0	34.7	66.9	15.8	27.4	27.2	20.8	33.8	25.0	18.0	12.5	12.4	3.8	55.3	63.7	23.0	15.8	40.7	20.3	17.5	11.0	48.2	37.7	3.3	4.2	20.5	30.5	24.2	69.6	10.6	15.2	37.8	39.2	1.0	42.0	18.9	9.2	2.5	4.0	39.0	14.5	10.1	65.8	39.2	12.8	43.7	25.9	11.9	0.0	22.3	24.9	15.9	31.3	19.2	32.7	22.0	23.4	18.1	28.4	39.3
C13orf46		ENSG00000283199	"Chromosome 13 open reading frame 46"	A0A1B0GUA9	13	113953705-113974076	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 9.5;stomach 1: 6.9;testis: 12.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.2;Exocrine glandular cells: 1.5"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 1.1;RPMI-8226: 1.4;T-47d: 1.0;U-138 MG: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"																					1.3	0.0	0.2	0.1	0.1	0.5	0.9	0.0	0.2	0.4	1.4	0.4	0.1	0.2	0.0	0.1	0.5	0.4	0.3	0.5	0.0	0.1	0.3	2.6	0.2	0.3	0.3	0.1	9.5	0.0	0.4	0.0	0.2	1.2	0.1	0.0	1.0	0.0	0.4	0.3	0.3	0.0	0.0	0.3	6.9	12.6	0.3	0.1	2.5	0.0	0.0	1.0	0.3	0.7	0.1	0.0	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.4	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.3	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.1	1.0	0.1	0.2	1.0	0.6	0.2	0.3	0.0	0.0	0.0	0.3	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.5	0.0	0.3	0.3	0.2	0.0	0.3	0.7	0.0	3.2	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
C19orf73	FLJ10490	ENSG00000221916	"Chromosome 19 open reading frame 73"	Q9NVV2	19	49118402-49119143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 8.5"									HPA062719	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA062719: AB_2684847"	"unprognostic (3.02e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.97e-3)"	"prognostic favorable (1.58e-4)"	"unprognostic (3.05e-1)"	"unprognostic (9.00e-5)"	"unprognostic (1.19e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.13e-3)"	0.9	1.3	3.7	0.4	3.9	0.1	1.5	5.8	4.6	0.7	2.3	1.7	2.1	1.0	1.3	2.0	0.5	0.3	1.7	4.2	3.7	1.7	3.4	1.0	0.2	4.1	3.7	0.2	4.8	0.8	3.8	0.2	3.9	1.5	0.7	1.0	2.5	0.4	1.8	2.5	1.5	0.2	3.9	1.8	1.4	1.3	3.9	0.6	1.9	0.9	0.3	0.7	1.2	4.5	1.7	2.1	0.8	4.0	1.3	0.2	0.9	0.5	0.3	0.8	0.6	0.1	0.9	1.2	0.4	0.3	1.2	1.1	1.0	0.1	0.1	2.4	8.5	1.1	1.6	1.4	1.3	0.0	0.4	0.1	2.7	0.6	2.2	0.6	0.1	4.2	2.0	2.0	0.4	1.8	1.4	1.3	0.6	1.8	0.4	1.2	1.6	1.6	1.5	0.7	4.2	1.9	0.8	1.0	1.6	0.5	1.0	0.4	0.8	1.0	1.8	0.3	0.4	1.2	2.5	1.4	0.7	1.5	1.2	0.0	2.0	0.4	1.6	1.3	2.7	1.5	1.2	1.5	3.4	4.4	2.4	1.8	0.0	5.0	2.8	2.7	1.2	1.5	3.7	3.9	5.8	4.6	4.2	3.7	4.1	3.7	3.9	3.9	3.9	4.5	1.6	0.0	0.0	1.3	2.8	2.2	10.3	2.9	4.0	3.9	6.1	6.1	0.7	4.3	2.6	3.7	0.0	1.0	1.0	3.5	3.9	2.6	0.5	1.4	1.1	1.7	3.0	5.7	1.3	2.0	0.9	1.3	3.1	1.0	0.0	0.3	2.2	7.2	1.3	1.7	1.4	4.8	10.2	0.8	0.6	0.7	0.0	1.5	3.6	0.0	0.9	6.9	4.1	1.5	3.0	1.7	1.9	1.5	3.3	8.6	5.0	8.9	2.5	4.8	0.0	1.1	1.6	0.7	4.9	5.4	2.6	0.4	1.7	2.6	5.0	4.1
CBS	HIP4	ENSG00000160200	"Cystathionine beta-synthase"	P35520	21	43053191-43076943	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Allosteric enzyme, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 174.9;pancreas: 99.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.3;Cardiomyocytes: 4.9;Hepatocytes: 3.6;Ionocytes: 2.0;Melanocytes: 5.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	51	"neutrophil: 5.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 177.5;HAP1: 172.8;HHSteC: 224.1;MCF7: 197.7;RPMI-8226: 197.4"	"Low region specificity"	"Detected in all"							HPA001223	Supported		Approved	Nucleoli,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.68e-4)"	"unprognostic (3.62e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	6.6	2.8	42.5	1.0	39.5	0.2	3.4	58.5	55.3	12.3	29.3	4.8	3.0	4.5	0.0	2.0	5.8	1.2	7.7	41.4	40.3	3.8	174.9	10.2	2.7	42.5	44.6	30.3	99.0	2.5	8.8	1.2	42.7	12.7	0.9	2.5	19.9	1.1	1.1	2.3	7.0	2.3	38.4	1.7	16.5	2.0	48.1	0.7	17.4	1.2	1.4	11.6	6.2	45.4	30.0	17.0	31.3	113.4	48.9	31.5	177.5	39.5	10.0	15.6	15.4	53.7	1.5	0.1	19.2	67.2	0.3	1.5	172.8	13.2	3.1	0.0	20.5	12.3	73.1	63.8	224.1	7.9	19.1	21.7	1.4	16.0	16.4	13.2	38.6	85.6	138.7	118.1	11.1	197.7	16.1	0.1	20.3	65.7	29.4	0.0	0.2	197.4	0.5	15.5	57.8	85.1	78.5	5.4	44.4	18.4	27.0	91.2	5.4	0.8	42.5	0.3	4.8	34.8	30.2	41.2	19.0	11.0	53.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	42.5	39.5	58.5	55.3	41.4	40.3	42.5	44.6	42.7	38.4	48.1	45.4	0.2	0.0	0.5	0.7	0.0	0.4	0.0	2.3	0.0	0.2	0.5	0.1	4.9	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.2	0.8	1.2	0.0	0.1	0.0	0.1	0.0	3.6	0.2	0.0	0.0	0.0	2.0	0.0	1.4	0.0	0.9	0.2	5.4	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.2	1.7	0.1	0.1	0.1	0.0	0.3	0.6	0.0	0.6	0.0	1.0	0.1	0.1	0.0	0.2	0.1
CCDC110	"CT52, KM-HN-1, MGC33607"	ENSG00000168491	"Coiled-coil domain containing 110"	Q8TBZ0	4	185445182-185471752	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"pancreas: 30.7;testis: 100.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 796.2;Late spermatids: 175.5;Spermatocytes: 552.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.4;U-266/70: 5.3;U-266/84: 8.8;U-87 MG: 4.0"					"Low region specificity"	"Detected in many"			HPA078808			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA078808: "	"unprognostic (1.18e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.42e-2)"	"unprognostic (9.84e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.95e-5)"	"unprognostic (4.92e-2)"	"unprognostic (5.81e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.21e-2)"	0.6	1.0	1.8	1.0	3.4	0.0	3.6	2.6	2.1	2.6	1.6	1.8	0.9	1.4	5.1	1.8	2.9	1.2	1.1	1.2	1.2	2.5	0.8	0.9	1.2	2.0	1.6	4.5	30.7	2.0	2.9	0.8	2.4	2.2	1.9	7.9	6.2	2.0	2.1	1.1	0.8	1.4	0.8	0.6	2.5	100.0	1.7	0.4	7.7	0.9	0.7	1.3	0.5	0.9	0.4	0.0	0.2	0.1	2.2	2.4	0.1	0.0	0.0	0.0	0.2	0.0	1.7	2.7	0.3	0.0	2.3	0.3	1.7	0.0	0.2	1.0	1.7	0.0	0.2	0.0	1.1	0.0	0.0	0.6	0.0	1.0	0.0	1.4	0.8	0.7	0.2	0.2	2.9	0.7	0.0	0.0	0.2	0.3	1.3	0.1	0.0	0.4	0.6	0.0	8.4	1.5	0.0	0.9	0.7	0.4	3.8	0.0	0.5	0.3	0.7	0.1	0.1	5.3	8.8	0.0	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.4	2.6	2.1	1.2	1.2	2.0	1.6	2.4	0.8	1.7	0.9	0.4	0.0	0.0	0.7	0.9	0.3	0.4	0.3	1.8	0.5	2.9	4.7	4.2	0.0	0.0	1.8	0.0	0.1	0.0	0.3	1.9	2.6	796.2	1.8	0.2	1.2	0.0	0.0	3.5	3.5	0.1	2.1	0.5	1.0	0.0	0.2	2.2	0.5	0.1	0.0	1.3	1.1	4.1	0.0	0.3	175.5	7.2	0.9	3.6	1.9	0.1	3.1	1.0	0.5	1.8	2.2	0.3	6.0	9.3	0.4	0.0	2.3	4.4	5.3	0.0	1.7	2.5	552.8	6.1	1.5	0.4	0.0	0.3	0.7	1.1	0.1
CCDC149	DKFZp761B107	ENSG00000181982	"Coiled-coil domain containing 149"	Q6ZUS6	4	24806117-24980204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044158, HPA047913"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA044158: AB_2678840, HPA047913: AB_2680207"	"unprognostic (1.68e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.11e-4)"	"unprognostic (9.71e-5)"	"unprognostic (2.68e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-2)"	"unprognostic (8.59e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.80e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.80e-2)"	9.7	5.3	11.0	6.2	12.1	2.0	11.9	7.8	13.1	10.4	7.5	11.1	3.7	10.4	6.3	4.6	10.1	6.8	8.4	12.1	10.7	8.4	8.7	8.9	2.2	9.1	9.2	10.6	19.1	8.1	7.2	8.4	9.2	11.4	5.9	8.5	18.8	6.7	7.0	6.6	5.9	10.2	7.9	4.9	13.1	3.7	12.3	2.5	8.8	7.6	2.2	9.0	7.0	11.5	6.0	2.3	4.8	0.8	7.5	13.4	1.3	8.4	13.4	6.9	7.9	0.1	6.9	0.0	3.9	17.0	7.8	1.1	1.4	1.0	4.5	0.0	0.0	0.0	0.4	0.5	6.2	0.0	0.0	9.3	6.5	4.1	0.0	18.8	5.6	0.0	0.0	1.2	4.2	6.3	0.0	0.1	5.3	0.6	5.3	0.0	0.0	0.4	12.5	4.2	5.3	0.1	3.2	5.5	17.8	5.1	9.3	13.8	12.0	10.0	0.9	7.5	7.3	0.1	0.0	0.0	30.6	1.4	6.8	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.5	0.2	0.0	0.5	11.0	12.1	7.8	13.1	12.1	10.7	9.1	9.2	9.2	7.9	12.3	11.5	14.3	0.0	9.5	23.5	0.4	6.2	7.2	2.7	6.8	11.9	11.7	6.9	5.7	5.7	3.7	7.3	10.4	7.1	0.1	2.3	0.0	6.6	1.1	7.4	6.6	13.6	1.8	2.7	30.2	10.4	1.5	8.1	6.6	7.8	0.0	8.3	10.4	6.4	12.2	5.0	39.8	11.9	0.0	9.7	2.1	1.7	10.8	8.1	8.8	16.9	6.7	9.1	0.0	27.6	20.9	8.7	5.6	11.7	1.1	11.0	0.7	2.3	3.1	11.6	6.6	12.5	9.7	1.6	2.8	1.7	3.1	10.7	0.7	2.0	5.2	6.7
CCKBR		ENSG00000110148	"Cholecystokinin B receptor"	P32239	11	6259806-6272127	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	29	"brain: 14.1;pancreas: 27.1;stomach 1: 42.0"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 14.6;Gastric mucus-secreting cells: 14.3;Granulosa cells: 23.3"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 73.4"	"Low region specificity"	"Detected in many"													NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (2.82e-1)"			"unprognostic (4.62e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.19e-1)"		"unprognostic (1.95e-1)"	"unprognostic (6.34e-4)"	"unprognostic (8.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.00e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-2)"		0.1	0.2	8.2	0.0	11.7	0.0	0.0	6.3	14.1	0.0	0.3	0.2	0.3	0.3	0.0	0.0	0.3	0.0	0.0	11.9	1.7	0.0	0.0	0.0	0.0	3.7	1.8	0.1	27.1	0.0	0.9	0.0	3.8	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	42.0	0.5	2.6	0.0	0.2	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	73.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	11.7	6.3	14.1	11.9	1.7	3.7	1.8	3.8	1.3	2.6	6.6	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	14.6	1.3	0.0	0.2	14.3	0.1	0.0	23.3	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.7	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
CCS		ENSG00000173992	"Copper chaperone for superoxide dismutase"	O14618	11	66593153-66606019	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 204.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008672, HPA040026, HPA044090"	Approved					NA	NA		190000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB008672: AB_1623300, HPA040026: AB_2676806, HPA044090: AB_2678805"	"unprognostic (1.19e-1)"	"unprognostic (8.46e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.22e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-3)"	21.1	26.6	29.6	18.5	30.5	34.4	14.1	33.4	40.5	18.5	30.7	21.9	27.9	19.8	18.3	16.5	17.7	21.1	21.4	30.7	31.1	21.3	56.2	15.6	23.8	32.4	30.9	23.6	31.1	22.6	17.3	17.9	30.4	22.6	14.7	24.9	36.8	20.0	19.1	21.9	30.1	17.2	30.3	21.8	23.3	16.9	31.3	15.9	17.3	14.2	17.3	17.7	14.7	35.0	24.6	34.1	24.4	26.9	22.0	21.4	29.9	22.4	18.7	15.9	10.7	38.8	26.5	14.4	31.3	19.9	23.8	24.6	7.2	25.8	5.3	26.8	10.9	23.3	30.5	51.1	42.3	6.0	18.3	35.8	18.9	16.9	11.1	33.6	26.0	16.5	12.3	19.2	16.5	55.0	9.5	30.1	22.7	40.2	23.9	17.4	23.3	29.8	25.0	25.6	19.9	12.9	37.2	25.4	49.7	14.4	38.9	17.4	23.6	10.8	17.7	24.4	10.8	32.1	19.2	7.6	29.7	9.2	26.5	23.6	26.4	60.0	19.7	21.0	17.0	32.5	16.9	16.0	31.1	25.3	17.7	17.9	17.8	19.1	13.0	83.7	18.4	17.3	29.6	30.5	33.4	40.5	30.7	31.1	32.4	30.9	30.4	30.3	31.3	35.0	37.8	19.2	33.7	58.8	56.1	24.2	52.9	44.7	31.3	42.4	33.6	37.5	29.9	45.8	30.4	36.8	25.0	55.2	59.3	49.7	82.2	34.1	25.4	16.5	38.0	28.7	73.0	204.4	20.2	59.8	43.8	60.4	44.4	27.2	21.5	63.9	39.3	163.5	64.9	11.8	19.1	41.1	26.4	35.8	32.3	12.6	71.4	43.8	44.4	23.4	38.5	65.4	44.3	15.1	20.6	40.5	44.9	57.2	50.6	31.2	90.4	132.9	19.7	104.2	19.7	31.8	67.1	46.7	31.4	30.1	20.3	51.6	41.0	191.3	46.7	37.2
CDC42EP1	"Borg5, CEP1, MSE55"	ENSG00000128283	"CDC42 effector protein 1"	Q00587	22	37560480-37569405	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 245.6;Exocrine glandular cells: 226.0;Pancreatic endocrine cells: 266.2;Urothelial cells: 161.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 7.3;intermediate monocyte: 1.9;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.4;monocytes: 7.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006379, HPA076536"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA006379: AB_1078486, HPA076536: "	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.79e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.38e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.09e-3)"	76.3	91.2	55.7	16.7	107.5	1.6	58.0	89.9	73.3	68.2	17.6	43.7	31.1	70.7	4.1	93.1	61.0	40.8	53.8	55.9	67.3	50.2	133.1	65.2	11.3	102.8	104.5	60.9	161.6	16.5	18.8	31.8	97.4	41.5	14.4	2.6	102.7	23.9	13.1	71.2	32.7	19.6	70.2	26.2	155.9	23.6	87.5	2.7	33.7	11.1	10.4	38.4	69.6	151.5	125.2	35.4	15.1	67.9	23.7	40.2	73.3	69.9	41.0	78.9	54.3	87.8	15.9	0.2	24.2	81.4	25.4	95.0	17.8	35.1	26.0	15.5	60.7	0.5	33.9	53.6	167.7	0.3	0.6	74.9	52.1	65.0	61.5	63.1	59.2	0.1	78.9	0.7	33.0	42.6	0.3	0.5	13.6	96.5	79.6	0.4	27.5	2.4	27.9	1.9	0.4	2.6	51.2	112.3	112.4	20.6	50.3	11.0	91.6	163.9	98.2	80.0	98.6	0.2	0.8	0.3	65.3	0.7	135.6	0.4	7.3	0.0	0.1	1.9	0.1	0.0	0.1	0.1	2.4	0.3	0.0	0.2	0.2	0.4	0.1	0.3	0.0	3.4	55.7	107.5	89.9	73.3	55.9	67.3	102.8	104.5	97.4	70.2	87.5	151.5	62.4	6.4	19.5	2.3	1.8	46.9	87.2	51.4	21.1	0.1	59.2	31.8	3.5	134.4	41.1	12.9	0.0	98.2	2.0	41.6	1.9	245.6	3.7	4.3	20.0	54.7	11.5	0.0	0.1	226.0	110.3	32.1	133.0	9.0	2.5	1.7	69.7	35.6	13.2	1.7	0.2	66.6	30.5	5.9	29.3	1.7	39.4	5.3	21.4	4.7	8.9	12.8	0.0	2.0	42.7	266.2	45.8	35.3	0.6	122.4	17.5	11.4	14.7	0.3	39.5	22.8	49.5	2.0	0.6	55.9	52.0	112.2	2.2	7.0	61.1	161.3
CDK5RAP3	"C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114"	ENSG00000108465	"CDK5 regulatory subunit associated protein 3"	Q96JB5	17	47967810-47981781	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022141, HPA022882, HPA027883"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Nucleoli, Vesicles"	"HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-3)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"unprognostic (5.98e-2)"	"unprognostic (7.19e-3)"	"unprognostic (3.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (3.61e-5)"	"unprognostic (8.35e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.58e-2)"	"prognostic favorable (7.31e-5)"	45.8	48.2	83.8	42.0	85.7	52.3	48.7	83.7	111.3	58.1	100.4	53.0	54.5	42.4	91.9	52.8	54.2	46.1	39.2	85.5	85.5	60.2	80.6	44.6	51.7	86.4	84.7	69.5	133.6	53.6	93.0	34.3	85.7	62.6	53.8	34.1	77.0	48.5	29.6	43.5	68.5	33.8	83.1	81.4	81.8	83.5	86.6	44.2	73.2	28.1	54.8	48.1	48.3	86.7	72.7	116.5	60.8	114.6	52.6	53.3	112.7	51.4	63.9	52.3	51.0	92.5	72.3	88.7	107.8	55.5	35.2	72.8	41.6	61.4	59.3	127.0	58.1	43.4	157.9	123.8	58.7	50.0	47.5	60.7	51.5	45.9	91.8	64.2	52.8	169.1	49.6	80.8	52.9	140.3	128.3	79.2	38.5	87.4	55.0	74.6	101.4	101.7	52.8	91.3	43.0	104.1	38.3	37.1	51.7	65.3	84.5	65.4	38.9	43.6	38.2	53.1	66.8	106.8	102.9	54.2	54.3	69.1	53.5	20.8	62.6	54.8	33.8	63.8	36.8	40.9	31.4	30.6	50.1	44.7	28.0	31.4	30.5	45.3	67.4	46.0	32.9	41.3	83.8	85.7	83.7	111.3	85.5	85.5	86.4	84.7	85.7	83.1	86.6	86.7	31.3	25.6	62.6	60.7	61.8	33.6	63.3	89.3	50.7	52.0	52.8	40.4	28.4	44.3	84.1	40.5	31.3	68.8	44.9	56.5	50.9	56.8	53.0	35.7	32.9	32.1	61.6	22.9	31.1	67.7	57.4	44.7	147.8	42.5	69.6	68.3	27.5	55.6	61.7	57.2	27.9	70.8	71.2	33.6	40.7	36.3	40.7	44.1	46.2	25.3	47.6	45.1	33.0	25.6	50.6	37.1	60.9	29.7	87.2	49.0	77.2	45.1	85.2	52.6	32.9	34.3	33.2	132.8	45.7	31.0	25.9	61.6	53.0	38.6	56.8	56.6
CERS4	"FLJ12089, LASS4, Trh1"	ENSG00000090661	"Ceramide synthase 4"	Q9HA82	19	8206736-8262421	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 71.3;Muller glia cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 55.1;NB-4: 99.8;U-937: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033734, HPA054729"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Vesicles"		"CAB033734: AB_2132977, HPA054729: "	"unprognostic (5.96e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (1.48e-2)"	"unprognostic (3.32e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (6.08e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.08e-3)"	13.6	13.0	31.8	10.0	38.9	3.4	31.1	26.6	37.1	35.9	18.7	17.7	6.3	21.5	61.5	64.3	21.3	11.2	14.8	35.3	25.2	27.8	57.7	19.4	19.9	36.9	30.5	22.0	89.1	29.0	22.2	1.9	30.8	32.9	3.9	36.9	55.0	17.6	3.1	47.7	15.2	12.0	26.8	17.7	26.8	11.5	30.7	13.1	51.9	5.3	20.4	18.4	32.7	44.0	0.4	2.1	2.1	25.0	0.8	0.2	1.7	3.1	8.4	3.7	1.7	19.5	1.7	40.0	27.4	0.0	9.6	13.6	16.4	0.4	1.7	35.5	12.4	7.6	0.1	55.1	31.6	0.0	21.3	12.3	20.7	8.8	18.9	10.5	0.3	17.7	5.9	1.2	0.0	0.8	2.6	99.8	25.4	0.2	8.7	49.1	0.8	3.0	6.3	0.0	9.3	12.2	4.3	0.7	14.5	16.7	18.8	8.8	0.2	2.9	7.8	18.6	0.1	24.5	21.1	32.0	0.1	61.9	2.8	12.3	7.1	27.4	7.5	3.9	5.7	19.8	4.3	4.6	4.1	17.7	3.9	3.8	22.4	22.4	2.4	3.9	5.5	5.8	31.8	38.9	26.6	37.1	35.3	25.2	36.9	30.5	30.8	26.8	30.7	44.0	3.2	6.4	10.7	27.1	31.2	18.0	13.2	12.0	15.4	24.5	47.0	28.8	4.1	22.8	22.2	1.8	18.8	3.4	17.2	0.2	7.9	20.0	1.7	7.9	11.2	8.6	23.9	4.0	38.3	30.5	0.9	15.7	3.1	7.6	12.7	14.4	8.2	71.3	16.4	11.8	24.4	1.3	8.2	7.1	7.2	7.3	14.3	6.7	26.6	16.9	19.6	150.3	27.8	47.7	48.1	9.4	2.5	16.1	12.4	40.6	0.4	44.6	27.8	29.5	6.6	6.9	13.8	1.0	1.6	20.6	25.9	2.9	15.7	2.7	2.5	11.9
CHCHD5	"C2orf9, MGC11104, MIC14, MIX14"	ENSG00000125611	"Coiled-coil-helix-coiled-coil-helix domain containing 5"	Q9BSY4	2	112584240-112589275	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038263	Approved		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA038263: AB_10671525"	"unprognostic (3.56e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.36e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.18e-3)"	"unprognostic (8.04e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-2)"	19.1	28.9	20.6	12.4	22.0	18.3	22.4	22.6	28.7	18.5	19.8	19.2	18.0	17.8	6.4	28.2	19.6	14.4	24.5	20.0	21.7	35.8	40.2	17.8	14.6	21.4	21.6	15.8	46.1	28.1	31.7	9.8	21.3	22.2	6.3	5.7	16.5	12.6	38.9	23.3	17.2	6.5	21.5	18.5	25.4	22.9	22.6	16.7	27.1	18.7	7.9	19.6	18.8	21.9	32.5	53.1	23.3	0.1	9.3	19.7	22.0	14.0	18.2	28.3	20.0	58.1	39.0	24.7	54.4	19.4	23.9	23.4	8.9	31.2	3.8	26.8	43.2	33.4	15.6	46.4	40.8	28.5	22.5	26.5	26.3	37.4	22.8	13.2	15.8	0.1	35.1	36.5	18.1	80.3	25.8	45.1	26.0	24.1	25.9	0.9	19.3	48.7	37.8	29.1	29.7	33.4	17.7	26.3	31.6	6.2	33.9	24.9	22.0	28.2	39.7	17.2	20.4	65.0	66.3	29.1	39.1	7.7	33.9	22.1	69.0	68.6	49.9	66.6	42.1	49.3	46.8	47.5	64.1	63.2	48.1	49.9	38.3	62.3	62.6	81.3	78.6	61.9	20.6	22.0	22.6	28.7	20.0	21.7	21.4	21.6	21.3	21.5	22.6	21.9	39.3	9.6	13.9	2.0	41.1	43.1	65.1	153.3	51.8	19.2	100.0	109.6	40.4	90.1	73.8	82.8	10.4	131.9	41.2	138.5	219.2	109.7	188.8	138.1	63.5	44.3	91.7	44.6	2.2	176.7	109.5	43.8	67.8	79.6	24.7	50.8	51.4	211.4	123.9	6.7	2.8	107.3	97.6	122.0	63.5	290.9	30.7	63.7	53.4	1.0	101.0	61.5	87.6	1.5	4.4	123.2	140.1	28.2	41.0	76.8	184.7	286.7	99.3	28.3	13.1	33.9	47.8	141.8	39.4	112.2	58.1	92.8	44.6	89.2	97.7	85.7
CHDH		ENSG00000016391	"Choline dehydrogenase"	Q8NE62	3	53812335-53846419	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 37.6;liver: 35.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 52.9;Hepatocytes: 51.8;Proximal enterocytes: 70.1;Proximal tubular cells: 87.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 3.1;T-reg: 1.3"	"Group enriched"	"Detected in many"	17	"granulocytes: 3.1;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 11.4;Hep G2: 35.8;OE19: 25.3;T-47d: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036633, HPA058130"	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036633: AB_10670841, HPA058130: AB_2683615"	"unprognostic (3.40e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.26e-3)"	"unprognostic (7.17e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.12e-2)"	"prognostic favorable (1.88e-8)"	"unprognostic (3.37e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.29e-2)"	0.6	2.8	13.6	1.8	14.3	0.6	7.3	12.5	11.4	3.7	16.5	8.9	8.4	2.7	1.4	0.9	2.6	2.7	2.4	11.3	10.9	37.6	35.8	2.4	1.0	14.5	13.9	1.3	16.4	8.3	7.8	0.4	10.1	5.8	9.2	1.5	15.0	1.0	3.9	2.4	14.7	0.9	10.3	0.5	8.0	6.9	15.9	0.2	2.6	1.2	1.2	0.4	0.9	12.0	0.4	4.6	1.2	0.1	0.0	0.0	5.2	0.3	0.5	0.0	0.0	11.4	0.8	0.4	0.8	0.8	0.1	0.0	7.4	0.0	0.0	0.0	4.0	0.0	1.7	35.8	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.6	0.0	0.0	5.7	0.7	0.0	6.9	0.0	0.1	7.2	25.3	0.8	0.0	1.8	8.2	5.1	4.0	3.0	4.0	1.8	0.1	0.0	0.9	11.2	0.1	0.0	0.0	0.8	0.2	1.0	1.0	1.6	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	13.6	14.3	12.5	11.4	11.3	10.9	14.5	13.9	10.1	10.3	15.9	12.0	0.6	3.2	6.8	19.6	1.3	6.6	5.6	1.1	1.2	23.8	23.5	19.8	11.3	52.9	5.9	11.0	14.6	3.7	0.4	16.6	7.9	19.4	28.9	3.2	11.0	1.4	47.9	0.0	2.4	13.8	2.3	2.3	21.4	9.4	7.0	2.2	1.4	51.8	0.3	1.7	3.5	38.9	0.0	1.9	2.5	46.2	5.9	2.6	3.6	1.0	0.1	18.8	0.0	27.2	5.2	8.0	15.1	15.4	5.3	19.8	70.1	87.8	3.8	13.4	0.0	1.0	3.4	15.1	2.3	0.7	5.3	0.8	2.4	2.0	45.4	2.2
CHRM3		ENSG00000133019	"Cholinergic receptor muscarinic 3"	P20309	1	239386565-239915452	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;salivary gland: 17.5"	"Group enriched"	"Detected in many"	28	"Excitatory neurons: 802.9;Inhibitory neurons: 624.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 17.2;SH-SY5Y: 53.5;U-266/70: 21.7;U-266/84: 16.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024106, HPA048036"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA024106: AB_1854211, HPA048036: AB_2680238"	"unprognostic (1.63e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.11e-3)"	"unprognostic (3.48e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.88e-2)"	0.3	0.4	4.6	0.8	7.3	0.2	0.8	0.0	11.8	0.4	0.0	7.0	1.4	1.9	0.4	7.5	0.8	0.7	0.4	7.5	0.0	1.1	0.4	1.1	0.1	0.0	0.0	4.8	10.6	0.5	0.5	0.8	0.0	1.1	2.8	1.7	17.5	3.0	0.0	1.3	1.5	4.1	0.0	0.7	5.0	2.5	4.1	0.1	2.0	0.1	0.1	7.0	0.4	2.9	0.0	0.1	0.4	0.4	0.0	0.0	0.9	0.6	0.1	0.3	0.1	0.0	0.0	0.0	2.1	0.0	0.0	5.8	0.6	3.8	2.7	0.0	3.7	0.6	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	1.1	9.1	0.9	1.4	0.0	0.0	4.6	4.6	9.1	0.0	1.1	17.2	0.7	0.8	0.1	53.5	0.0	0.1	0.1	4.0	1.8	0.0	0.3	2.3	0.8	0.1	0.5	21.7	16.3	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.6	7.3	0.0	11.8	7.5	0.0	0.0	0.0	0.0	0.0	4.1	2.9	6.1	0.0	3.7	6.2	0.0	0.0	2.1	0.0	0.6	19.0	4.6	3.2	1.2	0.0	0.8	0.0	0.0	3.2	0.3	11.0	1.9	0.4	19.6	0.1	0.1	3.0	3.5	4.6	802.9	17.3	0.7	3.9	11.7	0.2	1.3	7.5	4.2	0.3	0.5	0.0	624.0	6.0	0.0	0.0	0.0	3.9	0.0	0.2	7.2	22.5	0.0	0.3	0.0	8.5	11.2	2.6	25.3	0.4	0.2	2.5	2.2	1.4	1.6	0.6	0.0	0.2	1.1	12.9	3.0	0.2	0.0	0.5	0.1	0.8	15.5	0.2
CHST9	"GALNAC-4-ST2, GALNAC4ST-2"	ENSG00000154080	"Carbohydrate sulfotransferase 9"	Q7L1S5	18	26906481-27185308	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 13.8"	"Cell type enhanced"	"Detected in many"		"Club cells: 115.2;Muller glia cells: 69.2;Oligodendrocyte precursor cells: 167.4;Respiratory ciliated cells: 311.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 9.3;Hep G2: 13.8;RPTEC TERT1: 41.8;SCLC-21H: 9.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA011393	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA011393: AB_1846733"	"unprognostic (9.24e-3)"	"unprognostic (1.13e-2)"		"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (4.53e-3)"	"unprognostic (9.98e-3)"	"unprognostic (9.21e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.38e-1)"		"unprognostic (3.93e-3)"	0.0	0.2	0.8	0.1	0.9	0.0	2.9	0.7	2.4	2.8	0.0	1.6	0.2	0.1	0.4	1.6	10.3	3.1	2.6	2.7	1.2	1.6	8.2	4.3	0.0	3.5	2.3	0.0	9.3	0.0	1.9	0.0	1.2	3.5	0.2	7.3	13.8	1.8	0.2	0.1	0.3	0.1	2.0	5.7	0.7	6.9	1.2	1.0	0.0	0.9	0.6	1.5	0.7	1.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	41.8	0.0	9.0	0.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.7	2.4	2.7	1.2	3.5	2.3	1.2	2.0	1.2	1.9	0.1	0.0	2.7	24.8	0.0	0.6	32.6	56.6	4.6	1.3	8.2	8.0	9.2	35.8	115.2	5.5	0.0	0.4	0.1	0.0	11.7	13.0	7.1	49.9	0.7	0.3	3.5	0.0	10.1	0.6	0.1	4.2	0.0	1.8	5.1	0.1	0.0	10.7	0.3	0.0	29.3	0.1	22.4	0.0	0.0	4.4	0.6	0.5	7.2	1.0	0.0	69.2	0.0	167.4	1.0	1.3	0.0	0.4	0.0	8.9	0.0	0.3	311.6	3.2	0.0	3.2	3.7	0.9	1.3	4.7	0.0	0.3	0.4	0.0	0.0	40.3
CLDN10	"CPETRL3, OSP-L"	ENSG00000134873	"Claudin 10"	P78369	13	95433604-95579759	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"		"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 135.2;pancreas: 216.5;salivary gland: 91.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 182.4;Cholangiocytes: 328.8;Club cells: 251.6;Ductal cells: 394.1;Glandular and luminal cells: 220.2;Proximal tubular cells: 285.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 1.3;neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 4.1"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 14.9;NTERA-2: 12.7;RPTEC TERT1: 29.0;SuSa: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012969, HPA042348"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB012969: AB_2533386, HPA042348: AB_2677955"	"unprognostic (6.45e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (1.11e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (4.75e-3)"	1.0	0.1	33.0	0.0	31.3	3.2	3.1	28.6	45.8	30.4	24.1	0.3	1.1	9.3	20.8	7.9	19.2	25.5	0.5	32.6	30.5	135.2	3.7	2.1	0.0	27.9	30.2	0.9	216.5	0.4	3.1	0.8	27.2	1.3	0.4	2.7	91.5	0.4	0.1	16.8	0.2	0.4	27.4	0.7	0.9	1.5	30.1	0.5	0.2	0.7	27.4	0.5	0.4	29.8	0.0	0.0	0.9	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	2.7	0.0	4.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.3	1.9	0.0	0.0	2.9	0.0	0.1	0.0	0.5	14.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	12.7	0.2	0.0	0.0	0.1	0.0	29.0	0.0	0.2	0.1	0.0	0.0	0.0	73.3	0.7	1.8	0.6	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	33.0	31.3	28.6	45.8	32.6	30.5	27.9	30.2	27.2	27.4	30.1	29.8	0.6	0.0	0.0	93.4	1.0	0.3	5.5	182.4	0.0	0.3	22.6	5.0	0.8	328.8	251.6	99.3	0.0	15.0	0.4	0.0	135.0	394.1	3.4	83.2	28.5	4.2	0.0	0.0	0.6	82.5	7.9	1.4	0.0	220.2	0.0	0.1	1.1	0.4	1.9	0.0	1.6	0.0	77.3	0.3	0.3	2.5	0.0	2.8	69.4	4.7	1.6	78.7	0.0	33.7	0.4	103.1	0.0	0.4	0.1	22.1	0.0	285.9	43.3	3.8	6.6	0.2	16.8	12.2	19.9	1.5	0.6	23.1	2.2	0.5	0.0	5.0
CLDN6		ENSG00000184697	"Claudin 6"	P56747	16	3014712-3020071	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.1;pancreas: 1.0"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 35.8;Ductal cells: 23.7;Extravillous trophoblasts: 144.2;Syncytiotrophoblasts: 44.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 73.6;testis cancer: 112.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 477.8;CACO-2: 134.6;NTERA-2: 443.1;SuSa: 328.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 38: Extravillous trophoblasts - Unknown function"				"unprognostic (2.59e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.50e-4)"	"unprognostic (1.02e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.66e-4)"	"unprognostic (1.79e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.78e-4)"	0.0	0.2	0.7	0.0	0.9	0.1	0.0	1.1	0.7	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.6	0.3	0.8	0.0	0.2	0.0	0.4	0.4	0.0	1.0	0.0	0.3	0.7	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.9	0.3	0.7	0.0	477.8	0.1	0.0	0.0	0.0	134.6	0.7	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.2	0.1	60.2	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.2	0.0	0.0	0.4	0.2	0.1	1.0	0.0	0.3	443.1	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.4	0.6	0.6	0.0	328.9	0.2	0.1	0.5	0.2	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.9	1.1	0.7	0.6	0.3	0.4	0.4	0.4	0.1	0.3	0.4	0.2	3.2	0.0	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.8	1.3	0.3	0.0	0.1	0.0	0.0	35.8	0.0	0.0	0.0	23.7	0.2	1.4	0.1	0.2	0.0	0.0	0.1	0.0	144.2	0.6	0.0	1.6	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	1.8	0.4	0.6	5.4	0.0	0.4	44.1	0.2	0.0	0.1	0.2
CNKSR3	"FLJ31349, MAGI1"	ENSG00000153721	"CNKSR family member 3"	Q6P9H4	6	154387515-154510685	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 109.6;Glandular and luminal cells: 155.4;Oligodendrocytes: 142.3;Skeletal myocytes: 211.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 21.1"									"CAB037133, HPA049651"	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Cytosol	Mitochondria	"CAB037133: AB_477217, HPA049651: AB_2680841"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-3)"	"unprognostic (4.90e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (4.23e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.38e-1)"	3.7	1.1	6.4	1.9	7.6	0.9	3.2	4.8	5.5	4.0	15.0	6.5	5.8	7.6	1.9	13.3	4.1	4.9	6.4	3.6	4.2	7.7	9.7	3.7	1.4	7.8	8.3	6.1	18.9	0.7	2.3	5.6	7.2	3.3	3.4	2.6	5.7	4.8	1.1	3.9	6.4	6.6	5.3	4.5	4.0	4.4	12.7	2.1	2.1	1.4	2.5	4.3	5.3	13.3	0.4	4.9	3.3	6.8	5.8	4.1	0.4	6.0	3.5	10.2	8.3	21.1	0.5	0.1	6.4	6.6	3.4	2.1	9.5	0.7	5.3	0.0	6.3	15.4	1.0	12.1	2.5	0.0	2.7	6.1	3.2	3.9	4.1	1.6	3.2	1.3	2.2	0.1	2.8	1.2	0.1	0.2	2.3	4.1	6.2	4.6	5.9	8.0	11.7	3.1	2.0	12.6	2.8	1.5	1.3	1.4	0.0	1.3	3.7	0.9	3.0	7.7	4.0	0.1	0.0	0.2	0.2	0.3	4.4	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.7	0.1	0.1	0.2	0.0	0.0	6.4	7.6	4.8	5.5	3.6	4.2	7.8	8.3	7.2	5.3	12.7	13.3	24.7	12.8	38.4	9.4	0.9	26.5	15.4	7.8	12.5	2.0	11.0	8.3	33.8	30.0	20.2	25.8	0.0	9.2	0.4	31.0	9.8	20.3	42.5	109.6	14.7	66.8	43.2	15.6	23.8	12.3	1.1	12.9	9.2	155.4	5.7	10.8	61.8	65.9	1.7	0.0	1.5	18.4	10.2	7.1	22.5	23.6	5.9	3.5	32.0	24.4	0.8	22.8	0.0	54.8	142.3	7.3	18.5	10.5	0.5	18.7	43.6	31.8	11.7	2.5	0.0	211.8	8.0	1.2	6.3	29.4	23.9	21.5	2.6	14.8	14.1	10.0
COA3	"CCDC56, COX25, HSPC009, MITRAC12"	ENSG00000183978	"Cytochrome c oxidase assembly factor 3"	Q9Y2R0	17	42795147-42798704	"Disease related genes, Predicted membrane proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 710.2;Proximal tubular cells: 729.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031966, HPA071122"	Approved		Enhanced	Mitochondria		NA	NA		13000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA031966: AB_10602115, HPA071122: "	"unprognostic (1.20e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (5.65e-2)"	"prognostic favorable (8.93e-4)"	"unprognostic (7.62e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (6.62e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.01e-2)"	64.8	73.0	122.8	30.8	122.9	15.3	63.7	128.2	160.5	71.5	125.8	110.8	106.0	55.6	172.3	128.4	73.7	42.9	102.4	125.6	124.5	223.4	158.9	45.7	41.0	124.6	125.4	55.8	172.6	106.8	59.7	38.9	127.2	84.9	89.7	34.9	66.1	66.7	119.6	58.0	81.1	41.5	125.8	50.5	128.5	25.2	125.5	42.7	57.9	94.3	49.8	60.5	78.6	125.3	66.8	219.9	99.4	54.7	89.5	75.8	61.0	51.1	77.2	119.2	107.3	87.5	81.8	3.9	141.0	62.5	112.4	63.5	77.3	124.8	111.9	65.1	202.8	44.7	96.3	280.8	63.4	61.0	52.0	77.4	92.0	112.7	64.2	61.0	96.1	31.6	72.9	55.5	106.9	108.9	20.2	132.9	45.7	135.9	78.5	79.4	145.1	113.6	122.6	90.2	73.8	61.9	52.2	54.9	91.5	85.3	170.3	78.5	59.3	129.6	67.5	55.4	69.0	65.1	76.3	36.2	97.3	60.1	89.8	206.7	209.6	141.5	136.2	208.1	143.5	218.9	140.0	138.3	178.8	187.5	128.4	126.2	22.7	187.5	177.7	120.3	191.1	245.9	122.8	122.9	128.2	160.5	125.6	124.5	124.6	125.4	127.2	125.8	125.5	125.3	55.4	28.9	68.7	7.5	44.5	36.8	52.2	192.7	50.7	36.5	99.9	110.9	263.9	173.0	113.8	266.7	20.9	153.9	30.3	233.8	710.2	136.5	13.2	203.0	70.0	65.4	79.9	54.3	8.1	239.8	177.5	72.5	103.5	154.6	35.5	77.5	69.3	390.1	121.6	45.4	9.2	205.9	195.3	75.3	33.4	18.8	55.9	54.8	88.9	6.5	86.0	94.7	63.8	6.6	11.8	134.7	201.6	45.1	73.2	79.0	221.7	729.1	145.2	37.0	39.5	46.2	88.0	48.4	52.1	242.0	55.5	102.2	43.4	97.6	258.9	67.7
CRYBA2		ENSG00000163499	"Crystallin beta A2"	P53672	2	218990189-218993422	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.1;pancreas: 16.6;pituitary gland: 13.7"	"Cell type enriched"	"Detected in some"	34	"Enteroendocrine cells: 860.9"	"Cancer enriched"	"Detected in some"	15	"pancreatic cancer: 16.0"	"Region enhanced"	"Detected in many"		"midbrain: 11.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"BEWO: 69.6"	"Region enhanced"	"Detected in some"		"pons and medulla: 4.3"	"Low region specificity"	"Detected in some"			HPA062293	Supported					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA062293: AB_2732680"	"unprognostic (5.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.19e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-1)"		"prognostic favorable (7.62e-4)"	"unprognostic (2.91e-1)"		"unprognostic (1.90e-1)"	"unprognostic (2.19e-1)"			0.3	3.5	0.5	0.0	1.0	0.0	0.0	0.7	0.8	0.0	0.3	2.1	2.8	0.0	0.2	0.2	0.0	0.0	0.1	0.5	0.9	0.2	0.0	0.0	0.0	2.0	11.1	0.0	16.6	1.4	13.7	0.0	5.0	0.8	2.2	0.2	0.1	0.0	0.1	0.2	2.7	0.0	0.4	0.0	4.5	2.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	69.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	10.3	2.5	2.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	1.9	0.1	0.2	0.1	0.1	1.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.7	0.8	0.5	0.9	2.0	11.1	5.0	0.4	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.5	0.4	0.0	0.0	0.0	0.0	0.3	0.0	3.6	0.0	0.0	3.8	0.0	0.0	0.1	860.9	0.0	0.1	1.3	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	25.0	0.0	0.0	0.4	10.0	0.0	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	7.5	17.5	0.0	0.0	1.0	3.9	0.0	0.0	0.9	0.0	0.0	0.0	0.6	4.5	0.0	0.3	0.3	0.1	0.0	1.7	0.0
DALRD3	FLJ10496	ENSG00000178149	"DALR anticodon binding domain containing 3"	Q5D0E6	3	49015488-49022293	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 158.9;Late spermatids: 306.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036862	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA036862: AB_10673507"	"unprognostic (2.76e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.56e-1)"	"prognostic favorable (9.03e-4)"	"unprognostic (3.77e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.33e-2)"	"unprognostic (9.52e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.79e-5)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	11.8	18.5	11.2	6.0	10.9	5.4	14.2	10.6	12.4	14.1	14.5	10.1	7.8	9.8	13.1	18.3	36.9	10.5	10.0	10.8	10.8	21.4	9.0	9.9	9.1	11.5	12.6	15.2	38.7	13.9	14.4	9.6	10.9	10.2	7.9	6.5	11.6	9.5	11.0	18.8	9.6	6.9	12.0	10.8	14.7	51.0	11.2	9.4	19.2	6.9	12.3	10.7	11.5	10.8	12.0	16.6	10.2	20.0	28.5	37.8	12.4	9.9	27.5	16.5	15.8	11.7	14.9	4.9	13.7	27.3	14.3	7.8	13.4	26.1	11.5	7.0	9.1	5.3	13.9	22.0	18.7	15.0	10.5	25.7	26.6	20.9	46.1	42.0	26.0	11.2	4.3	12.0	16.4	20.8	6.6	10.1	16.8	25.3	15.5	3.5	1.5	35.7	44.4	19.0	6.5	21.1	10.9	30.1	23.7	16.8	21.3	16.2	15.9	6.4	9.7	22.6	9.2	37.8	21.9	3.0	24.2	8.3	12.9	12.0	11.1	5.5	13.9	13.7	25.0	23.9	22.4	17.1	11.7	21.1	18.7	12.5	10.9	22.6	12.8	8.1	29.5	12.8	11.2	10.9	10.6	12.4	10.8	10.8	11.5	12.6	10.9	12.0	11.2	10.8	26.8	16.0	12.2	8.5	27.3	25.6	21.6	28.5	22.8	30.2	35.5	40.5	1.2	27.1	20.8	27.6	18.8	28.2	30.0	25.0	37.2	40.7	158.9	61.2	21.5	16.3	19.1	11.1	10.7	39.4	40.0	19.8	28.5	24.6	24.7	32.4	15.0	5.9	19.2	40.4	9.5	22.3	20.3	12.9	24.5	306.6	24.2	16.8	21.4	2.8	23.5	25.8	13.4	6.6	5.5	21.5	21.3	18.4	18.2	10.0	50.4	49.9	75.3	58.4	46.0	19.1	19.0	110.7	33.4	26.5	34.1	18.3	27.1	29.7	30.0	17.3
DAZ2	"MGC126442, pDP1678"	ENSG00000205944	"Deleted in azoospermia 2"	Q13117	Y	23219434-23291356	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"stomach 1: 14.3;testis: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SK-MEL-30: 1.8"									HPA047113	Approved					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA047113: AB_2679936"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	14.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DAZ4		ENSG00000205916	"Deleted in azoospermia 4"	Q86SG3	Y	24833843-24907040	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"stomach 1: 23.7;testis: 11.8"	"Cell type enriched"	"Detected in single"	40	"Gastric mucus-secreting cells: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	124	"U-266/70: 153.6;U-266/84: 153.1"									HPA047113	Approved					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA047113: AB_2679936"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	23.7	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	153.6	153.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DNAJC12	JDP1	ENSG00000108176	"DnaJ heat shock protein family (Hsp40) member C12"	Q9UKB3	10	67796669-67838188	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 70.3;liver: 67.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 75.9;Enteroendocrine cells: 166.2;Hepatocytes: 74.5;Intestinal goblet cells: 98.0;Proximal tubular cells: 163.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 22.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 7.7"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 7.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 91.5;NB-4: 76.0;SCLC-21H: 72.0;U-698: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036289	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA036289: AB_10670794"	"unprognostic (1.52e-2)"	"unprognostic (3.65e-3)"	"unprognostic (4.12e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (6.59e-3)"	"unprognostic (6.35e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.97e-2)"	"unprognostic (7.31e-3)"	"prognostic unfavorable (1.97e-10)"	"unprognostic (7.35e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.81e-3)"	"unprognostic (7.99e-2)"	2.0	70.3	23.3	2.3	26.3	1.5	30.2	36.5	28.5	6.0	12.8	9.1	3.2	7.3	5.9	1.2	3.4	5.4	6.6	26.3	29.1	29.5	67.5	1.6	0.6	22.5	50.1	15.0	37.0	6.6	41.1	0.1	29.0	7.6	14.2	13.6	5.4	4.8	10.9	0.3	4.7	6.0	19.7	1.2	6.6	7.0	23.2	2.1	1.5	9.9	0.7	4.4	3.3	23.4	0.0	32.9	5.3	0.9	7.5	6.1	0.1	0.1	2.0	1.1	6.8	0.5	0.0	91.5	13.4	0.1	0.4	0.0	0.9	1.2	0.3	4.4	36.9	21.9	26.9	8.5	7.9	41.7	0.5	19.3	7.6	3.2	1.9	0.1	11.4	2.6	40.5	1.2	3.2	1.8	2.0	76.0	1.5	0.4	36.4	1.2	3.0	48.2	0.8	0.0	72.0	41.1	0.5	14.4	1.3	0.3	0.7	0.4	0.0	3.5	1.0	0.8	1.0	8.6	1.0	68.2	6.6	49.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.1	0.1	0.3	0.0	0.0	0.0	7.7	0.0	0.0	23.3	26.3	36.5	28.5	26.3	29.1	22.5	50.1	29.0	19.7	23.2	23.4	1.5	0.0	1.1	2.9	2.1	0.3	2.2	1.4	0.6	31.9	75.9	35.6	9.3	1.5	13.0	5.5	6.2	0.1	0.6	7.2	9.8	1.5	5.6	2.2	24.8	2.3	166.2	9.1	12.3	55.9	0.1	8.7	6.1	1.6	0.0	2.0	1.4	74.5	0.6	38.7	14.8	98.0	8.2	2.6	0.4	4.2	16.1	3.1	0.0	1.0	3.7	13.5	0.0	11.6	13.6	43.4	4.1	21.4	0.4	26.3	1.1	163.2	20.3	5.5	0.0	4.6	5.3	2.8	0.7	0.2	0.1	0.0	0.9	21.6	4.4	1.3
DPM2	"MGC111193, MGC21559"	ENSG00000136908	"Dolichyl-phosphate mannosyltransferase subunit 2, regulatory"	O94777	9	127935099-127937854	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 202.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064623	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA064623: AB_2685303"	"unprognostic (8.30e-3)"	"unprognostic (1.07e-2)"	"unprognostic (9.84e-3)"	"prognostic favorable (2.20e-4)"	"unprognostic (3.67e-1)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.62e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.71e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.48e-1)"	21.4	20.6	54.1	19.4	53.2	39.6	27.4	50.5	66.8	31.4	50.0	27.6	23.9	17.9	38.1	25.5	43.1	19.7	16.0	56.0	52.7	22.0	29.7	29.2	24.0	53.2	55.0	20.7	58.6	53.4	12.2	26.9	52.7	24.5	25.7	13.2	50.1	26.8	8.2	29.5	20.1	28.4	50.7	18.5	39.9	15.4	54.2	26.6	38.2	12.0	29.3	25.0	9.6	52.2	49.5	85.5	42.1	57.2	75.1	59.4	40.6	61.3	55.7	63.9	44.2	58.1	79.7	38.8	38.0	90.1	91.8	85.4	47.3	88.1	31.2	71.7	74.5	46.4	98.5	66.1	88.8	75.4	51.1	57.5	78.0	93.5	101.2	44.9	65.8	67.2	106.2	84.9	76.7	161.8	55.8	78.0	79.1	169.7	79.4	43.0	54.6	212.7	79.1	28.8	39.3	95.8	63.8	75.4	53.0	27.3	95.1	48.2	43.5	56.1	43.4	72.0	64.5	93.3	134.4	32.5	113.1	52.8	76.6	52.3	67.8	57.6	86.6	75.7	72.8	99.3	62.1	75.9	77.3	94.3	47.8	61.6	28.1	77.5	73.0	88.5	55.2	60.9	54.1	53.2	50.5	66.8	56.0	52.7	53.2	55.0	52.7	50.7	54.2	52.2	29.9	28.9	42.5	6.5	27.5	27.0	34.1	58.2	18.8	25.3	52.4	57.7	12.4	38.6	42.8	40.5	16.7	86.9	25.1	40.6	45.0	61.2	9.6	28.3	39.9	33.1	32.4	202.7	9.7	59.4	105.8	38.6	44.9	33.5	29.2	31.1	33.9	33.2	83.7	38.7	9.2	53.6	42.7	25.0	22.1	11.6	26.4	30.0	32.0	7.5	49.8	35.0	39.1	6.0	10.0	58.7	36.2	20.3	62.0	64.5	44.5	47.3	24.9	22.1	6.6	16.6	32.5	19.1	22.5	36.8	34.5	65.0	28.5	41.2	43.8	40.7
DPP10	"DPL2, DPPY, DPRP3"	ENSG00000175497	"Dipeptidyl peptidase like 10"	Q8N608	2	114442299-115845780	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 10.7;brain: 20.2;pancreas: 17.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 4634.9;Excitatory neurons: 3067.4;Inhibitory neurons: 3258.7;Oligodendrocyte precursor cells: 990.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.1;HAP1: 6.2;HMC-1: 4.3;JURKAT: 3.4;NTERA-2: 3.7;RT4: 6.7;SCLC-21H: 9.7;SH-SY5Y: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048767	Uncertain					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA048767: AB_2680515"	"unprognostic (1.19e-1)"		"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.29e-1)"		"unprognostic (2.03e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.33e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.22e-2)"	0.2	10.7	12.4	0.3	20.2	0.1	0.0	0.0	16.6	0.3	0.0	2.2	1.2	0.4	0.0	0.0	0.1	0.8	0.1	19.3	0.5	0.2	0.1	0.2	0.0	1.9	3.1	0.0	17.3	0.0	0.8	0.8	2.0	0.0	2.8	4.1	0.2	0.0	0.0	0.1	1.2	0.8	4.5	0.0	1.0	1.0	6.0	0.0	0.6	0.0	0.0	0.3	0.0	11.7	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	6.7	9.7	3.9	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	20.2	0.0	16.6	19.3	0.5	1.9	3.1	2.0	4.5	6.0	11.7	0.0	0.0	0.0	4634.9	0.0	0.0	0.0	0.0	0.6	21.7	0.0	0.0	1.5	4.3	0.6	0.0	0.0	1.5	0.0	2.3	0.0	0.0	12.4	0.1	0.1	0.1	4.2	2.1	3067.4	2.7	10.2	0.5	0.0	0.3	0.0	5.8	0.7	0.0	0.3	5.0	3258.7	1.4	0.0	0.0	0.0	5.7	0.3	0.0	1.8	58.1	0.0	1.4	0.0	990.7	48.3	0.8	1.9	0.0	0.0	0.0	0.2	0.2	0.0	0.7	0.0	0.0	0.1	1.6	2.6	0.3	0.0	4.4	0.0	0.4	3.2	0.0
EDF1	"CFAP280, EDF-1"	ENSG00000107223	"Endothelial differentiation related factor 1"	O60869	9	136862119-136866308	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Activator, Calmodulin-binding, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 2662.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035642	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA035642: AB_10611959"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	305.1	423.1	401.9	234.1	403.4	299.6	315.7	408.4	511.3	359.2	392.1	355.4	494.2	280.8	211.9	462.9	281.6	192.2	519.3	404.5	420.1	430.0	668.7	279.5	273.3	415.5	412.3	394.2	715.5	289.9	395.9	202.8	412.2	430.3	206.9	105.1	497.8	230.7	497.6	407.3	486.4	162.7	401.3	309.8	399.1	179.5	405.5	231.3	396.3	321.6	242.2	286.6	343.4	418.0	496.0	646.9	355.3	361.3	342.6	358.5	693.9	555.9	370.3	438.7	339.8	528.1	335.9	429.6	503.5	484.3	392.3	585.0	277.0	424.5	159.7	467.6	338.4	300.4	784.0	727.5	680.2	518.7	394.9	357.4	533.8	344.9	396.9	408.1	426.7	382.7	443.0	540.6	379.7	1071.4	465.6	818.8	375.6	761.1	548.0	404.2	517.5	875.8	592.2	515.4	450.8	433.3	579.8	807.6	587.1	231.9	781.1	715.8	526.6	477.5	363.8	524.5	528.0	311.5	555.7	366.6	625.8	305.7	448.8	290.4	378.6	327.2	351.6	334.9	388.7	430.9	373.6	364.9	379.2	400.3	328.8	343.7	149.3	396.7	282.8	621.6	471.0	544.4	401.9	403.4	408.4	511.3	404.5	420.1	415.5	412.3	412.2	401.3	405.5	418.0	375.9	227.6	290.8	27.1	357.5	522.1	601.8	717.4	314.1	139.5	530.5	691.1	336.9	480.4	421.8	314.5	39.6	683.0	405.4	1157.4	1154.3	668.1	148.4	266.8	317.2	365.7	443.4	277.0	19.1	1274.9	768.6	332.7	349.7	320.2	291.1	386.5	404.8	822.2	571.2	94.2	20.8	1032.8	376.4	394.7	535.9	292.1	581.6	323.0	526.5	15.9	787.1	352.5	460.3	23.1	39.0	1103.5	1413.9	426.5	409.6	625.2	2662.5	1566.5	314.5	155.6	276.1	389.0	469.0	238.7	237.4	408.3	620.3	1127.5	377.8	364.3	764.7	682.5
ENKD1	"C16orf48, DKFZP434A1319, FBB11"	ENSG00000124074	"Enkurin domain containing 1"	Q9H0I2	16	67662945-67667265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.2;Endometrial ciliated cells: 38.3;Respiratory ciliated cells: 42.5;Spermatocytes: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041163, HPA041478"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Centrosome"	Cytosol	"HPA041163: AB_10794986, HPA041478: AB_10794668"	"unprognostic (6.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.59e-3)"	"prognostic favorable (1.68e-4)"	"unprognostic (4.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	12.8	12.8	8.4	4.6	8.3	3.5	14.9	22.0	11.5	23.2	13.6	28.6	3.9	21.2	5.6	8.6	30.7	3.6	13.2	8.2	8.6	26.6	11.6	14.7	2.2	9.9	10.9	21.2	67.2	16.0	25.6	3.3	8.4	20.6	2.7	8.5	13.7	9.2	9.5	12.1	11.1	4.4	10.0	11.9	15.9	41.1	9.1	4.7	22.3	1.6	2.5	21.5	14.2	8.5	11.1	7.5	17.2	8.0	5.6	5.8	8.5	8.5	5.1	6.7	8.1	5.5	16.5	4.1	14.3	5.3	0.0	12.7	4.5	10.2	8.2	6.5	10.2	4.1	25.7	13.1	9.1	7.4	5.4	5.1	7.3	9.1	8.2	15.4	5.5	13.3	6.9	2.5	3.5	5.7	8.2	30.9	8.2	11.5	3.0	28.5	1.8	31.3	7.2	1.1	17.4	18.9	18.2	1.8	9.7	3.9	15.8	10.5	14.3	8.1	11.4	15.2	0.1	19.1	9.2	4.5	12.3	10.8	2.5	0.0	0.4	0.0	0.1	0.1	0.4	0.2	0.3	0.2	0.1	0.0	0.2	0.3	0.9	0.2	0.2	1.3	0.0	0.1	8.4	8.3	22.0	11.5	8.2	8.6	9.9	10.9	8.4	10.0	9.1	8.5	8.8	22.4	14.4	8.8	1.7	6.9	5.9	6.2	4.0	3.6	10.4	11.2	5.5	10.0	4.0	9.2	4.2	3.1	1.5	4.4	1.9	13.1	34.2	38.3	10.5	8.6	13.2	2.1	2.1	10.7	2.4	7.5	1.5	9.5	1.3	7.4	10.4	26.4	4.7	3.3	2.2	6.0	2.0	3.2	4.3	20.6	13.1	2.6	5.4	0.0	3.0	8.8	0.0	2.5	1.7	9.5	1.4	14.3	2.6	6.0	1.8	7.3	42.5	10.5	6.6	9.1	8.0	37.0	7.9	1.2	5.3	3.4	1.9	11.6	4.9	4.4
ENTPD6	"CD39L2, dJ738P15.3, IL6ST2, NTPDase-6"	ENSG00000197586	"Ectonucleoside triphosphate diphosphohydrolase 6"	O75354	20	25195693-25228075	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 289.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015491, HPA069555"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		41000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA015491: AB_2669200, HPA069555: AB_2686152"	"unprognostic (3.24e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.10e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.48e-2)"	24.8	55.4	54.3	22.8	64.0	15.2	27.7	39.7	65.9	22.9	26.5	61.0	60.0	21.8	18.4	25.3	23.2	26.5	75.9	56.0	49.8	40.4	38.9	25.4	16.1	29.6	32.2	36.2	49.6	23.5	60.0	25.2	45.2	55.7	44.9	15.7	71.2	17.2	38.7	19.4	63.0	18.6	25.7	19.8	47.2	36.3	48.5	29.8	28.8	21.9	13.0	24.5	21.8	38.9	78.8	122.8	32.9	64.0	41.0	50.8	70.8	63.0	45.0	54.0	48.3	65.5	60.0	47.6	91.4	60.9	104.7	100.3	40.1	96.2	35.5	29.2	36.2	38.3	18.2	150.4	60.7	52.7	57.3	47.4	53.1	67.7	51.4	39.4	43.7	46.1	51.5	78.8	40.0	75.6	49.2	32.6	20.8	63.9	96.0	27.1	102.9	108.4	67.8	46.3	52.0	26.7	17.7	105.1	289.4	29.6	75.3	43.4	48.6	61.9	63.7	51.6	75.7	50.5	43.8	21.0	44.5	34.1	116.3	0.1	25.2	4.9	18.8	17.0	25.6	8.7	16.5	15.0	26.4	11.0	16.9	15.5	1.1	14.1	7.6	18.5	17.2	22.1	54.3	64.0	39.7	65.9	56.0	49.8	29.6	32.2	45.2	25.7	48.5	38.9	6.4	19.2	28.5	12.4	9.9	9.8	16.2	23.6	6.2	19.2	25.8	21.8	5.8	25.8	14.8	18.4	10.4	63.2	11.0	81.4	9.8	42.5	22.1	10.5	7.6	7.6	34.0	4.2	18.6	40.1	21.7	12.8	52.5	15.4	3.8	65.2	14.3	15.0	26.7	25.2	19.4	57.5	26.4	17.7	17.4	65.2	20.5	17.6	10.6	11.2	16.0	4.2	10.3	13.0	9.2	33.8	59.8	42.2	16.5	27.9	68.4	13.5	10.7	9.1	6.6	6.3	9.6	3.0	8.8	8.6	6.0	59.8	12.0	25.8	72.6	12.1
EXOSC1	"CGI-108, CSL4, Csl4p, hCsl4p, p13, SKI4, Ski4p"	ENSG00000171311	"Exosome component 1"	Q9Y3B2	10	97435909-97446017	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038370	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"	Nucleoplasm	"HPA038370: AB_10672515"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.88e-9)"	"unprognostic (9.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.41e-2)"	21.9	25.4	31.4	23.5	34.3	28.7	22.4	50.4	39.9	25.5	27.7	25.6	24.3	24.0	42.6	28.4	22.2	17.0	23.5	29.7	33.6	25.3	26.9	20.5	32.3	33.3	32.2	23.6	38.8	21.1	24.2	17.6	32.6	24.5	23.5	21.2	26.6	17.3	29.0	23.5	22.3	22.1	32.6	30.3	31.2	15.2	32.8	32.5	21.6	14.8	31.9	25.3	22.9	36.3	62.9	49.6	34.8	61.7	42.1	44.3	47.0	52.2	73.9	57.2	64.4	86.5	62.1	60.4	59.0	50.2	44.1	64.0	52.5	58.9	56.6	77.3	61.3	39.5	48.0	68.9	74.5	94.2	46.1	45.8	77.9	69.6	101.3	70.2	66.3	90.5	45.6	108.0	43.2	70.3	88.0	153.3	58.1	64.7	43.2	65.8	43.4	106.4	39.4	32.8	20.4	38.3	38.6	30.0	87.6	44.1	71.2	113.2	43.6	31.9	40.1	50.4	117.6	72.5	103.1	119.5	54.3	113.2	26.3	79.0	91.0	93.5	75.5	132.8	96.5	109.6	93.1	87.9	96.4	94.7	89.4	78.1	35.7	57.9	121.7	82.9	144.0	86.4	31.4	34.3	50.4	39.9	29.7	33.6	33.3	32.2	32.6	32.6	32.8	36.3	22.5	25.6	24.6	15.0	42.4	19.1	35.7	59.3	18.2	31.0	22.5	27.3	20.5	27.1	35.8	44.1	27.1	48.6	41.2	15.4	39.2	36.0	17.4	22.6	24.1	27.7	14.3	23.8	24.7	41.8	58.1	27.0	21.9	16.7	25.3	31.0	34.6	25.3	50.9	30.3	22.2	28.1	36.7	31.4	20.7	17.0	32.6	28.7	30.2	17.8	61.0	29.1	61.8	12.1	25.5	35.9	20.0	24.0	43.6	24.9	30.1	53.8	47.1	48.1	26.3	20.7	35.2	35.8	39.1	27.6	24.4	41.2	44.3	26.4	25.7	31.7
FAM189A1	"KIAA0574, TMEM228"	ENSG00000104059	"Family with sequence similarity 189 member A1"	O60320	15	29120254-29570723	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 5.3;thyroid gland: 3.2"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 202.9;Inhibitory neurons: 198.0;Oligodendrocyte precursor cells: 59.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.6;HDLM-2: 12.0;REH: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009410, HPA010637"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA009410: AB_1852332, HPA010637: AB_1852333"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.12e-1)"	0.6	0.4	2.2	0.0	1.8	0.0	0.1	0.0	2.4	0.3	0.3	2.6	0.1	0.2	0.0	0.0	1.0	0.0	0.8	2.5	0.4	2.1	0.1	1.1	0.0	0.2	0.3	0.2	5.3	0.4	0.4	0.0	0.2	0.4	0.5	0.1	0.6	0.0	0.0	0.1	0.9	0.0	0.0	0.2	0.4	2.0	1.2	0.0	3.2	0.0	0.1	0.9	0.2	0.8	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.2	0.0	0.0	0.0	0.1	12.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	1.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.8	0.0	2.4	2.5	0.4	0.2	0.3	0.2	0.0	1.2	0.8	0.5	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	4.3	0.8	0.0	0.0	0.4	3.0	0.0	202.9	0.2	0.0	0.7	0.0	0.1	0.0	0.3	0.7	0.0	0.1	0.0	198.0	2.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	29.0	0.0	0.2	0.0	59.8	8.1	0.2	2.6	1.5	0.0	1.0	2.2	0.8	0.0	0.4	0.0	0.0	0.2	0.6	1.7	0.0	0.0	0.0	0.0	1.0	3.2	0.4
FAM221A	"C7orf46, DKFZp686F0810, FLJ45875, MGC72075"	ENSG00000188732	"Family with sequence similarity 221 member A"	A4D161	7	23680130-23703249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 69.2;Respiratory ciliated cells: 51.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 19.3;GAMG: 26.5;MOLT-4: 27.4;SCLC-21H: 23.4;SH-SY5Y: 41.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA019719, HPA026748, HPA026752"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA019719: AB_1853910, HPA026748: AB_1853911, HPA026752: AB_1853912"	"unprognostic (1.28e-1)"	"unprognostic (7.28e-3)"	"unprognostic (6.03e-3)"	"unprognostic (2.54e-1)"	"unprognostic (3.33e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.42e-2)"	"unprognostic (9.30e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.81e-2)"	5.5	3.6	14.9	3.2	17.2	1.7	4.3	18.2	24.4	3.5	15.4	6.5	9.9	2.5	3.4	7.2	9.3	3.4	4.1	14.2	15.7	6.4	9.7	4.7	3.8	17.3	16.1	3.8	20.4	2.7	5.3	1.6	18.1	4.8	8.5	4.8	7.5	2.4	2.6	3.9	7.3	1.9	16.7	2.6	11.9	19.7	16.2	7.7	6.0	4.3	4.9	4.9	4.1	23.8	0.0	1.0	11.1	8.9	0.4	0.0	5.4	0.6	0.8	1.4	1.6	11.6	5.5	1.5	19.3	0.3	26.5	2.4	0.0	0.1	2.2	0.0	15.3	3.3	1.1	0.0	3.0	0.0	17.3	0.7	0.7	0.2	0.1	2.4	3.4	11.7	0.0	0.0	0.4	5.5	27.4	0.0	0.0	0.0	5.8	10.8	1.1	0.0	5.8	5.4	23.4	41.3	1.9	0.0	0.0	2.6	5.6	8.0	0.5	0.1	4.2	2.4	1.1	0.1	0.1	0.0	1.1	0.0	2.0	0.0	3.1	4.2	5.1	2.0	10.7	6.6	8.6	6.4	5.4	6.8	9.8	5.5	0.1	7.8	6.0	4.7	12.2	3.3	14.9	17.2	18.2	24.4	14.2	15.7	17.3	16.1	18.1	16.7	16.2	23.8	7.2	16.0	7.2	13.4	7.2	16.2	9.5	10.0	14.8	6.9	17.8	7.7	5.5	20.0	20.0	7.3	2.1	3.5	5.3	8.2	9.8	15.4	8.5	24.7	2.0	6.9	14.9	3.8	13.7	10.6	0.3	12.3	36.7	11.2	5.1	10.2	6.1	16.0	6.7	6.7	16.3	25.7	18.3	4.1	10.8	10.4	4.7	6.1	8.8	12.2	2.1	8.5	2.1	11.6	69.2	11.5	25.2	3.8	7.1	11.7	15.2	12.3	51.6	8.0	19.7	8.5	5.3	45.2	27.6	14.6	18.9	0.8	7.6	4.4	22.5	11.8
FARP1	"CDEP, MGC87400, PLEKHC2, PPP1R75"	ENSG00000152767	"FERM, ARH/RhoGEF and pleckstrin domain protein 1"	Q9Y4F1	13	98142562-98455176	"Predicted intracellular proteins"		"Developmental protein, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 191.3;Early spermatids: 207.8;Inhibitory neurons: 176.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 125.3;Hep G2: 130.5;SuSa: 110.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000760			Approved	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol		"HPA000760: AB_1078816"	"unprognostic (4.78e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.73e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (1.39e-5)"	"unprognostic (4.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.18e-2)"	17.9	35.3	40.7	10.1	43.9	1.5	24.4	24.9	40.8	26.4	18.7	41.8	8.0	19.8	23.7	8.9	18.4	18.5	13.7	42.5	37.9	68.7	67.8	32.8	6.9	35.5	35.3	16.2	45.0	14.2	23.1	28.2	30.2	41.2	12.6	8.9	37.2	25.7	19.7	14.0	13.6	23.4	35.6	13.0	32.9	14.0	38.9	3.3	43.9	15.1	3.7	27.0	16.1	28.6	0.7	10.7	47.1	66.7	13.3	26.0	22.7	72.0	46.9	39.8	34.8	83.9	31.9	0.2	27.0	125.3	9.8	1.5	20.1	19.9	66.4	1.3	20.5	0.4	38.9	130.5	35.3	0.3	0.6	30.6	8.9	11.6	2.6	23.0	26.5	1.0	0.1	0.7	27.8	18.6	2.8	0.4	22.5	40.7	12.5	25.4	18.3	1.4	88.0	46.8	20.0	43.5	8.8	18.9	51.0	110.8	26.9	0.1	25.6	42.8	16.1	29.2	37.0	0.7	0.7	0.5	19.9	1.4	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.7	43.9	24.9	40.8	42.5	37.9	35.5	35.3	30.2	35.6	38.9	28.6	37.3	44.8	24.8	191.3	2.6	6.9	60.2	8.8	15.4	13.9	73.3	40.8	8.4	123.0	27.5	57.0	45.9	6.7	4.0	10.9	80.3	47.5	207.8	70.3	90.5	23.9	31.1	2.7	75.3	35.1	6.4	29.9	23.4	100.7	13.3	44.5	23.2	58.4	53.5	30.3	176.4	10.1	24.4	22.7	9.3	125.9	19.0	14.0	28.4	44.0	17.5	29.6	2.1	104.5	3.7	47.0	4.4	29.3	3.1	56.8	0.3	139.6	38.6	15.7	19.7	18.7	55.4	9.2	15.9	3.2	2.8	4.5	6.4	60.4	12.6	47.2
FBXO25	FBX25	ENSG00000147364	"F-box protein 25"	Q8TCJ0	8	406428-477967	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 97.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 625.7;Late spermatids: 312.5;Spermatocytes: 640.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 58.7;SK-MEL-30: 61.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (1.63e-1)"	"prognostic favorable (5.38e-5)"	"unprognostic (2.74e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.41e-1)"	14.4	20.4	9.3	7.6	9.4	9.1	13.8	13.4	11.8	9.1	8.3	16.6	15.4	8.4	16.8	10.0	8.6	9.3	15.3	8.8	9.2	15.8	30.0	10.4	12.0	8.8	10.2	8.8	28.6	14.2	12.1	6.8	9.1	24.9	18.7	7.2	16.3	10.5	18.3	12.4	11.1	11.0	8.4	8.1	15.1	97.8	8.6	20.7	18.6	19.7	12.1	11.3	9.0	11.4	13.4	10.6	4.5	8.8	6.9	4.4	18.6	12.6	18.5	11.8	18.1	6.0	12.7	0.3	3.4	19.4	17.8	8.5	8.7	24.5	16.1	10.0	14.5	7.1	6.3	28.3	20.5	11.4	13.7	12.7	37.6	3.6	18.7	17.9	5.0	58.7	8.4	0.1	13.9	12.8	50.8	13.6	2.1	29.0	4.6	2.4	3.4	18.1	15.4	22.5	13.7	14.4	12.7	4.2	61.5	11.2	9.0	8.1	7.5	4.8	4.1	0.8	10.1	9.2	14.4	13.6	13.0	4.7	14.7	1.6	9.1	6.6	9.0	10.8	11.1	16.2	10.7	8.5	9.1	10.9	9.5	9.4	0.7	9.9	9.9	9.0	12.5	6.9	9.3	9.4	13.4	11.8	8.8	9.2	8.8	10.2	9.1	8.4	8.6	11.4	21.3	19.2	28.5	15.3	24.2	34.8	19.6	28.0	19.9	31.8	35.9	21.7	36.6	42.9	20.4	35.0	10.4	20.0	26.8	30.4	72.4	53.3	625.7	20.0	17.8	25.7	43.3	12.6	20.5	102.6	18.9	18.2	16.3	27.4	20.3	15.4	28.2	77.0	25.4	53.8	20.0	58.2	42.7	32.7	24.2	312.5	38.8	17.4	39.2	11.2	36.2	22.1	38.1	8.5	28.3	51.5	41.2	29.3	21.4	39.1	34.9	58.3	13.2	36.3	26.3	17.8	16.2	640.9	142.1	17.4	40.5	16.1	19.5	14.4	47.2	21.8
FGFRL1		ENSG00000127418	"Fibroblast growth factor receptor like 1"	Q8N441	4	1009936-1026898	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.0;Granulosa cells: 30.9;Hepatocytes: 37.5;Muller glia cells: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.1;non-classical monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026019, HPA068828"	Approved		Supported	Vesicles		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"CAB026019: , HPA068828: AB_2686043"	"unprognostic (1.30e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.87e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.49e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.96e-2)"	38.1	56.0	40.8	5.0	43.3	7.6	24.1	40.6	49.5	15.7	29.8	10.2	7.3	9.9	3.4	5.5	36.0	9.3	19.8	39.2	33.5	25.4	52.8	15.1	3.1	49.9	45.8	25.4	71.6	16.1	21.6	3.0	46.5	12.4	4.9	10.5	37.6	2.7	20.6	10.7	13.5	4.0	42.2	9.1	27.2	5.5	47.9	1.4	67.1	9.6	2.2	11.2	8.0	42.1	23.2	31.6	11.3	34.3	11.9	12.3	2.9	40.4	6.2	12.9	8.4	23.1	47.9	2.6	49.3	63.3	58.3	5.8	21.8	14.1	11.8	8.3	21.0	0.3	41.2	61.5	24.0	13.7	5.6	25.7	11.7	22.4	9.5	48.4	12.5	9.3	25.3	8.9	7.9	30.8	16.0	37.7	14.2	39.7	83.8	24.7	16.3	16.7	22.6	3.6	1.2	2.2	38.1	0.8	15.2	13.4	22.5	11.9	26.1	68.8	27.2	35.2	99.8	8.9	12.9	3.8	18.1	15.6	22.8	0.6	0.0	0.0	0.2	1.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.1	40.8	43.3	40.6	49.5	39.2	33.5	49.9	45.8	46.5	42.2	47.9	42.1	3.8	3.2	4.1	34.0	2.8	6.5	3.7	5.4	2.2	5.4	13.2	6.1	8.5	11.5	6.9	7.3	0.0	1.6	4.1	4.4	0.0	9.6	0.2	6.0	4.2	2.6	1.8	4.8	3.2	10.2	26.6	5.1	6.6	13.5	1.3	30.9	5.3	37.5	3.2	0.0	2.8	11.0	0.0	1.6	2.5	1.2	4.4	3.4	7.2	1.9	1.3	94.0	1.0	5.0	5.4	19.9	2.7	3.4	2.2	11.4	2.9	7.6	7.0	5.6	0.0	3.3	5.1	0.4	4.2	1.2	4.7	1.5	4.2	17.5	3.6	8.8
FUT9	Fuc-TIX	ENSG00000172461	"Fucosyltransferase 9"	Q9Y231	6	96015974-96215612	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 18.9;stomach 1: 23.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 776.4;Excitatory neurons: 333.5;Inhibitory neurons: 238.2;Oligodendrocyte precursor cells: 168.9;Oligodendrocytes: 224.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.9;OE19: 2.8;RT4: 6.5;SCLC-21H: 6.3;SK-BR-3: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070923			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	No				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA070923: AB_2686323"	"unprognostic (1.60e-1)"	"unprognostic (2.48e-1)"		"unprognostic (5.99e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.97e-1)"		"unprognostic (1.35e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	0.0	0.4	10.5	0.0	12.6	0.0	0.6	14.5	11.7	0.0	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	11.8	13.6	0.2	0.0	0.0	0.0	3.4	18.9	0.0	4.8	0.0	0.4	0.4	3.2	0.2	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	5.5	0.0	23.2	0.0	15.3	0.0	0.1	0.0	0.0	0.9	0.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	1.4	2.8	0.0	0.0	0.0	0.0	0.0	6.5	6.3	0.1	0.0	3.6	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	12.6	14.5	11.7	11.8	13.6	3.4	18.9	3.2	5.5	15.3	6.4	0.0	0.0	0.0	776.4	0.2	0.0	0.6	0.0	0.0	4.2	1.4	1.7	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.5	0.1	1.3	0.0	0.0	333.5	2.0	0.0	0.1	56.1	1.4	0.0	0.4	0.0	0.0	0.1	0.0	238.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.2	0.0	168.9	224.7	0.5	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.2
GAREM1	"C18orf11, FAM59A, FLJ21610, GAREM"	ENSG00000141441	"GRB2 associated regulator of MAPK1 subtype 1"	Q9H706	18	32124877-32470882	"Predicted intracellular proteins"		Mitogen		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 29.9"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 54.7;Urothelial cells: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 15.5;hTERT-HME1: 20.7;RT4: 19.6;SH-SY5Y: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040709, HPA042046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA040709: AB_2677090, HPA042046: AB_2677818"	"unprognostic (9.52e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (6.73e-5)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.49e-6)"	"unprognostic (2.36e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	5.0	6.0	5.1	1.8	7.0	7.2	4.5	7.5	7.2	4.2	0.3	4.8	4.4	2.3	2.1	8.2	2.7	2.9	5.1	9.5	7.1	11.2	6.7	3.2	0.6	9.8	6.5	2.7	29.9	0.6	3.3	2.8	8.5	3.0	3.7	6.2	7.9	2.9	5.9	11.0	4.2	2.2	7.6	2.0	8.5	3.4	6.7	0.4	2.0	2.8	1.7	7.2	7.4	11.7	1.2	1.8	1.8	0.4	4.9	4.0	4.5	0.5	0.0	0.0	0.0	0.4	2.7	3.4	2.6	0.1	2.0	4.0	2.7	5.0	0.0	1.0	1.9	0.0	3.8	1.3	3.0	0.3	0.3	4.4	15.5	0.2	20.7	0.2	0.2	2.0	0.2	0.9	2.2	2.8	1.0	0.2	2.0	9.9	1.0	1.2	7.4	5.6	8.0	19.6	6.3	18.0	4.1	6.5	0.1	2.3	0.9	3.4	0.2	1.3	1.3	0.0	0.6	2.3	0.4	0.9	2.3	0.0	1.5	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.6	0.3	0.5	1.0	1.1	0.0	1.9	0.0	0.0	5.1	7.0	7.5	7.2	9.5	7.1	9.8	6.5	8.5	7.6	6.7	11.7	11.9	9.6	42.6	0.0	0.2	0.0	37.6	0.0	3.4	34.2	6.9	5.1	0.0	11.5	8.6	25.8	4.2	20.4	0.0	10.7	1.9	11.8	14.8	19.8	8.7	2.0	3.6	0.0	0.0	13.3	2.6	14.3	27.0	41.7	3.8	0.9	0.4	8.8	1.7	42.1	0.0	8.4	0.0	4.0	0.0	3.4	1.8	1.9	0.0	0.0	0.6	34.9	0.0	0.0	0.0	9.3	5.7	5.3	0.5	54.7	19.8	23.4	4.4	7.4	0.0	29.8	6.5	3.9	7.5	13.7	0.0	33.5	0.9	1.7	7.6	114.2
GATC	"15E1.2, FLJ37000"	ENSG00000257218	"Glutamyl-tRNA amidotransferase subunit C"	O43716	12	120446444-120463749	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"				"unprognostic (2.10e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.46e-2)"	"prognostic unfavorable (4.21e-5)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.92e-2)"	10.0	10.3	11.6	8.4	13.2	7.5	12.0	15.2	15.1	11.1	10.2	10.2	11.7	8.3	10.9	8.7	7.7	7.3	6.6	12.1	12.6	15.3	16.4	8.6	10.2	13.2	12.9	9.9	37.8	13.0	7.9	9.2	13.6	8.6	10.7	12.8	10.5	7.9	8.5	9.5	10.2	7.7	12.8	9.2	9.6	4.6	13.1	11.9	11.6	8.0	11.8	10.0	8.3	15.8	12.7	40.7	19.4	22.6	23.4	23.1	13.8	16.1	15.0	17.5	12.9	37.9	9.3	25.2	17.6	14.7	15.5	20.4	30.7	17.6	17.1	19.4	28.7	24.1	25.3	25.4	25.8	23.4	13.6	21.7	18.8	13.7	24.4	24.0	24.8	23.4	33.3	12.9	17.9	20.0	26.3	25.8	12.3	19.0	25.7	17.6	22.5	33.9	20.7	21.5	35.7	17.3	28.8	15.1	21.0	15.3	26.8	12.9	21.9	14.6	13.5	19.8	12.6	18.4	32.6	32.5	19.8	14.5	23.5	7.0	5.3	4.0	6.1	3.6	5.9	6.2	4.7	3.6	3.9	5.9	4.3	5.0	3.7	4.7	5.5	6.2	5.4	5.4	11.6	13.2	15.2	15.1	12.1	12.6	13.2	12.9	13.6	12.8	13.1	15.8	14.8	3.2	19.1	11.4	13.0	9.4	20.6	4.4	16.5	17.6	13.4	12.4	6.2	18.6	13.8	18.4	16.7	13.3	16.4	18.3	11.7	17.8	3.2	14.6	19.5	17.2	27.0	10.1	14.0	24.4	12.3	12.5	11.2	18.2	24.1	17.6	18.5	22.8	11.3	18.5	12.8	15.5	6.1	14.9	4.2	1.9	14.6	14.6	3.6	4.7	18.5	12.0	11.3	13.6	13.6	29.4	14.1	20.3	13.9	25.8	19.8	22.4	7.5	14.1	6.6	20.0	12.0	11.7	8.0	15.3	9.9	14.9	12.6	11.7	19.3	22.0
GCAT	KBL	ENSG00000100116	"Glycine C-acetyltransferase"	O75600	22	37807905-37817176	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 140.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 80.3;Hepatocytes: 66.1;Proximal tubular cells: 163.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020460, HPA063924"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Mitochondria"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 22: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA020460: AB_1849548, HPA063924: "	"unprognostic (1.61e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.73e-3)"	"unprognostic (3.99e-1)"	6.6	15.7	25.1	3.2	24.8	14.1	6.5	26.2	33.3	6.3	22.5	7.3	4.9	7.8	3.0	17.0	6.0	5.0	43.4	26.1	25.0	13.0	53.3	5.6	2.8	25.9	27.4	9.0	140.2	6.0	9.7	2.7	27.8	22.8	4.9	2.2	13.3	6.8	19.5	8.1	5.4	4.2	24.4	1.5	13.2	10.3	27.9	4.3	16.0	19.1	3.1	7.1	7.0	24.6	18.7	4.7	11.9	68.2	24.0	19.4	8.4	25.9	26.9	19.2	16.3	10.5	2.1	5.8	11.8	11.7	11.3	10.6	11.9	18.3	4.3	2.6	21.9	12.9	15.0	42.5	39.0	23.0	16.4	22.8	10.9	12.7	27.7	6.2	16.0	23.0	33.2	6.6	9.2	16.2	24.3	42.3	5.0	28.8	19.0	25.2	2.5	34.4	24.6	14.3	24.5	16.7	20.0	32.3	13.9	4.2	25.8	11.1	11.8	19.3	10.6	12.9	9.2	21.9	11.5	12.1	13.3	21.1	20.5	0.1	0.6	0.4	0.7	0.7	0.3	0.1	1.6	0.5	1.3	0.0	3.5	1.4	0.3	1.3	0.4	1.3	1.7	1.4	25.1	24.8	26.2	33.3	26.1	25.0	25.9	27.4	27.8	24.4	27.9	24.6	3.5	6.4	15.4	9.8	2.8	7.8	18.5	11.2	12.5	8.9	18.6	17.4	54.6	11.5	9.4	11.0	4.2	15.7	0.7	13.1	80.3	7.2	4.1	9.9	8.1	5.5	2.4	22.7	5.0	10.3	19.6	9.8	15.3	16.7	8.9	17.6	5.0	66.1	4.7	8.4	4.7	32.3	8.2	2.9	1.3	7.7	3.7	2.1	21.4	1.0	1.0	25.1	1.0	6.6	4.1	5.4	8.7	9.8	2.0	19.1	8.6	163.8	6.4	2.2	6.6	4.8	30.1	12.6	33.2	19.6	6.0	27.8	3.0	27.8	24.0	14.4
GLP1R	GLP-1R	ENSG00000112164	"Glucagon like peptide 1 receptor"	P43220	6	39048781-39091303	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7;heart muscle: 2.7;pancreas: 7.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.2;Early spermatids: 1.0;Inhibitory neurons: 1.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.1;SCLC-21H: 2.7"	"Region enriched"	"Detected in many"	4	"basal ganglia: 20.7"	"Low region specificity"	"Detected in some"									NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (4.06e-3)"			"unprognostic (5.38e-6)"	"unprognostic (1.80e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.76e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.42e-2)"	0.1	0.0	0.4	0.0	0.9	0.0	0.6	0.3	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.7	0.6	3.7	0.1	0.0	0.3	0.1	1.1	0.5	0.0	7.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.9	0.2	1.6	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.3	0.5	0.6	3.7	1.1	0.5	1.2	1.1	1.6	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR150	PGR11	ENSG00000178015	"G protein-coupled receptor 150"	Q8NGU9	5	95620087-95622142	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.7;pancreas: 6.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.0;Extravillous trophoblasts: 5.3;granulocytes: 5.7;Hofbauer cells: 3.5;NK-cells: 2.1;Spermatocytes: 2.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.4;SiHa: 1.2;TIME: 2.7"					"Low region specificity"	"Detected in some"			HPA026635	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA026635: AB_1849266"	"unprognostic (3.03e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.95e-2)"	"unprognostic (5.34e-4)"	"unprognostic (1.98e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.26e-1)"	0.9	0.1	1.9	0.0	2.7	0.0	0.7	0.0	2.6	0.3	0.0	0.3	0.1	0.2	0.1	0.1	0.3	0.1	0.1	2.5	0.8	0.0	0.1	0.3	0.3	0.0	0.0	0.0	6.9	1.2	0.6	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.2	0.6	0.3	0.0	0.0	0.4	1.6	0.2	2.2	0.1	0.1	0.0	0.1	0.3	0.2	1.8	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.8	0.5	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.5	1.2	0.0	0.3	0.0	0.0	0.4	2.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	2.7	0.0	2.6	2.5	0.8	0.0	0.0	0.0	0.0	2.2	1.8	0.5	0.0	0.6	0.0	0.9	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	4.0	0.1	0.1	0.2	0.0	0.4	0.0	0.2	5.3	0.9	0.0	0.0	5.7	0.0	0.4	0.5	3.5	0.0	0.0	0.3	0.0	0.3	0.3	1.1	0.0	0.9	0.0	0.0	0.7	0.0	2.1	0.0	0.0	0.2	0.7	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.3	2.5	0.5	0.1	0.3	0.0	1.4	0.0	0.8	0.1
GSTO2		ENSG00000065621	"Glutathione S-transferase omega 2"	Q9H4Y5	10	104268873-104304950	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 133.1;Early spermatids: 314.6;Late spermatids: 442.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 16.9;CAPAN-2: 17.1;hTCEpi: 16.2;hTERT-HME1: 18.3;OE19: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA048141	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"			"HPA048141: AB_2680281"	"unprognostic (5.77e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.10e-7)"	"unprognostic (4.56e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.47e-1)"	0.5	3.5	5.0	0.3	5.7	2.0	5.2	3.4	5.3	4.3	0.4	4.4	2.8	2.2	4.9	11.8	4.3	1.2	0.6	4.4	4.1	14.0	2.8	2.4	0.3	2.2	2.5	5.4	16.7	5.0	14.6	1.0	2.6	8.3	3.1	6.0	7.5	3.2	1.4	14.8	3.5	1.2	1.1	0.5	10.9	35.9	4.3	2.2	7.0	1.3	0.7	3.8	7.5	5.3	10.2	1.4	0.5	0.6	0.6	1.3	1.4	9.6	16.9	4.7	4.9	0.6	17.1	1.6	4.0	0.8	0.5	10.7	0.5	5.3	1.2	1.1	3.2	0.5	3.1	2.4	2.1	0.7	0.7	1.7	16.2	0.3	18.3	1.3	0.8	1.7	1.5	2.9	1.3	12.3	0.1	0.5	1.7	22.1	1.1	0.5	0.7	0.3	4.6	6.5	0.6	1.1	3.3	2.4	2.9	0.8	12.6	0.3	2.4	1.5	5.1	0.6	0.5	2.8	6.4	0.4	1.5	0.8	0.5	0.2	0.1	0.7	0.5	0.2	0.3	0.3	0.5	0.3	0.0	0.5	0.7	0.4	1.7	1.0	0.1	0.3	1.2	0.2	5.0	5.7	3.4	5.3	4.4	4.1	2.2	2.5	2.6	1.1	4.3	5.3	3.6	3.2	21.0	13.1	1.3	34.2	62.1	94.5	50.1	19.0	61.7	78.2	3.0	21.5	46.4	40.5	16.7	14.4	3.8	12.8	133.1	30.6	314.6	26.9	7.6	5.4	54.2	3.6	33.9	63.3	9.9	4.7	31.6	37.6	2.5	3.3	15.7	3.6	1.8	0.0	28.7	34.0	50.8	1.6	3.7	442.8	2.8	2.7	17.8	1.9	2.1	11.1	1.0	24.1	20.1	31.6	29.1	9.8	0.9	25.6	27.1	43.8	31.2	23.0	6.6	3.1	7.4	22.0	8.9	46.0	47.3	6.7	4.3	11.6	40.7	58.0
GTF2E2	"FE, TF2E2, TFIIE-B"	ENSG00000197265	"General transcription factor IIE subunit 2"	P29084	8	30578318-30658236	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004816, CAB009603, HPA025065"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB009603: AB_2114537, HPA004816: AB_2667252, HPA025065: AB_10601658"	"unprognostic (4.84e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (9.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.38e-1)"	"unprognostic (6.05e-3)"	"unprognostic (8.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (5.82e-7)"	"unprognostic (8.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.24e-1)"	24.5	29.1	14.9	17.8	16.1	9.4	19.9	19.9	19.3	25.1	16.9	20.9	19.5	19.4	17.2	26.4	16.4	13.2	16.2	15.9	17.3	21.4	28.1	17.8	25.9	14.8	15.1	30.3	51.8	15.4	20.1	16.8	15.0	18.7	16.0	11.6	15.9	14.6	13.4	20.6	17.5	18.5	14.7	20.4	24.4	32.7	16.5	22.4	17.4	11.0	26.6	24.1	24.1	15.8	53.7	43.7	29.2	31.2	77.4	68.2	22.0	57.7	52.4	46.5	58.6	26.2	38.2	70.0	48.0	51.9	67.0	37.8	49.1	53.8	61.5	31.8	28.2	34.9	28.9	63.0	75.4	17.1	29.5	50.6	70.7	49.7	50.7	46.3	65.3	51.2	68.7	42.1	74.5	37.3	83.7	42.9	33.1	66.0	51.9	43.2	31.6	35.4	50.9	36.7	22.4	29.1	32.1	21.5	46.5	38.3	20.8	20.9	49.9	30.6	31.4	25.9	39.8	42.6	62.7	77.0	48.2	28.8	41.3	4.3	4.2	6.4	3.6	3.5	4.1	18.8	5.7	7.6	7.3	11.7	5.6	5.5	2.2	9.7	3.7	8.2	7.0	2.8	14.9	16.1	19.9	19.3	15.9	17.3	14.8	15.1	15.0	14.7	16.5	15.8	20.2	0.0	8.4	16.6	48.7	47.9	48.1	44.3	48.3	9.2	19.1	17.5	9.9	17.2	28.2	14.7	10.4	43.0	32.3	26.5	19.6	31.5	96.7	42.2	33.8	22.9	13.2	14.1	30.2	33.1	51.4	30.0	31.1	29.0	11.4	17.7	26.4	27.0	34.1	5.0	30.1	24.2	22.4	21.6	39.3	58.9	39.4	28.4	21.4	13.1	58.8	9.0	46.4	17.1	21.8	43.3	23.4	70.7	35.9	72.7	46.5	48.2	40.0	14.9	26.3	17.5	28.0	74.3	87.9	38.3	46.5	62.1	36.9	26.1	24.5	91.8
HDDC3	"MESH1, MGC45386"	ENSG00000184508	"HD domain containing 3"	Q8N4P3	15	90929968-90935196	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040895	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA040895: AB_10795494"	"unprognostic (1.03e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.65e-1)"	13.0	13.1	15.5	7.9	15.1	10.4	9.2	15.0	20.0	6.5	13.9	11.2	10.3	4.3	8.2	5.9	10.4	4.6	13.3	15.1	14.8	12.1	11.4	6.4	8.2	15.1	14.8	6.5	20.0	15.7	8.0	7.0	14.7	7.0	9.1	7.1	20.7	5.8	13.3	7.7	11.9	3.9	15.3	9.3	9.7	4.5	16.1	7.4	9.8	14.6	9.2	5.5	5.5	15.7	12.7	15.7	5.3	6.4	11.8	11.8	9.0	8.5	11.4	7.7	11.5	7.7	25.5	24.2	8.5	7.0	6.1	19.3	11.1	19.3	6.3	30.4	24.4	30.5	6.0	17.7	23.9	11.6	14.1	10.5	30.1	13.9	24.8	12.2	17.0	19.5	24.6	20.7	6.9	19.1	16.1	10.0	4.3	47.2	15.6	13.2	2.1	38.2	15.8	13.2	13.3	8.5	7.1	19.2	21.4	11.0	29.2	30.5	9.8	4.7	10.5	8.1	10.9	33.5	41.4	16.7	17.5	22.4	14.3	10.1	20.1	8.5	23.3	27.4	30.1	35.1	30.0	26.3	27.4	31.4	34.6	25.5	4.7	31.5	26.7	44.0	31.9	25.6	15.5	15.1	15.0	20.0	15.1	14.8	15.1	14.8	14.7	15.3	16.1	15.7	42.8	28.9	7.4	5.9	23.5	5.6	14.1	22.5	6.8	13.8	27.8	30.1	1.1	44.3	21.6	16.5	4.2	48.2	19.1	18.1	76.3	42.3	4.6	18.8	12.4	19.0	19.9	34.3	4.8	56.5	33.0	12.7	13.7	18.6	7.0	14.3	15.7	41.4	45.9	15.2	5.2	32.9	12.2	15.1	10.9	4.3	14.3	19.6	14.2	1.9	36.3	39.9	34.0	1.0	3.9	28.4	30.2	11.7	31.7	14.7	59.7	71.5	20.6	38.8	6.6	13.2	11.5	29.6	38.4	17.2	8.4	24.2	21.4	21.7	33.0	13.5
HID1	"C17orf28, DMC1, HID-1"	ENSG00000167861	"HID1 domain containing"	Q8IV36	17	74950742-74973166	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 111.2"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 71.4;Intestinal goblet cells: 89.5;Paneth cells: 87.8;Proximal enterocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 115.9;OE19: 99.2;SH-SY5Y: 56.7;SK-BR-3: 172.6;T-47d: 101.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031406	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Cytosol"		"HPA031406: AB_2673866"	"unprognostic (7.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.47e-3)"	"unprognostic (6.79e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.34e-4)"	13.2	5.8	21.7	6.6	26.9	2.0	23.2	41.5	33.3	19.9	2.8	17.9	39.1	11.9	29.1	5.5	19.0	21.6	12.4	22.0	24.3	12.3	4.4	20.4	5.3	27.4	22.7	3.0	111.2	14.4	44.0	20.1	30.3	36.2	17.9	8.7	86.2	20.2	4.6	7.6	27.3	6.3	10.4	16.7	68.7	6.8	25.4	2.8	16.8	5.7	6.3	12.3	7.6	39.1	5.2	11.4	1.3	15.8	0.0	0.0	2.7	0.0	0.6	1.1	1.0	10.6	5.8	0.0	1.0	0.0	1.4	4.9	14.5	1.0	0.8	0.0	11.4	0.1	0.3	10.1	2.7	0.0	1.1	0.2	6.0	0.1	2.4	0.3	26.0	3.8	0.7	4.0	0.0	115.9	0.7	0.2	0.4	99.2	7.1	0.2	0.0	21.8	14.5	44.8	21.1	56.7	0.0	172.6	0.0	3.6	101.2	0.0	0.5	0.1	1.4	0.4	0.0	2.0	0.3	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.9	0.7	0.0	0.1	1.0	1.1	0.0	0.0	0.0	2.6	0.0	0.4	21.7	26.9	41.5	33.3	22.0	24.3	27.4	22.7	30.3	10.4	25.4	39.1	21.4	0.0	5.5	4.9	4.6	1.5	2.6	3.1	0.6	14.3	20.4	12.3	3.8	4.3	8.6	0.0	0.0	26.3	1.1	16.0	3.9	19.0	0.4	10.2	3.0	19.1	35.3	0.0	16.1	26.9	1.7	1.0	71.4	20.3	0.0	1.1	20.7	0.4	2.5	20.2	15.5	89.5	16.2	0.8	0.4	1.0	0.9	0.7	7.2	6.5	0.6	2.8	0.0	8.0	50.9	22.9	87.8	0.0	22.7	17.8	107.4	0.5	6.5	4.4	0.0	1.5	1.8	0.4	2.1	0.5	0.4	35.0	1.8	0.1	15.6	13.9
HIP1R	"FLJ14000, HIP12, HIP3, ILWEQ, KIAA0655"	ENSG00000130787	"Huntingtin interacting protein 1 related"	O75146	12	122834453-122862961	"Cancer-related genes, Predicted intracellular proteins"	Endocytosis	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 103.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.5;Oligodendrocyte precursor cells: 168.9;Oligodendrocytes: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 9.3;naive B-cell: 10.6"	"Group enriched"	"Detected in many"	8	"B-cells: 10.6;granulocytes: 2.9;T-cells: 3.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017187, HPA038135, HPA038136"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Cytosol"	Vesicles	"CAB017187: , HPA038135: AB_2675851, HPA038136: AB_2675852"	"unprognostic (4.52e-1)"	"unprognostic (6.39e-2)"	"unprognostic (7.07e-2)"	"unprognostic (6.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.11e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.72e-2)"	"prognostic favorable (6.50e-7)"	"unprognostic (2.18e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.54e-3)"	"prognostic favorable (7.26e-4)"	18.5	24.0	68.6	10.4	95.5	13.3	22.6	78.8	80.3	16.0	33.5	16.3	31.8	9.0	3.8	18.0	9.0	7.7	18.9	68.0	67.8	50.2	25.6	15.4	17.5	87.3	83.8	5.6	50.2	8.9	42.0	4.7	75.6	21.0	4.9	5.5	58.7	10.5	7.2	51.7	36.0	2.2	65.3	20.9	66.7	8.5	85.7	12.6	21.5	4.4	11.7	11.4	19.7	103.4	38.1	10.8	8.0	33.1	2.3	6.1	39.2	5.9	9.5	5.9	4.6	16.8	11.1	36.0	19.0	4.3	8.9	32.4	9.7	21.4	0.5	5.8	14.0	0.8	13.8	17.8	7.1	2.8	24.5	3.8	14.9	8.0	13.4	8.1	40.5	16.5	9.6	2.0	3.4	54.4	17.4	8.8	7.4	32.8	12.8	9.0	10.2	12.5	19.6	45.4	8.1	17.9	7.1	18.0	9.5	4.3	36.6	1.5	32.8	3.7	27.5	11.7	5.7	24.8	14.2	21.8	6.0	6.0	3.1	0.0	0.0	2.9	2.7	0.0	1.5	9.3	1.7	2.1	0.0	10.6	3.0	1.9	0.2	0.7	0.0	0.0	0.4	2.0	68.6	95.5	78.8	80.3	68.0	67.8	87.3	83.8	75.6	65.3	85.7	103.4	57.0	0.0	13.4	134.5	38.0	13.3	16.8	8.4	6.8	16.4	21.2	18.2	4.2	60.1	11.1	60.7	29.2	3.7	18.2	28.4	0.0	40.1	3.1	21.9	4.7	18.2	7.8	1.3	11.2	28.7	13.1	2.3	80.5	37.5	5.7	25.3	19.2	24.4	0.6	18.5	9.7	29.9	22.4	1.2	4.2	2.9	1.5	2.2	10.6	9.4	0.1	12.5	7.2	168.9	117.8	22.7	25.3	1.2	17.2	20.2	47.5	17.9	14.2	16.6	0.0	2.5	4.1	6.5	13.3	11.5	21.0	1.9	15.0	1.3	23.9	28.4
HSBP1L1	"FLJ10967, MGC189743"	ENSG00000226742	"Heat shock factor binding protein 1 like 1"	C9JCN9	18	79964582-79970822	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"granulocytes: 31.9;T-cells: 26.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 162.8;SK-MEL-30: 100.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048273	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA048273: AB_2680337"	"unprognostic (2.08e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.70e-2)"	"unprognostic (8.15e-3)"	"unprognostic (8.86e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.53e-3)"	"unprognostic (7.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.76e-2)"	9.6	17.4	18.4	2.9	17.8	2.9	9.6	19.9	26.4	10.0	23.4	16.0	6.7	7.6	11.1	17.4	8.7	5.7	6.7	17.2	18.1	18.6	29.7	10.7	4.2	19.1	18.5	6.6	20.4	19.7	6.7	9.9	19.6	10.2	13.1	14.8	12.8	7.6	12.5	16.0	6.5	5.7	18.1	5.2	10.1	0.8	20.3	4.3	8.9	10.6	4.9	6.2	10.6	17.2	32.2	8.6	0.3	0.5	4.6	15.4	12.7	14.3	32.2	14.8	13.0	16.5	21.7	0.0	3.6	18.8	0.2	18.3	28.5	18.9	7.0	30.6	6.7	0.0	8.8	9.6	162.8	0.0	0.0	18.0	49.6	1.7	10.8	31.5	0.3	4.8	0.0	0.0	0.7	26.8	0.1	0.0	0.0	17.6	30.1	0.3	0.0	0.0	53.7	7.6	0.5	1.8	15.2	20.9	100.2	1.4	11.9	7.6	0.0	0.1	0.0	0.4	0.1	0.0	16.7	0.0	0.2	8.9	0.6	31.9	6.8	8.6	5.8	4.4	6.9	2.2	10.1	6.2	2.8	2.5	26.0	14.0	0.4	5.2	1.6	3.3	4.9	6.2	18.4	17.8	19.9	26.4	17.2	18.1	19.1	18.5	19.6	18.1	20.3	17.2	36.4	54.5	34.5	12.1	5.0	39.8	66.0	135.5	67.2	12.0	89.8	93.6	12.4	48.6	109.2	49.7	22.9	126.6	9.6	119.8	68.4	63.8	1.3	47.2	13.2	23.0	11.5	11.4	5.7	62.1	67.1	16.0	31.6	59.4	19.0	37.2	30.0	122.5	44.7	20.2	11.0	81.3	71.2	20.5	18.0	1.3	19.9	16.0	39.2	6.5	4.0	33.2	6.2	1.0	3.1	137.3	99.6	24.5	2.3	80.2	70.6	80.6	80.3	33.0	0.0	6.3	15.9	1.3	1.3	46.8	57.8	117.4	12.2	34.5	99.6	104.4
HSF4	CTM	ENSG00000102878	"Heat shock transcription factor 4"	Q9ULV5	16	67164681-67169945	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 38.5;Excitatory neurons: 30.9;Horizontal cells: 43.7;Inhibitory neurons: 30.0;Leydig cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 17.1;T-47d: 12.9;U-266/70: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048584			Supported	"Nuclear speckles"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nuclear speckles"		"HPA048584: AB_2680452"	"unprognostic (1.90e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (9.20e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.48e-2)"	"unprognostic (8.74e-3)"	12.4	23.7	43.6	1.3	44.3	1.8	12.7	44.6	69.2	17.9	39.2	10.1	4.8	12.4	4.8	11.0	21.1	3.6	20.0	44.6	43.7	17.1	20.3	8.7	1.6	45.0	41.9	19.8	35.9	4.3	30.1	3.3	46.4	28.3	1.8	5.6	19.0	1.9	25.9	14.5	6.1	2.1	41.3	6.0	14.4	7.0	43.3	1.1	17.9	4.1	1.1	18.8	10.9	45.8	1.6	1.1	0.0	1.1	0.5	3.0	5.2	0.5	0.6	0.2	0.0	2.4	3.5	0.1	2.5	1.1	0.7	5.9	0.4	0.7	0.2	2.3	2.2	0.6	4.5	3.1	2.3	0.3	4.4	1.3	4.8	0.2	2.5	17.1	0.9	4.0	1.5	5.1	2.3	1.5	0.8	1.8	0.1	3.4	3.2	2.0	1.7	8.7	4.4	2.5	3.5	7.6	4.9	3.0	7.8	2.1	12.9	4.5	0.9	1.6	1.6	6.4	1.5	22.3	3.7	1.5	4.9	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.6	44.3	44.6	69.2	44.6	43.7	45.0	41.9	46.4	41.3	43.3	45.8	2.6	3.2	7.7	38.5	1.1	3.1	3.4	2.9	4.6	10.8	9.1	7.7	5.3	4.3	2.7	3.7	2.1	1.0	0.7	2.9	0.0	1.0	0.5	4.1	2.8	1.6	1.2	0.0	30.9	1.3	0.6	6.0	14.8	7.0	1.3	2.3	2.9	5.7	21.9	43.7	30.0	3.0	2.0	0.8	2.5	1.8	32.9	4.6	10.6	5.6	1.5	8.8	0.0	4.0	15.2	1.4	3.5	22.2	1.5	4.0	0.4	2.4	4.8	11.4	0.0	5.4	3.2	0.4	2.3	3.6	3.4	0.7	0.9	1.9	2.9	2.0
HSPB9	CT51	ENSG00000260325	"Heat shock protein family B (small) member 9"	Q9BQS6	17	42122804-42123352	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 17.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 375.3;Late spermatids: 1017.0"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;HEK 293: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053091			Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA053091: "	"unprognostic (2.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.42e-6)"	"unprognostic (2.31e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.82e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.68e-4)"	"unprognostic (4.78e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.24e-1)"	0.4	0.2	1.3	0.4	1.4	0.6	0.2	1.6	1.7	0.2	0.9	0.3	0.3	0.2	0.0	0.1	0.7	0.6	0.2	1.2	1.3	0.5	3.6	0.2	0.4	1.4	1.2	1.3	4.8	0.2	0.5	0.2	1.4	0.5	0.0	0.0	2.9	0.5	1.5	0.4	0.4	0.1	1.2	0.5	0.4	17.8	1.4	0.0	0.2	1.0	0.0	0.2	0.2	1.7	0.2	0.2	0.3	0.9	0.0	0.0	3.3	0.0	0.0	0.0	0.3	1.0	0.1	0.3	0.1	0.0	0.1	0.0	0.4	0.2	0.0	0.3	3.0	0.5	1.2	0.4	0.0	0.3	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.4	0.2	0.0	0.4	0.3	1.1	0.1	0.3	0.0	0.1	0.2	1.0	0.0	0.7	1.4	0.3	0.0	1.5	0.2	0.1	0.2	0.1	0.4	0.7	0.0	0.6	0.2	0.6	0.3	0.6	0.1	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.0	1.3	1.4	1.6	1.7	1.2	1.3	1.4	1.2	1.4	1.2	1.4	1.7	0.7	0.0	0.0	0.0	0.0	0.4	0.5	0.1	0.6	0.6	0.6	0.5	0.6	2.8	0.0	0.0	2.1	3.2	0.2	0.4	19.6	0.0	375.3	0.5	0.3	0.6	0.0	0.0	0.1	1.1	0.8	0.7	0.0	0.3	0.0	0.5	1.8	15.3	0.2	3.3	0.1	0.7	0.0	0.8	0.4	1017.0	7.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.3	6.8	0.0	0.4	0.6	0.9	0.1	0.4	0.0	0.8	0.3	127.3	4.5	0.1	0.3	0.3	0.2	0.6	0.3	0.2
HYI	HT036	ENSG00000178922	"Hydroxypyruvate isomerase (putative)"	Q5T013	1	43450989-43453989	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 232.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 29.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 97.7;HUVEC TERT2: 106.7;U-251 MG: 99.2;WM-115: 105.5"					"Low region specificity"	"Detected in all"			HPA040092	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA040092: AB_10795374"	"prognostic favorable (9.18e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (2.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (5.10e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.58e-2)"	"prognostic favorable (2.72e-5)"	31.7	22.8	28.1	9.3	29.2	12.1	19.3	29.6	36.3	23.4	27.9	21.3	44.1	23.3	15.4	15.0	24.2	18.7	20.8	27.0	31.2	29.5	44.6	23.0	11.3	30.9	28.9	42.1	53.7	25.2	14.6	10.5	30.9	19.8	12.3	4.1	35.3	47.0	20.8	16.2	34.4	13.2	30.0	12.2	23.9	3.9	28.4	8.8	19.1	10.2	9.2	17.4	15.3	32.4	58.7	7.3	2.2	3.5	9.8	15.1	0.2	48.4	35.7	52.6	34.3	24.2	97.7	0.0	4.1	29.7	25.1	10.9	0.0	45.8	21.6	15.2	20.5	10.2	25.0	0.0	58.8	0.0	0.0	9.4	12.4	64.0	0.0	56.3	106.7	0.5	1.2	0.0	34.5	1.2	9.6	8.8	11.1	5.6	15.5	46.0	0.0	0.3	37.5	2.2	27.2	20.3	56.0	30.4	13.2	8.7	9.2	72.0	59.5	3.7	0.0	12.4	99.2	0.0	0.0	0.0	4.1	13.4	105.5	10.6	1.7	3.7	4.2	1.3	5.5	4.3	7.1	3.3	5.8	5.3	6.6	2.0	0.1	7.5	1.8	29.9	0.7	4.0	28.1	29.2	29.6	36.3	27.0	31.2	30.9	28.9	30.9	30.0	28.4	32.4	29.8	19.2	64.4	5.9	16.1	28.0	45.2	22.8	51.8	16.9	41.0	65.3	0.4	65.8	23.0	57.0	10.4	18.6	19.2	56.6	45.0	106.7	1.2	9.9	23.6	23.2	69.5	21.5	1.4	86.1	115.9	45.7	25.5	18.7	43.2	33.5	25.0	59.0	29.8	8.4	1.9	89.1	16.2	8.5	31.0	4.5	31.7	23.5	40.9	1.9	15.8	45.0	8.2	4.5	4.8	109.6	97.0	30.5	41.7	33.7	232.5	146.9	12.4	16.7	26.3	31.3	58.2	1.4	3.0	27.3	22.0	12.0	12.3	49.8	47.6	38.4
IFI6	"6-16, FAM14C, G1P3, IFI-6-16, IFI616"	ENSG00000126709	"Interferon alpha inducible protein 6"	P09912	1	27666064-27672212	"Predicted membrane proteins"	"Antiviral defense, Apoptosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 4084.0;Extravillous trophoblasts: 1291.2;Syncytiotrophoblasts: 4273.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 1349.9;BJ hTERT+ SV40 Large T+ RasG12V: 1570.7;EFO-21: 544.1;SK-MEL-30: 1075.0"					"Low region specificity"	"Detected in all"			HPA005543	Approved		Approved	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA005543: AB_1849342"	"unprognostic (4.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.96e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.77e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-1)"	"unprognostic (8.40e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.72e-2)"	84.0	161.4	117.5	37.5	142.0	113.2	73.1	106.8	159.3	99.7	164.7	76.3	44.0	55.6	39.1	30.5	49.6	56.8	114.2	126.4	168.7	154.1	135.6	143.5	14.9	200.8	145.5	81.4	57.2	116.0	316.7	298.2	155.6	60.6	24.5	17.2	334.3	23.0	23.8	35.3	52.1	43.6	299.5	91.0	96.1	61.9	153.1	62.2	166.9	20.1	14.5	43.8	47.4	139.2	15.6	4.4	22.7	14.1	72.4	38.8	90.6	48.5	220.1	1349.9	1570.7	8.0	58.5	6.1	544.1	22.1	352.4	5.2	5.5	10.8	43.7	117.3	18.4	36.4	11.2	4.8	19.4	12.4	45.1	43.3	1.8	82.1	1.1	20.9	12.6	31.6	2.5	95.2	15.3	4.4	44.1	153.4	4.4	28.7	46.4	29.6	12.1	14.9	12.2	0.9	32.2	28.8	59.9	13.6	1075.0	6.7	6.9	46.5	21.7	12.6	19.3	9.4	8.4	113.5	68.1	4.4	24.6	105.3	35.8	193.3	265.8	252.0	128.7	374.6	127.9	57.3	128.2	118.0	117.6	47.0	132.7	130.9	506.8	102.0	259.4	12.8	172.9	113.2	117.5	142.0	106.8	159.3	126.4	168.7	200.8	145.5	155.6	299.5	153.1	139.2	158.0	141.1	74.4	5.2	26.1	23.5	19.8	39.3	29.0	15.2	17.5	14.4	12.9	54.3	42.2	64.4	10.4	4084.0	44.7	13.2	19.6	244.0	3.4	61.4	76.4	194.8	58.4	27.6	3.6	340.0	1291.2	149.3	21.4	91.8	63.3	186.3	82.8	40.4	685.3	3.3	7.4	60.5	67.1	71.8	49.1	11.5	110.6	169.4	71.2	24.4	93.8	95.1	46.4	16.1	3.9	214.2	11.7	204.7	96.0	48.2	16.9	32.7	89.3	5.6	111.7	60.9	63.1	7.9	1.6	5.8	22.4	4273.1	59.6	138.6	13.0	49.0
IFITM5	"BRIL, DSPA1, fragilis4, Hrmp1"	ENSG00000206013	"Interferon induced transmembrane protein 5"	A6NNB3	11	298200-299526	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Mineral balance"	"Developmental protein"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 4.9;pancreas: 7.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	8	"cerebral cortex: 4.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA039258			Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA039258: AB_10673608"	"unprognostic (9.84e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.46e-2)"		"unprognostic (4.20e-2)"	"unprognostic (4.42e-2)"		"unprognostic (8.31e-2)"	"unprognostic (7.99e-3)"		"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"		"unprognostic (4.90e-2)"	0.1	0.0	0.0	0.1	0.0	0.7	0.2	0.0	4.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.4	0.1	0.1	0.1	0.0	7.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INSR	CD220	ENSG00000171105	"Insulin receptor"	P06213	19	7112255-7294414	"CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Carbohydrate metabolism"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 9.8;granulocytes: 5.9;monocytes: 12.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 54.9;U-266/70: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036302, HPA036303"	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	Yes		190000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Plasma membrane"	"HPA036302: AB_2675048, HPA036303: "	"unprognostic (4.64e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.65e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.45e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.82e-2)"	13.0	22.6	12.5	2.8	16.8	5.6	13.0	17.3	12.8	14.6	18.8	15.0	10.0	18.4	6.3	4.1	16.9	8.2	26.3	10.0	12.2	21.8	33.0	7.2	2.3	18.3	16.3	39.9	64.2	13.0	16.3	7.4	18.7	15.2	10.4	6.5	16.9	9.9	23.5	11.5	12.2	11.5	14.1	48.2	12.5	5.4	16.6	2.7	14.5	13.3	3.5	12.3	9.2	22.5	6.2	3.2	3.6	5.7	18.8	6.1	11.1	3.5	2.9	1.6	1.6	8.4	7.0	9.0	8.2	6.8	4.0	1.6	8.9	1.4	1.2	0.0	6.4	0.0	2.3	22.6	8.2	4.3	6.7	10.0	4.5	0.2	4.9	4.2	3.8	4.8	9.5	54.9	1.8	3.2	3.1	7.8	3.3	3.8	5.2	29.0	2.1	7.6	0.1	27.8	6.6	5.2	6.5	3.8	3.3	6.4	1.4	21.6	3.6	3.4	2.1	8.2	5.1	40.4	23.9	20.2	4.3	7.3	0.0	2.7	8.6	5.9	0.2	8.8	0.3	0.8	0.3	0.1	9.8	1.1	0.7	0.1	1.9	1.0	12.5	8.2	0.0	1.6	12.5	16.8	17.3	12.8	10.0	12.2	18.3	16.3	18.7	14.1	16.6	22.5	75.6	48.1	34.7	64.9	10.6	64.9	63.6	34.7	8.0	40.4	134.0	76.2	92.1	137.2	83.3	62.5	79.2	17.8	6.7	124.1	15.6	55.1	4.7	26.8	106.8	123.9	163.6	25.0	68.3	78.7	53.7	43.7	20.4	42.1	3.8	168.4	255.2	246.0	9.2	38.7	100.8	97.3	32.6	49.0	31.1	9.0	96.3	35.0	51.6	62.8	24.2	31.6	0.0	62.8	183.5	50.7	68.8	245.3	21.8	107.9	122.9	114.1	65.3	23.6	59.2	37.6	44.2	5.2	3.6	3.2	68.8	38.3	4.7	81.4	65.2	130.0
INTS10	"C8orf35, FLJ10569, INT10"	ENSG00000104613	"Integrator complex subunit 10"	Q9NVR2	8	19817391-19852083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039129, HPA050570"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA039129: AB_10794424, HPA050570: AB_2681180"	"unprognostic (9.11e-2)"	"unprognostic (8.41e-3)"	"prognostic favorable (4.00e-4)"	"prognostic favorable (1.22e-4)"	"unprognostic (4.54e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.33e-1)"	27.7	24.0	42.2	24.6	44.1	34.3	29.1	44.2	57.6	27.5	40.3	28.5	26.6	22.5	20.3	26.6	38.7	21.5	21.7	44.4	43.2	29.9	47.6	24.2	30.5	43.0	42.3	25.3	42.6	28.3	18.7	23.0	42.9	29.2	27.3	37.2	30.4	20.0	25.6	31.8	24.1	26.1	42.1	22.7	25.0	15.2	43.7	29.2	43.7	18.6	33.2	24.6	18.0	45.1	40.0	57.3	32.5	42.1	48.7	53.3	41.5	29.5	50.6	40.3	38.4	33.6	19.7	113.9	47.9	33.1	43.9	42.3	39.5	38.5	44.8	22.4	40.0	51.7	62.6	63.2	35.0	45.2	34.2	42.3	58.9	29.8	46.5	24.8	40.2	65.4	66.3	88.2	28.4	33.9	86.7	53.4	42.6	92.9	32.2	43.7	35.9	73.1	52.8	60.7	32.2	26.1	41.1	51.0	37.1	29.1	26.2	43.6	29.2	25.5	35.0	59.1	39.5	24.7	30.5	81.5	51.4	64.4	41.1	10.0	23.7	14.5	19.6	21.4	30.8	26.5	25.6	25.2	30.9	21.7	28.1	25.1	7.7	27.7	18.6	27.1	31.8	20.2	42.2	44.1	44.2	57.6	44.4	43.2	43.0	42.3	42.9	42.1	43.7	45.1	25.5	16.0	51.1	74.4	40.3	37.6	40.9	29.3	43.3	60.2	28.3	20.3	22.5	37.1	39.1	20.2	52.1	33.7	41.5	22.9	35.2	43.6	53.9	78.8	23.1	33.0	20.4	27.3	88.8	40.0	49.2	34.1	25.5	33.4	35.5	63.6	35.3	61.0	42.4	70.7	61.0	34.3	22.4	34.0	25.5	31.9	34.8	35.6	17.8	37.5	37.8	33.9	45.3	80.9	74.9	33.1	27.4	35.0	48.6	53.4	33.9	37.5	70.0	99.0	13.1	29.1	32.5	8.3	32.3	50.8	45.0	22.3	40.6	41.2	42.0	32.7
IPO4	"FLJ23338, Imp4"	ENSG00000196497	"Importin 4"	Q8TEX9	14	24180219-24188869	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 40.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 80.5;Late spermatids: 118.0;Spermatocytes: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039043, HPA064572"	Uncertain		Approved	Cytosol		NA	NA		17000	"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA039043: AB_10673233, HPA064572: AB_2685291"	"unprognostic (2.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (9.45e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.28e-2)"	"prognostic unfavorable (3.20e-4)"	"unprognostic (8.59e-4)"	"unprognostic (5.45e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.15e-2)"	8.9	13.2	1.6	4.7	1.4	4.2	8.0	1.5	1.6	6.9	4.4	7.2	3.2	7.7	2.0	14.0	8.0	1.1	7.8	1.3	2.1	14.1	14.7	6.7	2.8	1.6	1.4	6.9	27.7	2.6	9.4	2.5	1.8	6.8	1.4	0.3	8.7	3.6	21.0	10.7	5.9	1.9	1.4	7.3	8.6	40.4	1.6	2.1	7.0	1.0	1.8	8.7	7.0	2.0	21.9	49.2	6.0	36.0	4.1	8.6	28.4	14.8	6.3	23.5	12.5	39.2	22.4	31.3	16.1	10.6	12.2	25.6	20.4	28.8	2.6	12.1	29.8	20.4	18.6	77.0	8.7	45.4	18.1	7.5	12.3	24.3	6.0	5.3	11.8	15.8	37.5	8.5	15.0	76.6	21.8	21.2	29.1	28.5	41.7	24.4	17.3	23.2	12.6	25.7	29.3	21.1	19.7	31.8	13.9	2.9	27.1	14.7	12.4	22.9	30.8	21.0	32.4	19.8	27.1	34.2	10.8	19.3	31.8	0.0	1.1	0.4	3.3	1.9	3.8	1.8	2.8	2.7	2.4	2.6	2.3	2.9	0.0	2.7	2.4	3.2	1.7	1.9	1.6	1.4	1.5	1.6	1.3	2.1	1.6	1.4	1.8	1.4	1.6	2.0	3.5	0.0	7.9	0.7	4.9	5.9	3.8	5.0	4.6	0.8	11.1	9.7	1.6	8.6	8.7	5.5	4.2	12.1	5.5	3.1	0.0	13.3	80.5	8.3	3.9	5.6	4.2	3.4	1.3	11.0	11.1	4.5	1.1	5.0	0.0	3.1	2.9	5.8	7.9	1.7	1.1	5.9	2.0	2.2	2.6	118.0	5.0	1.3	0.0	0.0	1.7	1.6	2.1	1.0	0.8	6.8	2.5	5.7	2.9	6.1	0.7	11.7	15.1	2.7	6.6	7.0	4.7	52.1	18.8	3.9	6.3	5.9	3.1	6.1	10.4	2.7
ITPRID2	"CS-1, KIAA1927, KRAP, SPAG13, SSFA2"	ENSG00000138434	"ITPR interacting domain containing 2"	P28290	2	181891730-181930738	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 175.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 30.7;Cardiomyocytes: 30.0;Cytotrophoblasts: 25.7;Extravillous trophoblasts: 26.8;Hofbauer cells: 20.4;Syncytiotrophoblasts: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.7;granulocytes: 6.1;monocytes: 5.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034665, HPA039989"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034665: AB_2674271, HPA039989: AB_2676788"	"unprognostic (1.68e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (2.91e-5)"	"unprognostic (3.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (5.79e-5)"	30.8	20.7	55.0	20.6	62.9	42.4	32.1	57.2	66.2	30.9	50.3	50.4	36.4	25.8	18.4	22.8	20.3	37.7	24.4	45.5	61.5	48.4	79.3	44.9	17.6	65.2	60.5	13.6	175.8	20.9	18.3	34.7	63.3	34.0	44.2	16.9	69.9	17.1	31.9	112.9	34.0	25.6	57.3	32.4	56.1	37.4	62.6	24.1	36.5	23.4	16.0	31.3	29.5	61.1	56.0	25.8	71.6	12.6	53.8	41.3	21.7	94.6	82.6	29.1	37.0	25.9	56.0	1.2	30.7	59.7	31.5	46.2	14.5	41.6	56.6	25.2	20.3	52.5	106.6	23.5	45.7	28.5	48.9	30.0	64.4	51.3	57.7	66.7	145.8	22.3	25.0	29.5	82.9	28.7	25.4	41.0	5.0	47.0	62.5	18.7	29.3	19.2	87.0	16.3	13.7	12.1	55.7	19.7	91.0	27.6	14.2	61.6	68.1	73.1	37.0	27.5	50.3	20.9	9.4	21.9	34.0	17.1	57.2	6.1	2.8	4.2	0.9	2.7	0.6	0.4	0.6	0.6	2.7	0.9	0.8	0.7	4.7	0.8	5.1	2.1	0.4	1.3	55.0	62.9	57.2	66.2	45.5	61.5	65.2	60.5	63.3	57.3	62.6	61.1	30.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	25.7	5.8	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	26.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	33.4	1.1	0.0	0.0	0.0
JTB	"hJT, PAR"	ENSG00000143543	"Jumping translocation breakpoint"	O76095	1	153974269-153977674	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006514	Approved		Uncertain	Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA006514: AB_1079164"	"unprognostic (1.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.40e-1)"	"unprognostic (5.66e-3)"	"unprognostic (8.62e-3)"	"unprognostic (5.60e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (1.00e-3)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (6.65e-9)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.58e-3)"	105.6	119.8	121.1	60.4	125.1	127.0	103.0	122.3	153.9	99.8	149.0	117.8	89.5	89.8	96.3	110.8	91.8	53.7	121.0	120.8	122.2	135.4	207.1	110.2	80.4	125.4	122.2	98.4	232.2	93.9	185.9	68.0	121.5	131.0	86.7	49.8	162.0	68.0	166.5	99.8	115.3	50.1	123.3	136.9	164.8	46.6	126.6	77.7	120.5	82.7	80.2	96.3	89.4	123.4	206.3	139.4	57.9	108.0	189.0	116.2	163.5	144.6	142.3	95.9	96.0	135.3	166.7	193.7	198.7	171.8	59.1	181.0	151.0	113.2	78.1	180.5	296.0	112.5	158.4	139.0	198.1	221.4	165.7	110.4	210.4	101.1	119.1	131.0	115.4	223.7	169.3	139.2	68.4	359.6	161.5	280.5	125.8	402.1	239.1	163.9	79.3	393.1	123.7	110.9	158.4	158.8	115.3	332.7	208.4	107.4	209.1	316.4	89.6	46.5	80.4	144.4	189.0	201.8	244.7	211.3	114.5	209.6	103.7	98.7	119.5	173.2	74.7	86.4	90.9	143.5	104.0	118.7	88.9	139.9	107.0	85.6	104.9	85.3	96.5	147.4	98.5	97.7	121.1	125.1	122.3	153.9	120.8	122.2	125.4	122.2	121.5	123.3	126.6	123.4	127.7	80.1	101.1	15.7	184.3	156.8	177.4	227.5	104.7	56.6	253.4	207.3	96.5	213.1	171.4	99.3	22.9	308.8	237.3	273.4	258.2	251.9	7.1	145.0	95.3	120.4	212.0	178.8	26.3	411.8	405.0	155.6	149.9	125.9	82.5	113.2	125.7	341.3	289.1	57.2	24.0	423.4	213.6	235.8	185.8	20.1	151.6	176.3	170.7	19.7	207.9	140.4	257.5	19.6	29.1	274.1	302.2	123.4	344.8	346.0	368.2	274.1	138.2	60.2	105.2	105.3	114.0	58.9	71.5	173.4	190.2	289.5	173.6	136.6	315.2	304.0
KRTCAP2	KCP2	ENSG00000163463	"Keratinocyte associated protein 2"	Q8N6L1	1	155169408-155173475	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.57e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.44e-3)"	"unprognostic (3.64e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.13e-2)"	"unprognostic (7.81e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (9.70e-11)"	"unprognostic (3.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.94e-3)"	183.2	179.0	153.7	82.9	160.0	113.0	186.4	165.1	197.1	206.8	161.1	178.7	105.1	203.1	309.3	136.3	165.8	104.6	185.5	152.6	163.7	157.0	226.1	143.3	104.0	167.1	159.7	177.0	451.1	155.2	182.6	93.3	169.7	139.8	121.2	50.4	207.5	155.2	171.1	130.2	147.0	139.1	160.0	156.0	209.9	203.8	159.3	99.6	180.3	112.4	126.1	160.7	158.4	171.0	171.1	302.5	141.8	157.5	406.7	291.1	152.1	197.0	225.2	226.2	188.5	369.9	321.6	129.2	303.3	357.0	130.3	230.5	160.2	221.2	142.5	180.6	327.0	143.5	333.2	207.5	377.1	276.8	154.3	277.6	498.5	264.6	340.2	175.3	202.0	246.4	207.8	581.7	234.0	572.8	152.0	273.6	152.4	564.9	399.1	176.1	90.2	692.0	335.5	254.6	232.8	147.7	193.5	340.8	222.6	208.4	248.9	445.8	138.6	145.6	138.6	124.1	193.4	332.5	302.4	222.4	239.1	266.5	163.0	657.8	346.6	372.1	445.7	304.5	504.5	497.9	498.4	474.3	371.6	441.5	374.6	405.8	152.9	330.1	260.7	840.7	513.4	491.8	153.7	160.0	165.1	197.1	152.6	163.7	167.1	159.7	169.7	160.0	159.3	171.0	170.9	70.5	119.1	10.1	161.8	63.2	53.4	187.5	152.0	13.9	158.3	151.1	1.3	148.7	132.1	207.8	4.2	79.2	146.7	150.7	45.0	219.3	257.4	113.6	153.2	143.6	131.7	119.2	5.1	298.2	211.4	153.4	189.1	159.7	84.9	52.4	201.7	235.3	160.9	8.4	6.2	246.7	105.8	156.3	173.9	95.0	228.3	122.9	252.5	12.2	110.7	41.5	138.0	6.0	12.6	244.5	206.1	164.4	517.4	49.9	267.4	179.0	146.8	15.2	118.3	76.2	156.1	349.7	78.0	194.1	90.5	94.1	162.9	43.1	183.3	59.3
KSR1	"KSR, RSU2"	ENSG00000141068	"Kinase suppressor of ras 1"	Q8IVT5	17	27456470-27626438	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 101.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 73.0;Glandular and luminal cells: 50.3;Inhibitory neurons: 50.2;Oligodendrocyte precursor cells: 53.3;Oligodendrocytes: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 393.5;HEL: 140.5;HMC-1: 93.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009623, HPA011215, HPA011878"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol	Vesicles	"CAB009623: AB_2265455, HPA011215: AB_1852649, HPA011878: "	"unprognostic (2.03e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.92e-5)"	"unprognostic (8.36e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (1.00e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.61e-2)"	22.6	17.5	19.6	19.9	22.0	16.7	15.6	17.4	35.8	36.9	13.2	13.1	8.1	26.5	9.9	29.8	20.8	21.4	13.6	33.1	19.3	40.7	6.5	26.2	14.3	28.6	20.2	26.4	101.4	7.3	15.1	44.9	23.0	15.6	8.5	19.4	8.4	18.5	30.0	21.6	15.2	20.0	17.5	22.5	9.3	25.3	22.9	11.6	31.0	14.0	14.6	14.6	23.1	26.7	4.6	18.1	11.1	5.8	9.2	6.5	64.7	4.2	9.1	6.2	7.2	55.0	0.8	4.4	9.5	8.0	40.8	2.8	11.0	2.5	3.7	393.5	12.1	140.5	19.3	23.0	16.0	1.8	93.0	8.1	4.0	17.8	0.5	25.3	34.8	6.1	75.0	0.5	3.6	4.4	2.1	5.4	8.3	4.0	3.2	9.1	61.5	3.2	25.1	3.3	17.1	11.3	22.3	5.1	6.0	29.4	0.7	7.5	32.5	1.8	8.2	5.1	3.0	0.5	0.1	0.1	1.8	7.9	10.5	0.0	1.0	3.8	0.3	2.1	0.3	0.4	0.1	0.2	0.5	0.1	0.1	0.1	1.1	0.9	1.1	0.0	0.5	0.4	19.6	22.0	17.4	35.8	33.1	19.3	28.6	20.2	23.0	17.5	22.9	26.7	19.7	6.4	3.4	33.6	4.1	3.1	3.6	3.1	1.8	11.8	1.9	2.3	1.2	1.5	11.9	14.7	73.0	19.2	4.9	7.1	3.9	2.0	33.4	24.0	21.6	9.1	6.6	0.4	26.2	5.3	21.0	8.2	3.6	50.3	0.0	10.8	11.7	1.3	6.7	10.1	50.2	2.2	0.0	8.3	6.9	47.7	1.5	9.0	8.8	27.2	10.4	5.7	4.1	53.3	49.2	2.1	7.1	2.2	2.8	1.6	6.7	3.2	14.9	25.8	0.0	5.3	4.8	2.6	6.1	11.3	6.0	19.4	5.7	8.4	1.2	6.2
LFNG	SCDO3	ENSG00000106003	"LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q8NES3	7	2512529-2529177	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 74.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 40.3;Enteroendocrine cells: 87.4;monocytes: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.7;OE19: 46.4;RH-30: 46.0;U-2 OS: 49.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069130	Approved		Approved	"Nuclear membrane,Golgi apparatus"	"Intracellular and membrane"	NA	NA		880000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	"Nuclear membrane"	"HPA069130: AB_2686091"	"unprognostic (4.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (6.36e-4)"	"unprognostic (1.85e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.28e-2)"	16.7	6.5	23.3	17.3	25.9	9.8	13.7	29.3	22.4	9.9	11.1	23.1	15.5	9.4	2.2	11.4	6.1	11.8	13.1	17.4	30.1	9.0	2.5	14.4	18.6	34.1	35.6	1.8	74.4	3.0	3.7	6.5	24.8	17.1	12.0	3.0	33.4	4.6	4.6	58.2	17.2	5.8	25.0	20.9	37.8	4.2	38.1	5.8	6.7	3.6	10.8	12.2	13.8	23.6	1.5	14.3	18.4	2.5	2.0	1.7	1.2	5.4	2.8	4.7	5.9	6.0	37.7	1.1	16.7	14.8	8.1	27.1	2.9	5.1	2.3	8.6	0.6	4.3	7.7	3.2	0.1	6.2	7.7	3.3	12.6	7.8	0.8	3.2	1.9	0.3	0.7	0.2	3.6	34.5	0.1	8.7	22.4	46.4	10.3	1.8	46.0	2.9	1.8	4.5	16.9	4.2	6.2	1.4	0.3	4.7	10.2	7.3	4.5	10.5	49.7	0.4	15.4	0.2	0.0	1.4	11.8	16.4	2.0	6.3	5.3	12.7	1.8	6.9	2.0	1.1	1.7	0.9	2.3	2.0	1.8	1.8	2.8	1.3	6.6	0.6	4.2	1.7	23.3	25.9	29.3	22.4	17.4	30.1	34.1	35.6	24.8	25.0	38.1	23.6	23.3	6.4	6.0	18.9	15.6	6.8	2.5	10.6	3.4	8.5	5.3	12.4	3.6	5.7	2.8	0.0	0.0	0.1	40.3	23.1	0.0	1.2	0.1	2.4	8.5	16.0	87.4	2.7	0.0	6.4	0.3	5.7	30.5	1.2	17.7	0.1	13.9	0.6	7.0	0.0	0.1	34.5	6.1	30.4	13.8	0.5	1.8	30.6	3.6	11.2	38.2	31.3	19.6	1.5	0.1	21.7	3.1	0.0	12.6	2.2	8.8	0.4	1.2	0.8	0.0	0.6	5.0	0.3	3.1	0.6	4.0	0.0	15.9	0.5	15.3	0.7
LMF1	"C16orf26, FLJ12681, FLJ22302, JFP11, TMEM112, TMEM112A"	ENSG00000103227	"Lipase maturation factor 1"	Q96S06	16	853634-981318	"Disease related genes, Human disease related genes, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 67.6;Excitatory neurons: 90.8;Oligodendrocyte precursor cells: 217.6;Oligodendrocytes: 167.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"				"unprognostic (5.42e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.16e-3)"	"unprognostic (5.58e-3)"	"unprognostic (1.20e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.41e-2)"	"unprognostic (6.22e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.01e-3)"	"prognostic favorable (7.95e-8)"	"unprognostic (2.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.03e-3)"	7.7	11.9	11.5	4.1	13.9	4.3	8.4	8.7	16.0	7.9	8.5	6.9	4.3	7.3	14.0	6.9	8.2	4.5	6.6	8.5	6.7	8.3	11.8	6.3	4.5	13.1	10.4	8.5	21.8	10.4	7.2	3.3	10.1	10.0	3.1	4.3	15.0	5.3	4.2	9.2	6.4	4.8	9.6	7.2	10.3	5.4	9.3	3.5	12.6	3.2	3.8	7.4	7.5	18.4	0.9	11.2	7.8	14.1	9.6	9.8	3.4	5.5	17.7	1.9	3.4	2.3	14.8	2.4	8.3	14.2	5.1	4.1	2.9	0.1	1.1	7.4	4.0	0.8	0.5	2.7	4.9	2.1	2.8	5.7	0.0	0.4	4.6	8.7	4.2	4.1	1.8	9.5	6.5	13.1	4.4	1.2	4.0	9.0	6.2	4.4	7.9	16.3	7.1	2.5	0.0	4.2	2.7	2.9	10.3	4.0	6.7	6.8	4.5	1.2	1.7	4.3	0.8	11.6	1.7	3.5	2.9	2.2	8.9	2.0	5.4	1.2	6.9	5.9	3.9	2.6	3.8	4.7	8.2	2.2	3.8	3.2	0.2	6.2	3.8	7.6	4.1	4.4	11.5	13.9	8.7	16.0	8.5	6.7	13.1	10.4	10.1	9.6	9.3	18.4	11.9	12.8	12.4	67.6	12.0	4.1	7.7	16.6	4.6	12.1	8.3	8.8	3.6	11.5	13.2	5.5	14.6	1.5	5.4	6.0	3.9	13.9	0.7	5.0	6.5	8.5	8.4	1.3	90.8	17.3	1.8	9.9	12.2	4.7	2.5	10.0	6.1	9.3	7.0	13.5	27.0	6.5	18.3	6.3	3.4	3.7	14.6	5.9	16.0	27.2	4.4	19.4	10.3	217.6	167.4	16.9	4.1	9.8	23.7	6.0	15.0	9.0	13.1	10.7	6.6	5.7	6.5	10.2	9.3	6.2	2.0	1.1	6.8	10.1	6.2	6.7
LRIG1	"DKFZP586O1624, LIG-1, LIG1"	ENSG00000144749	"Leucine rich repeats and immunoglobulin like domains 1"	Q96JA1	3	66378797-66501263	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 144.4"	"Cell type enriched"	"Detected in many"	5	"Astrocytes: 331.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 79.7;hTEC/SVTERT24-B: 55.2;U-698: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011846	Approved		Approved	Cytosol		NA	NA		78000	"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA011846: AB_2668545"	"unprognostic (6.41e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (3.01e-5)"	"unprognostic (5.12e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (1.50e-4)"	31.0	1.8	33.1	17.0	29.2	4.0	27.2	15.1	21.0	29.9	0.0	38.6	16.8	21.9	3.0	13.5	26.7	20.9	37.0	21.4	26.7	3.6	11.2	17.6	7.9	29.4	39.2	17.1	144.4	5.2	6.5	4.7	17.2	24.8	14.7	5.0	19.2	7.2	37.2	11.7	13.4	30.5	14.3	3.9	36.5	12.5	51.0	3.5	16.2	32.9	9.6	5.9	5.2	17.7	1.4	1.3	27.6	0.5	7.6	4.8	2.8	4.9	26.6	4.6	14.0	23.6	0.3	79.7	13.1	2.2	6.1	0.0	5.5	10.0	10.1	0.0	16.8	0.0	4.1	2.0	1.8	0.7	16.7	6.0	5.4	55.2	9.0	18.8	24.3	0.3	0.3	0.0	1.0	3.6	0.0	0.1	22.8	2.3	0.0	14.1	8.7	3.7	5.1	0.0	3.9	1.0	4.6	4.1	0.2	4.6	25.6	6.7	8.2	13.9	6.3	27.9	12.9	6.2	3.2	59.5	24.3	0.0	5.0	0.0	0.0	0.3	0.1	0.0	0.6	0.1	0.4	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.1	0.1	33.1	29.2	15.1	21.0	21.4	26.7	29.4	39.2	17.2	14.3	51.0	17.7	12.5	38.5	50.2	331.1	4.3	11.3	7.8	8.0	14.2	2.1	51.9	35.8	32.0	11.5	25.0	0.0	8.4	0.2	5.8	9.6	1.9	5.6	1.6	29.1	9.7	9.2	26.5	0.0	10.6	17.1	0.1	17.1	19.9	58.8	1.3	14.9	6.4	20.7	2.0	8.4	15.6	26.2	12.2	1.9	7.7	2.1	11.5	2.4	10.6	57.1	1.7	39.8	0.0	37.7	58.3	6.0	10.2	17.3	8.7	15.6	5.7	1.2	33.7	6.8	0.0	65.5	19.9	1.6	20.0	8.9	11.5	0.1	15.2	2.1	22.8	5.0
LRRC74A	"C14orf166B, LRRC74"	ENSG00000100565	"Leucine rich repeat containing 74A"	Q0VAA2	14	76826372-76870302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"testis: 3.9"	"Group enriched"	"Detected in some"	84	"Early spermatids: 58.0;Late spermatids: 111.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035094	Uncertain					NA	NA				"Cluster 22: Non-specific - Unknown function"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA035094: AB_10600793"	"unprognostic (7.71e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.77e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.29e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.30e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.11e-2)"	"unprognostic (5.21e-4)"	"unprognostic (1.72e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	3.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	111.9	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MAGEB17		ENSG00000182798	"MAGE family member B17"	A8MXT2	X	16167481-16171464	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"pancreas: 2.0;testis: 1.7"	"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-138 MG: 2.7;U-2 OS: 6.0;U-266/70: 14.8"									HPA003756	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA003756: AB_2250114"	"unprognostic (1.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.04e-4)"	"unprognostic (2.75e-1)"	"unprognostic (5.11e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.44e-2)"	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	1.5	0.0	0.0	2.7	6.0	0.0	0.1	14.8	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGIX	"FLJ21687, JM10, PDZX"	ENSG00000269313	"MAGI family member, X-linked"	Q9H6Y5	X	49162564-49168483	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 46.9;Hepatocytes: 35.0;Proximal tubular cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 5.5;RT4: 12.8;SK-BR-3: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007390, HPA035302"	Uncertain		Approved	"Nucleoplasm,Mitotic chromosome"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Mitotic chromosome"	"HPA007390: , HPA035302: AB_10603015"	"unprognostic (1.11e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-3)"	"unprognostic (2.64e-6)"	"unprognostic (6.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-2)"	"prognostic favorable (6.91e-9)"	"unprognostic (4.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (2.10e-4)"	1.3	2.1	3.9	0.7	3.6	1.4	1.8	9.5	4.3	2.4	7.9	3.4	1.7	1.8	1.2	4.3	4.0	1.3	9.9	3.9	3.9	9.7	19.1	2.8	0.4	4.2	4.2	1.0	13.9	3.7	5.9	0.5	4.2	5.1	1.0	1.1	10.0	2.8	2.1	2.7	1.5	0.3	3.5	1.2	12.4	0.7	4.0	0.6	7.0	0.5	0.3	2.8	2.1	3.7	0.3	1.9	0.4	0.5	0.5	0.1	1.4	0.3	0.3	0.3	0.3	1.1	5.5	0.5	0.5	0.6	0.7	1.2	0.3	1.3	0.0	1.6	1.8	2.4	3.4	0.6	0.2	0.6	4.7	0.5	0.2	0.4	0.1	0.6	0.4	0.8	0.3	2.0	0.4	0.7	0.5	1.7	0.5	1.5	1.0	0.3	0.1	1.0	1.0	12.8	2.4	0.5	1.1	5.7	0.6	0.3	4.5	0.5	0.2	0.6	1.4	0.5	0.4	1.3	0.7	0.4	2.3	0.8	1.8	3.1	1.1	2.0	0.1	1.0	0.4	0.6	0.5	0.0	0.7	0.5	0.3	0.5	4.2	0.7	1.1	1.4	0.1	0.6	3.9	3.6	9.5	4.3	3.9	3.9	4.2	4.2	4.2	3.5	4.0	3.7	1.6	3.2	5.4	1.0	2.8	3.2	10.3	5.6	4.6	8.0	18.7	10.4	8.5	11.5	7.0	12.9	2.1	2.1	3.9	33.7	46.9	13.1	0.2	24.7	2.5	2.0	17.5	0.4	1.2	20.8	4.1	2.4	28.5	16.0	0.0	0.8	4.2	35.0	5.1	8.4	1.1	23.4	2.0	3.2	5.7	0.0	0.6	5.7	1.8	0.0	4.8	8.3	0.0	1.0	1.3	8.9	30.7	0.4	5.2	5.8	15.2	44.3	20.4	9.7	0.0	6.9	3.8	3.0	2.7	8.0	4.4	3.8	3.9	1.7	15.3	9.9
MAT2A	"MATA2, MATII, SAMS2"	ENSG00000168906	"Methionine adenosyltransferase 2A"	P31153	2	85539168-85545281	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 874.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009968, HPA043028"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1800000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB009968: AB_675710, HPA043028: AB_10960707"	"unprognostic (1.38e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (5.29e-5)"	"unprognostic (9.89e-3)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.87e-4)"	"prognostic favorable (8.94e-4)"	"prognostic unfavorable (5.94e-5)"	"unprognostic (4.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-2)"	270.4	277.5	184.1	153.2	226.7	98.3	136.1	199.3	235.9	173.0	152.6	193.2	141.4	165.5	236.0	166.2	200.1	209.5	189.6	191.5	207.3	203.6	115.7	168.5	121.8	226.8	219.3	211.0	874.7	165.8	284.1	122.3	208.0	196.2	146.5	248.7	137.7	120.0	278.9	141.1	155.6	127.2	194.4	116.7	225.5	132.3	219.2	102.1	388.8	112.0	127.7	262.9	168.2	289.7	175.3	253.0	290.4	181.6	195.3	236.7	171.1	213.5	195.6	219.3	232.4	208.4	569.9	404.5	137.0	261.0	178.9	264.3	369.6	318.6	279.8	207.0	271.0	242.5	408.7	181.9	355.6	364.3	259.7	215.9	315.8	237.4	164.1	278.1	211.5	230.7	277.9	309.0	505.1	149.5	334.4	398.2	193.5	148.7	320.8	350.3	275.0	264.2	328.9	271.2	227.9	209.6	193.2	183.4	354.6	145.9	156.0	192.3	207.7	267.4	160.9	149.3	260.5	189.0	161.4	290.6	175.0	447.3	143.8	9.1	24.7	8.2	22.3	26.9	32.7	19.8	25.2	23.7	23.6	18.9	23.1	20.5	2.5	27.3	22.3	16.6	24.2	24.9	184.1	226.7	199.3	235.9	191.5	207.3	226.8	219.3	208.0	194.4	219.2	289.7	150.5	48.1	83.6	122.4	104.2	143.5	217.1	47.1	206.1	73.5	116.3	134.6	6.5	82.9	57.6	71.7	68.8	36.2	126.3	60.6	19.6	59.2	75.2	28.8	49.2	83.6	83.3	87.1	56.1	58.5	40.6	121.9	106.0	47.4	84.4	83.3	45.0	44.6	67.4	26.9	60.4	65.1	26.4	118.8	141.9	25.8	72.1	165.7	67.6	26.2	64.6	58.8	27.8	28.6	95.5	53.6	48.0	83.8	78.4	66.7	73.8	138.7	35.2	89.0	111.7	298.5	231.0	54.1	56.2	168.2	118.3	38.2	102.0	51.1	70.6	88.4
MFSD12	"C19orf28, MGC20700, PP3501"	ENSG00000161091	"Major facilitator superfamily domain containing 12"	Q6NUT3	19	3538261-3574290	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Melanin biosynthesis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.7;Extravillous trophoblasts: 142.4;Melanocytes: 195.7;Syncytiotrophoblasts: 92.6"	"Cancer enriched"	"Detected in all"	7	"melanoma: 124.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HeLa: 261.4;SK-MEL-30: 339.8;WM-115: 628.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042149, HPA043088"	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"			"HPA042149: AB_2677875, HPA043088: AB_2678308"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (5.66e-6)"	"unprognostic (1.56e-2)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (6.61e-4)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (3.19e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.95e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	23.3	26.4	25.8	24.1	26.4	30.5	19.3	21.8	33.0	18.9	9.3	17.7	15.0	18.0	12.9	22.7	21.8	9.5	17.6	41.2	18.1	55.0	35.8	29.2	20.3	29.0	23.8	14.7	38.5	13.9	25.9	17.6	28.9	21.4	6.1	10.8	29.7	11.2	16.4	53.7	27.2	11.6	19.2	37.9	22.8	13.6	29.9	24.7	19.0	4.0	10.8	19.5	17.0	58.0	97.6	76.4	18.6	48.9	37.9	29.2	66.9	58.3	31.2	66.6	72.7	33.1	32.4	27.3	43.2	31.2	106.4	60.1	24.3	30.2	23.8	60.0	69.0	15.9	261.4	34.9	47.4	34.9	51.1	26.2	44.9	68.6	15.9	25.5	18.1	40.2	77.1	38.2	17.3	58.0	35.0	61.8	34.9	42.9	62.1	24.3	26.2	115.1	27.9	41.0	70.0	35.5	115.0	53.4	339.8	23.1	18.2	71.6	75.8	30.1	44.4	123.8	67.1	43.8	26.9	25.1	132.4	88.2	628.4	0.1	3.7	2.6	1.8	7.7	1.8	2.3	2.8	1.4	2.7	1.4	2.4	1.9	1.2	0.5	7.7	12.1	0.5	1.7	25.8	26.4	21.8	33.0	41.2	18.1	29.0	23.8	28.9	19.2	29.9	58.0	15.4	6.4	2.8	5.5	12.9	26.5	6.8	4.9	1.8	15.6	19.9	14.0	1.9	8.6	6.1	20.2	6.2	16.8	21.5	11.6	0.0	23.1	120.7	26.9	20.9	13.1	28.1	3.8	10.2	31.4	142.4	10.9	14.8	42.5	0.0	57.3	6.4	22.3	76.9	37.0	8.0	18.4	2.0	24.8	54.4	30.4	2.5	47.7	195.7	13.1	20.7	9.3	5.2	7.5	25.5	34.2	16.2	3.4	12.6	16.7	18.7	34.0	8.1	12.7	13.1	5.4	12.0	4.0	9.0	8.4	25.4	92.6	10.9	11.1	13.2	13.8
MFSD6L	FLJ35773	ENSG00000185156	"Major facilitator superfamily domain containing 6 like"	Q8IWD5	17	8797110-8799365	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"pancreas: 9.4;testis: 25.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 125.7;Ionocytes: 28.5;Late spermatids: 46.1;Spermatocytes: 45.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 8.3"	"Not detected"	"Not detected"							HPA023164	Uncertain					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA023164: AB_2142777"	"prognostic favorable (1.84e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.07e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.25e-1)"	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.1	1.8	0.0	2.7	2.3	0.1	1.3	0.6	2.0	0.7	0.2	0.0	0.0	1.6	0.0	0.3	0.0	0.1	0.1	0.0	9.4	4.1	4.9	0.4	0.1	0.4	3.1	0.0	6.8	2.1	0.0	0.3	1.5	0.0	0.0	0.2	4.0	25.5	0.2	0.2	3.4	0.0	0.2	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1.7	0.8	0.2	4.3	1.1	1.8	0.0	2.9	0.0	1.7	0.0	7.2	125.7	1.2	0.1	0.1	1.2	0.0	0.0	7.6	0.3	0.0	3.6	2.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.9	28.5	0.6	0.0	46.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.7	1.2	0.1	0.8	0.2	0.0	0.8	0.0	0.0	0.0	0.2	45.0	0.3	0.6	0.0	1.5	0.0	0.0	4.5	1.0
MISP3		ENSG00000141854	"MISP family member 3"	Q96FF7	19	14072536-14075062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 17.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 19.3;Breast myoepithelial cells: 20.8;Collecting duct cells: 14.7;Distal tubular cells: 35.2;Endometrial ciliated cells: 12.4;Exocrine glandular cells: 11.5;Proximal tubular cells: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.3;OE19: 11.3;RPMI-8226: 6.3;U-266/84: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042225	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"			"HPA042225: AB_10795396"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.76e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.52e-4)"	"prognostic favorable (3.11e-5)"	"unprognostic (2.97e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.78e-2)"	1.4	2.1	7.2	0.3	7.3	0.5	2.0	7.6	10.3	2.0	6.3	7.6	3.9	1.0	0.4	3.0	3.0	0.3	6.3	7.6	8.1	17.7	5.6	2.9	0.0	7.4	7.4	0.5	12.1	2.8	2.6	0.5	7.6	3.6	1.4	1.1	7.8	1.0	2.5	7.9	5.2	0.1	7.7	1.3	11.1	0.9	7.5	0.2	3.0	1.0	0.1	1.7	2.8	7.8	1.7	0.9	0.3	0.7	0.6	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.3	0.1	1.1	0.1	0.0	0.6	0.8	0.0	0.0	2.1	1.5	0.2	0.3	0.8	0.1	0.1	0.3	0.1	0.0	0.0	0.1	0.7	0.2	1.0	0.2	5.3	0.0	3.0	0.3	0.7	0.0	11.3	0.7	0.5	0.1	6.3	1.1	0.0	1.5	0.4	0.0	0.5	0.6	0.0	0.9	0.0	0.1	0.0	0.4	0.5	0.0	3.6	4.3	0.4	0.8	1.3	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	7.2	7.3	7.6	10.3	7.6	8.1	7.4	7.4	7.6	7.7	7.5	7.8	3.2	9.6	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	19.3	20.8	0.0	0.0	1.8	14.7	0.0	0.2	3.7	0.0	35.2	2.5	0.0	12.4	0.8	0.7	0.0	0.0	0.0	11.5	0.1	1.0	0.0	5.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	1.3	0.0	0.0	22.8	2.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.0	1.5	0.3	0.0	0.0
MYO10	KIAA0799	ENSG00000145555	"Myosin X"	Q9HD67	5	16661907-16936288	"Plasma proteins, Predicted intracellular proteins"	Transport	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 189.5;Muller glia cells: 233.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"non-classical monocyte: 2.5"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 182.1;SK-MEL-30: 205.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015224, HPA024223"	Enhanced		Supported	"Nucleoli rim,Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoli rim"	"CAB015224: , HPA024223: AB_1854248"	"unprognostic (1.13e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (8.93e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.84e-1)"	13.8	3.0	47.4	6.2	46.3	3.2	7.9	24.6	41.1	6.7	55.1	19.3	22.8	6.2	3.5	9.3	4.3	8.4	4.5	39.8	24.8	14.7	7.7	19.0	1.3	32.6	30.9	15.8	32.2	10.7	9.5	31.5	27.6	5.8	19.1	15.1	11.0	5.0	8.2	15.6	19.5	4.9	27.3	13.9	32.0	15.6	46.4	4.9	37.5	4.4	2.0	11.1	7.8	45.7	68.2	108.3	31.3	14.9	24.7	17.0	35.1	117.2	89.2	35.5	27.4	63.1	10.2	1.5	78.9	52.9	42.3	33.4	139.1	73.7	57.1	0.2	16.7	0.1	182.1	13.7	81.5	0.4	1.5	30.9	26.8	78.5	92.1	57.4	110.5	0.2	0.2	4.8	28.7	10.5	0.2	0.4	80.5	56.6	37.2	26.1	10.3	66.9	22.0	49.6	5.2	2.8	27.0	11.4	205.0	53.2	8.1	9.1	137.8	77.6	23.6	0.7	61.1	0.7	0.5	0.5	38.3	11.2	76.2	0.5	0.2	0.2	0.1	0.5	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	0.3	0.1	2.5	0.1	0.1	0.1	47.4	46.3	24.6	41.1	39.8	24.8	32.6	30.9	27.6	27.3	46.4	45.7	53.5	35.3	34.6	158.7	1.4	40.9	31.0	23.0	29.6	11.0	18.6	11.6	3.8	55.8	26.3	31.3	18.8	20.4	0.3	46.4	17.6	110.8	30.2	118.5	20.8	61.3	74.0	0.0	3.9	40.6	63.4	13.7	68.3	116.0	27.8	189.5	77.1	1.7	5.6	82.4	5.4	53.2	20.3	7.1	4.8	9.5	12.8	5.7	67.6	87.1	3.8	233.8	0.0	103.5	23.5	114.7	50.3	19.2	0.4	42.6	28.3	4.2	18.8	9.2	65.7	8.2	31.5	3.8	12.2	30.7	31.8	147.8	2.4	4.1	66.9	38.6
NBAS	NAG	ENSG00000151779	"NBAS subunit of NRZ tethering complex"	A2RRP1	2	15166914-15561334	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 217.8;Inhibitory neurons: 187.9;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 159.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036817	Approved		Approved	"Nuclear membrane,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nuclear membrane, Nucleoli"	"HPA036817: AB_10670925"	"unprognostic (1.72e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (3.80e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (5.84e-5)"	16.8	21.0	37.4	7.2	38.8	16.1	15.9	37.7	42.7	18.8	35.7	22.7	8.2	18.4	13.7	17.2	18.8	8.1	38.3	37.2	36.3	19.9	21.6	15.8	9.4	37.0	35.2	22.5	34.4	16.3	29.6	10.1	38.7	19.0	10.5	13.4	15.4	10.4	30.5	21.8	20.1	11.8	34.4	21.1	24.5	41.2	37.2	14.5	17.4	17.7	9.1	19.7	16.5	38.1	10.5	13.7	14.8	10.7	37.8	41.5	15.2	19.1	20.8	14.5	14.6	13.8	15.0	13.4	4.3	29.3	15.1	12.5	16.5	23.9	17.2	13.5	10.4	51.3	11.5	38.8	38.8	13.4	25.1	27.3	18.9	19.2	32.8	30.2	30.4	18.7	40.6	15.0	22.4	13.0	11.2	30.1	12.8	17.1	12.8	11.7	26.0	16.2	30.5	14.0	8.7	14.2	16.2	13.4	25.2	18.3	9.4	12.0	26.6	18.5	11.2	13.5	13.9	22.1	20.3	18.7	33.1	15.5	16.8	1.5	4.4	2.5	5.7	3.1	6.7	4.1	4.2	7.3	4.0	3.4	4.2	4.3	0.8	7.2	7.5	4.5	5.3	2.9	37.4	38.8	37.7	42.7	37.2	36.3	37.0	35.2	38.7	34.4	37.2	38.1	16.1	19.2	13.8	96.6	15.1	7.4	9.3	11.9	12.0	17.3	11.7	9.4	32.3	17.2	13.8	18.4	29.2	11.5	15.1	9.4	0.0	11.1	39.3	22.2	21.3	14.6	7.3	38.7	217.8	14.0	13.1	13.4	20.9	14.8	38.6	30.2	8.9	9.1	9.0	13.5	187.9	14.8	10.2	6.9	8.0	61.9	11.5	11.6	5.4	106.8	18.4	12.5	9.2	159.3	159.2	8.6	9.5	16.6	27.2	9.2	39.3	8.5	26.0	25.5	0.0	24.7	16.3	33.7	22.4	12.9	11.2	10.4	19.9	70.0	12.5	7.6
NMRAL1	"FLJ25918, HSCARG, SDR48A1"	ENSG00000153406	"NmrA like redox sensor 1"	Q9HBL8	16	4461691-4495763	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041353, HPA062287"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA041353: AB_10796343, HPA062287: AB_2684738"	"unprognostic (2.56e-1)"	"prognostic favorable (3.33e-7)"	"unprognostic (4.16e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.52e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	20.8	39.6	40.2	8.8	42.5	13.4	25.5	41.2	49.4	25.5	36.7	23.3	16.1	24.0	24.7	27.4	23.8	16.1	25.3	41.0	40.4	36.7	57.3	19.9	18.1	42.5	40.4	30.3	44.1	16.2	27.3	13.9	42.4	36.7	11.5	5.0	32.8	19.3	5.2	34.3	23.6	13.6	39.6	26.2	41.4	11.5	41.2	18.6	27.3	4.3	14.8	22.2	24.0	43.5	36.7	47.6	10.3	28.5	26.1	23.7	34.9	26.5	12.0	32.9	25.3	44.3	69.2	0.8	46.2	41.8	9.9	35.3	26.3	43.7	15.7	28.5	10.5	31.1	38.0	24.5	50.5	36.5	22.2	32.4	54.4	41.5	16.7	28.6	39.8	116.3	32.7	0.9	19.2	116.0	81.7	39.2	31.4	55.8	39.7	73.7	0.7	42.4	42.1	21.2	12.9	26.6	50.4	78.1	27.4	6.5	66.5	39.4	17.9	17.5	0.8	14.9	0.3	0.9	0.6	57.1	8.9	35.6	31.5	13.1	59.3	6.1	61.1	35.9	45.6	38.9	42.6	57.2	53.9	35.0	43.2	44.3	32.5	27.9	26.6	52.7	42.3	53.7	40.2	42.5	41.2	49.4	41.0	40.4	42.5	40.4	42.4	39.6	41.2	43.5	16.2	25.6	26.0	11.1	19.3	27.3	38.1	48.8	43.3	11.7	48.7	46.4	22.6	40.0	38.7	42.3	0.0	105.8	30.6	29.1	52.8	34.6	12.5	24.9	21.8	19.0	20.4	20.8	9.1	49.8	102.5	23.8	46.4	34.4	20.8	41.3	26.4	78.7	67.1	5.0	11.1	38.2	30.5	29.5	18.7	35.7	29.2	23.1	35.6	8.4	30.9	45.5	54.6	7.5	19.0	37.4	36.5	30.5	27.8	29.0	46.3	114.5	35.7	10.0	26.3	10.6	24.0	5.4	37.3	29.6	30.5	64.2	32.9	37.9	38.5	32.8
NOMO2	"NOMO, PM5"	ENSG00000185164	"NODAL modulator 2"	Q5JPE7	16	18417325-18562211	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 300.4"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 124.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA046697, HPA061174"	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 22: Non-specific - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA046697: AB_2679758, HPA061174: AB_2684444"	"unprognostic (2.58e-3)"	"unprognostic (4.11e-3)"	"unprognostic (2.58e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.54e-2)"	55.9	66.1	119.0	27.6	128.5	31.1	54.7	106.5	141.4	54.0	108.0	65.4	34.8	59.8	53.5	57.2	48.2	22.4	191.7	133.8	124.9	76.7	96.6	73.8	23.9	112.0	108.8	48.4	300.4	76.8	104.2	49.1	112.6	59.5	35.6	42.3	63.3	31.7	126.2	60.5	56.7	41.5	100.3	61.8	88.5	50.4	112.7	23.1	55.9	52.2	29.6	61.3	50.5	116.5	71.1	101.3	37.5	104.5	141.0	85.9	110.3	122.1	144.6	101.5	125.4	87.7	108.6	83.0	433.3	213.4	71.0	80.5	81.2	84.8	88.1	67.7	64.5	37.0	98.2	313.5	195.5	88.7	252.1	91.2	112.6	117.2	106.8	107.9	113.1	70.3	52.3	185.4	120.6	213.9	33.2	197.2	72.9	107.0	42.3	71.1	50.8	230.1	150.9	63.6	52.6	44.2	94.4	128.5	82.4	75.2	99.6	185.8	106.1	60.7	47.0	127.4	86.8	95.6	112.0	44.6	135.3	92.9	85.1	21.8	12.6	11.8	14.3	11.9	11.6	10.8	14.0	14.5	14.1	9.8	9.3	11.8	13.8	8.3	15.4	22.8	22.4	17.5	119.0	128.5	106.5	141.4	133.8	124.9	112.0	108.8	112.6	100.3	112.7	116.5	0.5	6.4	2.8	2.0	3.8	0.4	0.4	0.6	2.8	0.9	0.5	0.3	124.4	0.0	1.4	0.0	4.2	0.4	1.3	0.4	1.9	0.2	0.2	0.3	0.8	3.2	0.0	2.5	6.4	0.7	0.3	9.1	4.1	0.6	0.0	0.7	0.7	0.8	0.1	0.0	5.1	0.2	0.0	0.8	0.2	0.4	0.0	1.2	0.0	5.6	0.2	0.3	2.1	8.5	7.6	0.4	0.1	0.4	22.7	0.4	0.6	0.1	1.9	0.6	6.6	0.6	4.8	1.2	1.3	3.3	0.6	0.4	3.2	1.1	0.4	0.1
NOXA1	"FLJ25475, NY-CO-31, SDCCAG31"	ENSG00000188747	"NADPH oxidase activator 1"	Q86UR1	9	137423350-137434406	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 37.5;Gastric mucus-secreting cells: 54.6;Paneth cells: 34.7;Proximal enterocytes: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 12.6;EFO-21: 11.3;MCF7: 19.8;T-47d: 18.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA044781	Uncertain		Approved	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA044781: AB_10960532"	"unprognostic (2.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.42e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.97e-3)"	"prognostic favorable (2.65e-4)"	"unprognostic (4.97e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-2)"	3.7	6.6	11.4	3.5	11.9	3.0	6.9	7.4	24.4	7.5	5.1	12.6	19.3	6.1	1.2	9.6	9.3	6.9	3.9	11.2	10.8	14.7	12.5	4.6	2.5	13.0	11.7	10.1	17.2	6.1	15.4	1.2	9.6	10.4	3.8	2.6	19.9	7.1	10.3	18.4	13.2	1.3	7.7	7.1	17.6	3.9	11.5	2.7	12.9	1.4	1.4	5.6	8.7	8.5	2.0	5.0	0.1	3.8	0.4	0.0	2.6	0.4	0.6	0.2	0.3	0.8	12.6	0.0	11.3	0.1	0.8	8.6	0.2	0.2	0.0	5.5	4.2	0.0	3.6	1.9	1.2	0.1	2.4	0.4	2.7	0.0	0.1	2.2	0.3	0.0	0.7	0.8	0.0	19.8	0.0	1.1	0.2	5.2	1.7	0.1	0.0	7.8	3.3	4.3	1.0	0.3	0.3	2.0	2.0	0.2	18.8	1.6	1.3	0.2	2.6	2.9	0.4	0.8	0.0	0.1	0.3	0.7	0.6	0.0	0.4	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.7	0.1	0.1	0.4	0.0	0.6	2.5	0.0	0.0	0.2	11.4	11.9	7.4	24.4	11.2	10.8	13.0	11.7	9.6	7.7	11.5	8.5	4.0	0.0	5.4	6.5	4.0	3.4	6.1	2.8	3.4	9.8	16.2	11.2	1.3	14.3	7.2	12.9	8.4	0.4	2.3	37.5	7.9	7.4	0.3	11.2	2.1	2.4	6.7	2.7	22.4	11.0	0.4	1.7	54.6	20.0	2.5	3.8	0.7	6.5	5.4	3.3	17.0	20.5	4.1	3.8	9.0	0.5	1.2	6.1	8.8	6.5	3.8	10.7	4.1	8.0	3.8	7.0	34.7	0.7	2.1	4.4	39.5	19.9	5.9	8.2	6.6	3.2	3.8	5.1	5.0	12.8	4.1	0.3	3.5	1.0	24.6	7.4
NQO1	"DHQU, DIA4, DTD, NMOR1, QR1"	ENSG00000181019	"NAD(P)H quinone dehydrogenase 1"	P15559	16	69706996-69726668	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 522.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 539.8;Respiratory ciliated cells: 471.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 2434.0;OE19: 4177.0;SiHa: 2756.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007308, CAB012421"	Enhanced		Supported	Cytosol		NA	NA		490000	"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"CAB012421: , HPA007308: AB_1079501"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.76e-3)"	"unprognostic (9.03e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.27e-1)"	100.9	95.1	88.9	20.7	97.2	0.8	264.8	88.1	165.6	24.3	113.4	85.6	106.8	16.1	27.2	162.2	29.3	183.1	24.3	86.7	95.0	93.9	5.6	36.5	4.8	83.5	86.2	8.9	9.2	19.5	15.3	12.0	85.9	20.7	74.0	21.4	47.7	25.1	34.2	11.7	56.1	35.0	83.0	22.8	522.7	6.4	93.6	4.3	112.7	27.0	16.5	79.0	34.2	86.8	224.2	2434.0	203.4	901.3	473.1	682.7	77.5	363.1	632.7	363.9	547.0	302.0	1395.7	7.1	433.1	1850.6	634.3	232.1	79.1	410.3	185.2	91.3	3.3	10.9	564.4	2169.9	631.7	53.8	170.6	166.2	246.8	642.8	74.4	537.9	903.9	18.5	95.3	16.3	1914.1	725.9	11.6	98.7	107.0	4177.0	237.1	18.9	44.0	101.6	708.3	781.5	73.0	17.2	2756.6	384.8	1690.4	226.6	631.3	173.1	626.5	368.8	155.8	140.0	297.1	12.7	53.1	11.2	470.2	29.1	1864.0	1.1	3.9	0.3	6.3	0.4	3.1	5.7	7.3	8.3	3.8	2.4	2.2	5.3	0.9	18.7	0.4	1.3	15.6	5.1	88.9	97.2	88.1	165.6	86.7	95.0	83.5	86.2	85.9	83.0	93.6	86.8	88.5	25.6	14.6	8.8	2.9	5.2	26.4	185.5	32.5	10.0	31.1	30.5	4.8	138.7	90.9	42.3	4.2	1.7	3.5	165.7	146.8	25.6	0.4	117.2	11.7	81.0	20.4	1.3	1.9	147.5	4.3	32.9	539.8	65.7	19.7	10.1	28.5	2.6	15.2	3.3	1.6	81.7	107.8	3.5	7.6	1.2	25.1	10.9	17.8	4.7	128.5	10.6	7.2	0.0	5.0	75.1	59.4	12.0	2.3	22.6	62.9	44.3	471.3	15.1	6.6	21.1	72.1	0.3	1.3	128.3	4.5	1.9	5.6	17.3	51.5	40.6
NUDT14	UGPP	ENSG00000183828	"Nudix hydrolase 14"	O95848	14	105172938-105181323	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 176.1;Proximal enterocytes: 206.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046755, HPA058759"	Approved		Approved	Nucleoli,Microtubules		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Microtubules	Nucleoli	"HPA046755: AB_10963433, HPA058759: AB_2683809"	"unprognostic (1.05e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.05e-3)"	"unprognostic (9.17e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.16e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.38e-1)"	16.5	23.9	17.4	3.5	20.1	2.1	19.3	19.9	28.4	9.0	27.5	14.5	12.5	6.4	3.5	17.5	8.9	6.4	27.5	19.9	21.5	28.8	19.5	20.1	5.9	19.0	17.4	6.4	40.4	16.0	61.1	3.2	19.1	18.6	2.9	4.7	17.2	2.9	31.6	14.1	16.3	1.8	17.9	12.5	17.6	13.9	17.2	3.6	22.1	12.7	2.1	8.4	11.3	21.1	18.1	24.2	2.1	9.4	2.8	3.3	38.1	5.0	6.5	8.0	11.5	17.5	18.7	1.3	24.4	2.6	17.8	22.7	1.1	13.6	0.7	9.5	17.7	4.0	10.4	12.2	19.9	4.8	46.7	4.7	16.7	1.9	1.4	3.4	15.9	8.8	6.4	2.9	2.8	52.5	0.6	0.0	12.6	42.7	33.5	9.4	21.9	10.8	8.8	51.2	32.8	4.8	9.0	0.2	21.7	3.9	18.8	23.1	38.3	13.2	5.8	9.5	5.1	1.4	1.0	2.2	19.4	5.5	4.9	6.2	40.5	1.2	12.6	40.8	7.5	12.8	9.6	8.0	33.5	10.2	9.4	10.8	1.3	15.2	68.6	17.0	6.0	19.2	17.4	20.1	19.9	28.4	19.9	21.5	19.0	17.4	19.1	17.9	17.2	21.1	66.1	12.8	28.5	5.2	12.4	38.9	101.7	123.4	52.9	12.1	46.8	78.5	54.5	40.0	41.2	35.0	18.8	44.7	16.1	88.2	176.1	94.1	3.1	59.3	8.0	61.6	37.3	10.1	5.9	30.8	18.2	14.7	30.5	31.0	38.8	11.9	27.1	28.0	137.0	35.3	3.0	62.6	73.2	27.4	27.1	9.8	11.5	33.9	46.2	12.2	35.6	38.3	22.6	0.5	5.8	51.2	132.4	3.8	7.7	51.9	206.9	169.1	65.7	19.1	0.0	39.0	11.4	12.4	48.5	30.4	19.0	38.2	26.8	5.2	75.4	82.2
OGFOD2	"FLJ13491, FLJ37501"	ENSG00000111325	"2-oxoglutarate and iron dependent oxygenase domain containing 2"	Q6N063	12	122974580-122980043	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 431.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039448, HPA040306"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA039448: AB_10795035, HPA040306: AB_10794026"	"unprognostic (2.14e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	6.5	15.0	10.8	7.7	11.1	8.4	7.5	10.9	14.0	9.1	12.4	9.9	13.8	6.8	5.9	10.7	10.2	4.8	10.3	10.6	10.9	14.1	21.2	7.7	11.0	12.3	11.4	9.4	20.9	6.5	13.2	5.6	11.5	12.0	5.5	4.9	14.7	7.8	10.9	11.9	12.7	3.3	10.8	14.4	13.0	29.1	11.6	9.3	11.8	4.5	6.6	7.8	8.3	13.5	11.7	18.6	7.6	12.4	5.2	5.5	20.4	6.9	7.1	9.5	8.6	17.6	10.2	13.0	14.1	6.0	5.6	16.5	5.5	9.5	3.6	9.1	12.0	20.6	17.8	18.3	11.1	20.7	15.5	8.1	14.0	8.8	7.8	13.7	10.1	24.7	24.4	9.3	4.8	22.4	17.6	39.0	4.6	8.0	23.5	19.2	7.3	23.2	7.2	10.4	9.7	8.8	9.4	13.4	13.8	5.0	34.0	17.6	6.5	13.0	13.2	15.5	7.3	23.4	15.1	12.4	17.9	10.7	12.8	18.7	11.7	18.9	9.1	12.9	7.8	15.9	7.5	9.0	13.1	11.3	8.1	7.7	9.6	9.7	18.2	7.8	16.0	9.0	10.8	11.1	10.9	14.0	10.6	10.9	12.3	11.4	11.5	10.8	11.6	13.5	4.1	0.0	7.0	4.6	10.0	2.9	6.5	10.3	8.0	3.6	9.2	8.6	0.4	10.0	8.6	12.9	2.1	25.9	5.6	9.2	9.8	11.8	97.3	13.0	5.2	5.9	2.4	17.2	3.2	15.0	14.0	5.4	8.6	5.3	0.0	8.6	7.9	21.1	12.5	11.8	3.6	8.0	16.2	11.9	3.4	431.0	8.7	6.4	7.2	1.0	7.7	7.8	10.3	3.0	2.6	12.7	7.8	4.5	18.4	4.6	32.4	34.1	30.5	6.4	13.1	4.1	5.7	36.8	16.2	7.3	4.5	16.4	7.2	11.5	10.1	4.3
PAK3	"bPAK, hPAK3, MRX30, MRX47"	ENSG00000077264	"P21 (RAC1) activated kinase 3"	O75914	X	110944285-111227361	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Allosteric enzyme, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 31.9;pancreas: 42.7;pituitary gland: 13.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 104.1;Excitatory neurons: 364.0;Inhibitory neurons: 323.5;Oligodendrocyte precursor cells: 165.9;Peritubular cells: 81.3"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.8;HAP1: 9.9;HDLM-2: 12.4;NTERA-2: 9.7;SCLC-21H: 12.4;SH-SY5Y: 7.7;U-2197: 7.6;U-251 MG: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044791, HPA060219"	Approved		Approved	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA044791: , HPA060219: AB_2684223"	"unprognostic (1.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.27e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.63e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.89e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	1.0	5.2	16.9	1.6	16.2	0.1	5.2	0.0	17.6	2.3	0.0	0.7	0.2	5.4	5.8	0.7	2.5	1.6	0.3	17.8	31.9	0.7	0.2	0.9	1.7	1.6	0.0	6.2	42.7	0.1	13.7	0.6	6.0	3.4	0.7	7.0	2.2	4.8	1.6	1.3	0.5	4.7	0.4	2.0	2.0	2.6	13.2	0.6	6.2	0.4	0.8	0.9	0.7	2.8	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.3	0.4	1.1	0.0	0.0	0.0	0.0	10.8	1.2	1.6	0.0	9.9	0.6	1.3	12.4	0.4	0.0	1.3	0.0	0.0	0.0	0.4	0.3	0.0	0.1	2.2	5.7	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.2	9.7	0.0	2.2	0.1	4.3	0.0	0.8	0.0	12.4	7.7	0.0	0.4	0.0	6.6	0.0	0.0	0.0	0.7	4.7	7.6	13.6	0.1	0.1	0.1	1.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.9	16.2	0.0	17.6	17.8	31.9	1.6	0.0	6.0	0.4	13.2	2.8	0.9	3.2	1.1	16.0	0.6	0.3	13.3	0.2	0.0	104.1	6.9	10.4	1.0	20.0	0.7	0.0	0.0	0.3	0.2	0.2	0.0	4.7	4.4	1.0	10.8	2.3	3.6	0.0	364.0	13.1	0.4	10.3	10.2	1.7	1.3	21.9	1.4	0.2	0.2	6.7	323.5	0.3	0.0	0.3	5.7	7.0	34.2	1.1	0.0	17.8	0.7	27.5	1.0	165.9	12.0	5.3	0.0	81.3	1.0	1.7	0.0	0.6	0.0	6.0	0.0	1.6	7.8	1.4	1.4	0.3	1.1	6.7	2.4	29.2	0.3	0.9
PARD6A	"PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40"	ENSG00000102981	"Par-6 family cell polarity regulator alpha"	Q9NPB6	16	67660946-67662774	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.5;testis: 42.9"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 266.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 27.9;RPMI-8226: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009733, HPA041551"	Approved		Supported	"Cell Junctions,Actin filaments,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Cell Junctions, Actin filaments"	Cytosol	"CAB009733: AB_2159676, HPA041551: AB_2677545"	"prognostic favorable (5.40e-4)"	"unprognostic (6.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.13e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (9.22e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-2)"	3.2	8.0	25.1	2.4	24.8	1.3	2.8	32.4	38.5	2.1	19.3	7.7	1.1	2.6	2.1	2.0	2.7	1.9	4.2	28.1	22.3	8.8	6.5	3.1	3.1	25.3	22.8	3.9	27.9	6.6	30.2	0.7	26.8	3.6	1.0	2.7	2.7	2.7	8.7	1.8	4.1	1.6	21.9	4.8	5.9	42.9	25.8	3.4	2.4	5.3	2.2	3.7	1.7	25.4	8.9	9.4	2.6	23.5	1.7	0.4	4.7	0.2	1.1	3.4	3.2	4.7	3.6	14.8	4.3	0.3	1.2	7.0	5.2	1.1	0.7	6.9	5.0	6.0	4.1	5.5	2.4	2.5	13.5	0.1	0.5	3.2	1.3	2.1	1.7	21.7	0.6	3.4	0.6	8.7	15.6	3.2	3.3	12.0	6.0	27.9	1.7	24.5	8.8	5.1	21.8	11.7	1.4	3.2	3.7	0.7	19.9	0.9	1.4	0.3	0.8	2.1	4.6	3.5	12.1	13.5	2.6	5.3	1.0	2.1	0.9	0.4	4.3	0.6	7.8	10.9	5.9	5.4	1.1	8.3	2.8	2.2	3.4	1.3	0.1	5.1	6.3	2.0	25.1	24.8	32.4	38.5	28.1	22.3	25.3	22.8	26.8	21.9	25.8	25.4	4.4	3.2	5.8	2.0	17.0	0.9	2.2	1.6	1.2	11.1	7.7	6.7	1.7	10.0	2.6	20.2	4.2	5.7	8.2	3.5	33.2	7.2	61.0	4.1	0.5	3.2	34.0	4.0	7.2	15.0	0.4	3.3	6.1	2.7	5.7	5.2	3.9	4.6	4.3	32.0	7.3	3.3	0.0	4.1	5.7	266.5	3.7	4.7	5.4	3.7	2.2	19.1	1.0	2.0	2.2	6.0	2.1	1.5	12.1	2.1	2.9	16.3	3.4	10.1	0.0	8.0	9.7	5.5	3.9	1.4	1.6	2.9	15.0	1.9	4.7	2.4
PEX16		ENSG00000121680	"Peroxisomal biogenesis factor 16"	Q9Y5Y5	11	45909663-45918812	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043286	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"			"HPA043286: AB_10794179"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.06e-3)"	"unprognostic (9.06e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.75e-3)"	"unprognostic (5.72e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (9.06e-4)"	23.4	27.1	22.3	10.9	23.8	20.3	22.2	23.4	24.4	18.2	16.6	20.6	21.3	18.7	6.3	21.3	18.9	10.1	17.0	23.0	22.7	26.7	50.2	16.2	16.6	26.2	23.6	18.3	40.0	10.1	32.0	6.7	23.2	21.7	5.1	4.4	21.6	9.7	18.1	27.2	25.3	6.0	21.9	24.5	27.6	25.8	23.6	11.8	21.8	7.5	8.6	20.1	18.0	26.0	15.0	19.9	6.7	16.8	11.0	13.2	19.4	11.6	15.2	15.5	12.0	22.6	10.7	25.6	15.0	10.9	14.7	27.2	6.9	23.0	3.7	22.4	23.6	16.7	28.8	20.1	34.8	24.9	33.8	21.3	20.1	9.4	15.1	9.1	17.0	21.9	13.4	29.6	10.7	42.0	21.3	32.5	15.1	28.7	20.0	18.4	16.8	29.4	10.0	26.5	17.0	22.7	13.3	27.1	24.5	4.2	40.4	21.1	13.6	14.8	19.0	36.9	21.5	47.1	33.1	16.2	16.2	14.7	16.2	35.3	44.1	36.8	47.9	51.0	44.9	57.0	48.9	49.6	47.8	50.5	44.4	46.7	32.2	44.9	38.6	44.7	61.1	46.1	22.3	23.8	23.4	24.4	23.0	22.7	26.2	23.6	23.2	21.9	23.6	26.0	25.1	3.2	5.4	3.9	35.7	16.6	24.4	47.6	19.4	15.7	25.9	22.4	3.8	22.8	25.1	14.7	10.4	39.9	31.9	45.8	50.9	37.3	25.9	19.7	13.8	21.5	28.1	25.9	4.8	88.7	22.2	15.7	17.9	20.3	21.0	16.2	21.8	68.6	34.2	15.2	5.1	26.5	30.5	37.7	19.7	32.6	19.3	20.0	21.4	3.7	46.6	28.8	26.8	5.0	10.6	55.9	49.2	14.3	27.1	26.1	90.5	68.1	26.4	18.0	32.9	16.8	24.4	27.2	15.4	21.6	21.0	64.0	33.0	19.9	29.6	28.2
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963865-42979181	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 76.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025924, HPA074179"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA025924: AB_1855230, HPA074179: "	"unprognostic (7.32e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-1)"	11.6	20.5	24.9	9.2	25.2	9.5	12.1	23.9	27.7	19.1	25.5	16.3	9.3	15.5	7.7	16.4	22.7	9.6	18.7	25.1	25.5	16.5	27.7	10.0	14.5	27.2	25.5	26.1	76.2	15.2	24.3	9.6	24.2	21.6	7.8	9.9	14.8	11.4	23.4	14.0	16.3	9.6	23.9	17.5	16.3	16.2	25.1	14.7	19.8	15.0	10.4	17.3	15.7	25.2	35.0	16.4	8.1	30.6	29.6	28.3	8.4	6.0	9.4	4.8	10.0	10.5	10.1	14.1	8.2	14.3	20.5	32.2	28.7	31.1	5.0	27.6	15.2	4.7	24.4	6.2	20.0	4.8	9.4	35.5	35.5	19.9	5.5	39.1	24.7	18.9	25.2	14.1	10.7	3.9	12.7	15.8	10.0	78.8	14.3	26.8	14.3	5.8	12.3	10.0	25.4	11.1	5.6	21.9	32.7	13.1	43.2	21.2	14.0	15.2	2.9	7.5	14.0	21.0	19.8	19.7	5.2	24.6	12.4	1.3	1.3	2.1	1.2	1.1	2.1	1.0	1.8	2.5	1.9	1.9	2.2	2.1	0.8	2.0	0.7	1.0	0.9	1.1	24.9	25.2	23.9	27.7	25.1	25.5	27.2	25.5	24.2	23.9	25.1	25.2	5.6	6.4	2.6	19.9	5.6	5.0	10.2	6.2	10.8	15.2	11.8	12.7	4.1	10.0	5.6	7.3	2.1	11.4	5.4	10.2	13.7	2.8	2.5	17.6	10.6	5.8	5.4	1.7	24.6	1.5	6.7	9.2	11.2	9.1	0.0	19.8	8.6	14.1	5.8	21.9	22.4	8.5	6.1	9.7	3.2	3.6	14.6	5.4	8.8	9.4	4.5	11.8	9.2	13.0	16.6	1.9	10.4	9.4	3.1	6.3	15.1	13.9	14.3	7.0	0.0	13.0	6.6	7.3	2.6	6.3	5.5	7.4	7.8	26.1	10.5	6.6
PGAP3	"CAB2, MGC9753, PER1, PERLD1, PP1498"	ENSG00000161395	"Post-GPI attachment to proteins phospholipase 3"	Q96FM1	17	39671122-39696797	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"OE19: 800.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016591	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA016591: AB_1855203"	"unprognostic (1.29e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.53e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.68e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.57e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (5.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.94e-2)"	10.5	11.9	17.0	5.6	17.2	5.0	12.9	14.0	19.6	14.6	16.2	18.6	14.9	11.3	18.3	25.8	15.9	13.4	14.8	17.5	16.7	20.6	35.6	12.1	7.4	14.9	15.4	13.5	27.1	22.7	14.9	11.8	14.6	18.5	13.7	7.1	25.1	11.7	8.3	21.0	17.1	6.1	14.7	12.3	16.6	9.1	16.5	4.8	27.1	4.5	7.5	12.2	13.7	15.5	3.7	9.6	7.7	7.0	7.9	8.1	7.9	4.3	10.1	6.7	6.1	5.4	23.8	4.2	19.7	8.3	2.2	12.6	2.4	2.9	3.1	8.6	7.7	5.2	6.0	9.3	10.6	12.9	12.8	14.9	15.0	3.1	6.8	7.6	2.2	1.9	4.9	9.6	6.1	8.7	2.9	11.7	7.6	800.4	2.1	3.2	4.7	12.1	10.7	12.0	7.1	4.7	11.9	134.0	6.9	0.8	11.4	12.4	3.4	7.2	7.6	3.5	3.3	8.5	2.0	1.4	8.1	4.9	8.1	2.6	7.2	4.6	15.2	11.6	8.3	8.1	10.6	12.5	5.7	7.7	10.1	10.1	2.0	10.4	4.3	3.9	5.4	7.3	17.0	17.2	14.0	19.6	17.5	16.7	14.9	15.4	14.6	14.7	16.5	15.5	6.5	3.2	14.9	7.8	3.7	3.8	3.3	5.6	3.4	12.6	9.1	7.0	7.7	14.3	10.1	14.7	8.4	8.1	5.3	20.3	1.9	7.6	0.1	3.5	4.5	5.0	8.4	3.0	9.0	11.1	6.5	5.1	9.2	5.7	8.9	6.8	4.6	9.0	4.4	13.5	6.3	15.3	8.2	5.1	2.8	0.1	3.1	3.7	1.8	2.8	1.9	7.5	4.1	9.0	6.1	6.3	13.9	1.5	2.8	3.7	22.9	3.4	4.9	22.1	0.0	5.0	3.3	0.7	2.4	8.1	2.8	10.4	4.9	5.8	13.3	3.1
PHGDH	"PDG, PGDH, SERA"	ENSG00000092621	"Phosphoglycerate dehydrogenase"	O43175	1	119648411-119744218	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 135.0;Exocrine glandular cells: 136.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD8 T-cell: 25.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 975.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003681, HPA021241, HPA024031, CAB068216"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1100000	"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB003681: AB_425928, CAB068216: AB_2665666, HPA021241: AB_1855299, HPA024031: AB_1855300"	"unprognostic (2.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (1.48e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (9.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-3)"	51.4	3.0	113.6	9.4	125.3	11.4	30.1	130.7	125.9	46.1	89.1	27.2	7.6	25.4	79.6	56.6	49.3	7.6	22.4	108.8	128.8	40.9	126.0	18.0	14.9	121.8	113.9	46.1	171.1	103.9	23.7	13.2	122.4	52.6	7.0	7.5	156.2	33.5	2.6	92.5	13.3	15.0	117.0	6.5	41.7	40.3	115.8	34.0	29.5	4.3	13.3	35.8	62.9	153.6	156.8	35.2	148.0	444.6	64.9	82.8	286.1	101.0	209.3	132.9	257.6	195.7	28.6	0.1	58.1	270.5	16.6	205.6	216.8	224.6	83.9	1.1	162.1	29.1	151.3	153.3	135.7	214.3	1.7	147.6	338.6	146.8	142.2	83.0	100.1	519.7	71.4	443.9	66.8	380.9	222.8	90.1	440.0	93.3	274.6	228.0	181.1	24.8	9.6	120.4	160.8	146.0	65.9	63.9	975.9	103.9	164.8	505.7	0.9	38.3	172.1	207.3	134.8	294.0	79.9	246.1	456.9	328.2	302.7	5.3	1.1	0.2	4.7	0.3	0.2	11.1	2.4	8.2	5.3	4.0	13.0	25.2	2.2	1.8	0.3	2.6	4.5	6.3	113.6	125.3	130.7	125.9	108.8	128.8	121.8	113.9	122.4	117.0	115.8	153.6	5.3	3.2	12.6	31.6	10.0	51.9	118.1	24.2	42.7	0.7	29.7	38.0	2.1	128.7	12.5	20.2	2.1	49.9	2.2	1.6	135.0	60.2	51.2	15.6	3.8	6.9	1.8	5.5	0.3	136.1	54.0	58.7	8.6	12.2	5.7	30.9	3.6	96.1	9.2	0.0	0.6	3.6	18.3	2.2	4.3	116.9	67.7	6.5	56.9	2.8	11.0	82.4	0.0	14.1	32.3	35.6	2.0	127.9	27.4	62.1	0.2	118.4	24.7	3.4	13.1	11.2	48.8	20.0	19.4	57.5	77.1	25.3	5.9	71.4	3.2	56.8
PLA2G12A	PLA2G12	ENSG00000123739	"Phospholipase A2 group XIIA"	Q9BZM1	4	109709989-109730070	"Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035908, HPA035909"	Approved				"Secreted to blood"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA035908: AB_2674856, HPA035909: AB_10672074"	"unprognostic (8.40e-2)"	"unprognostic (3.87e-1)"	"unprognostic (3.81e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.54e-9)"	"unprognostic (3.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.16e-3)"	"unprognostic (3.64e-2)"	10.0	9.0	11.4	3.4	12.7	6.2	12.0	12.6	13.8	8.4	11.9	11.5	10.5	8.1	7.3	11.4	8.4	7.3	16.0	10.4	12.2	14.7	21.2	7.4	4.0	13.9	14.4	10.5	34.5	23.0	12.5	3.7	13.1	15.1	10.8	15.5	11.8	7.1	22.1	9.3	10.6	7.0	14.2	5.2	9.8	5.0	12.7	4.9	17.8	19.3	4.6	7.0	7.6	15.1	17.2	6.2	4.8	7.4	15.0	14.9	9.4	14.9	11.0	8.5	8.9	15.6	29.1	24.5	11.6	11.1	14.0	9.3	14.9	20.1	13.0	8.3	22.8	8.7	17.5	11.5	14.2	19.2	5.9	15.1	22.9	8.6	21.3	14.3	7.7	22.5	48.8	10.7	14.7	30.3	15.7	8.6	8.6	39.0	24.1	9.3	14.3	19.5	16.2	25.0	30.8	10.1	13.7	35.5	11.9	12.3	21.3	4.0	10.4	12.4	10.1	12.9	10.8	18.5	36.0	17.8	13.5	11.0	15.5	5.4	4.1	2.7	6.2	2.7	5.7	3.7	7.8	6.0	8.2	4.3	8.7	8.0	1.8	5.0	4.5	7.0	8.3	12.1	11.4	12.7	12.6	13.8	10.4	12.2	13.9	14.4	13.1	14.2	12.7	15.1	11.7	25.6	21.8	14.4	11.7	36.7	36.3	39.7	25.0	52.5	27.5	18.3	56.8	30.0	24.9	22.0	50.1	42.7	8.3	31.5	27.4	15.0	26.7	15.1	9.5	17.1	107.7	48.4	24.1	25.9	53.4	29.3	32.6	14.0	14.0	147.4	23.9	103.1	19.4	26.9	28.6	52.8	34.6	22.4	17.1	8.7	33.2	64.6	30.2	18.7	6.1	47.7	13.4	16.6	20.1	13.9	38.9	34.6	20.6	67.8	78.9	19.2	16.4	42.3	19.7	38.2	21.1	62.7	47.5	39.0	42.6	34.5	14.3	28.6	58.9	44.9
PLPP2	"LPP2, PAP-2c, PPAP2C"	ENSG00000141934	"Phospholipid phosphatase 2"	O43688	19	281040-291403	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 204.5;Ductal cells: 352.1;Proximal enterocytes: 209.8;Rod photoreceptor cells: 234.9;Urothelial cells: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.2;MAIT T-cell: 6.6"	"Lineage enriched"	"Detected in single"	41	"T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"A549: 144.1;CAPAN-2: 154.6;OE19: 255.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055540, HPA058428"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"HPA055540: AB_2682839, HPA058428: "	"prognostic unfavorable (4.55e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.21e-8)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-3)"	4.8	13.2	37.7	8.5	61.6	0.0	36.9	57.1	50.0	63.4	26.2	40.5	62.7	16.8	8.4	27.2	81.8	52.4	1.7	38.8	43.5	11.5	3.7	8.3	1.4	57.3	53.6	2.7	37.3	19.5	11.8	3.6	56.2	31.7	32.1	29.6	105.7	32.9	0.6	53.2	51.0	6.4	44.8	4.7	50.3	7.6	49.2	5.2	5.7	0.5	6.0	36.5	14.2	83.9	85.5	144.1	2.1	0.1	0.0	0.3	0.2	8.2	0.0	25.3	18.9	41.7	154.6	0.0	88.3	11.9	0.1	45.3	0.0	17.6	11.1	0.8	2.6	0.0	55.9	0.0	28.6	0.0	5.5	5.2	7.6	12.7	16.7	53.4	4.2	0.0	0.7	0.1	0.0	98.5	0.4	0.1	61.5	255.8	0.0	0.0	0.0	2.4	62.1	13.7	17.4	40.9	23.3	38.3	60.3	5.8	50.0	2.5	4.5	55.7	36.5	0.5	61.9	0.8	101.7	70.4	15.5	0.0	46.9	0.0	0.0	0.0	3.2	0.0	6.6	0.0	1.3	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	37.7	61.6	57.1	50.0	38.8	43.5	57.3	53.6	56.2	44.8	49.2	83.9	17.0	6.4	7.5	0.0	1.5	0.0	134.2	0.0	8.0	19.7	137.1	149.9	0.0	204.5	35.3	22.0	10.4	0.5	2.7	77.0	3.9	352.1	0.3	115.2	9.2	15.2	8.5	0.0	0.0	139.5	15.1	3.0	91.3	90.1	1.3	0.0	0.0	0.5	0.9	16.8	0.0	38.8	0.0	1.0	0.0	1.6	0.0	1.9	0.0	0.0	2.6	21.7	0.0	0.0	0.0	128.8	85.2	0.0	1.6	97.4	209.8	1.4	91.1	234.9	0.0	0.8	2.7	0.6	35.1	20.3	0.0	0.8	3.5	0.1	87.2	205.8
POLL		ENSG00000166169	"DNA polymerase lambda"	Q9UGP5	10	101578882-101588270	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076828			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA076828: "	"unprognostic (3.71e-3)"	"unprognostic (6.93e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.47e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.64e-3)"	17.4	22.4	17.3	12.4	18.0	12.8	19.6	15.9	19.0	21.1	18.2	21.8	16.8	19.4	22.6	18.1	22.1	15.6	19.9	17.5	16.0	24.8	26.9	15.6	17.0	16.3	16.3	26.3	45.6	21.3	28.5	13.7	17.2	26.0	17.1	17.4	20.8	15.4	34.4	16.1	18.7	14.2	14.1	22.7	27.6	41.4	17.1	7.4	26.1	18.2	17.1	20.9	17.7	17.4	23.5	21.0	16.2	23.0	16.2	30.0	22.7	15.3	26.4	22.9	23.9	15.5	27.8	5.7	23.5	13.9	12.6	28.8	18.4	22.6	18.4	20.8	24.8	18.1	23.1	17.7	29.8	19.0	16.2	27.5	30.3	25.0	51.8	64.1	24.7	11.1	20.4	19.2	14.7	18.8	0.0	20.8	8.6	13.0	12.4	0.1	14.6	9.9	19.2	14.1	11.2	16.6	9.4	15.7	26.5	23.8	47.3	11.0	13.5	8.1	16.4	9.8	16.8	28.4	15.3	8.9	17.5	16.6	6.3	0.6	9.2	1.3	6.5	6.6	10.6	8.4	7.4	6.8	11.6	6.8	11.7	8.0	1.0	9.5	6.7	0.2	10.2	7.6	17.3	18.0	15.9	19.0	17.5	16.0	16.3	16.3	17.2	14.1	17.1	17.4	7.5	6.4	12.9	13.7	11.4	3.7	6.7	9.7	7.4	16.9	14.7	19.0	8.6	11.5	7.4	7.3	47.9	16.9	7.5	9.1	5.9	9.6	25.2	7.3	7.5	7.6	13.1	25.9	10.4	21.5	9.8	9.6	20.9	6.6	14.0	20.9	8.6	10.9	11.2	21.9	7.9	13.6	18.3	17.7	6.0	51.6	14.0	9.6	10.6	2.8	18.0	10.1	13.4	8.5	9.9	13.7	9.2	11.3	10.9	6.5	13.7	11.6	7.2	24.0	13.1	10.8	9.6	35.5	11.0	8.4	2.0	11.5	9.4	14.4	15.6	5.6
PPP1R36	C14orf50	ENSG00000165807	"Protein phosphatase 1 regulatory subunit 36"	Q96LQ0	14	64549920-64589381	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 12.5;testis: 37.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 350.6;Late spermatids: 791.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"CAPAN-2: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077492	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 22: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA077492: AB_2732348"	"unprognostic (3.43e-4)"	"unprognostic (5.75e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.04e-4)"	"unprognostic (1.12e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.52e-3)"	"unprognostic (9.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.80e-3)"	"unprognostic (9.77e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.12e-2)"	"unprognostic (5.46e-2)"	1.9	0.5	1.2	0.4	1.6	0.0	1.4	1.2	2.0	1.0	1.6	6.5	6.6	0.9	3.0	0.6	12.5	2.0	0.5	1.2	1.4	2.4	0.1	1.2	0.2	1.8	1.6	0.1	10.8	0.4	1.9	0.9	2.1	0.2	5.6	0.1	3.8	0.3	0.2	1.0	4.7	0.5	1.8	0.1	7.2	37.1	1.5	0.2	0.2	0.6	0.3	0.9	0.3	2.2	0.2	0.1	0.3	0.1	1.4	0.7	1.0	0.8	0.4	0.5	1.2	0.2	13.9	0.0	0.1	0.7	0.5	0.4	0.0	0.0	0.6	0.1	0.1	0.4	0.8	0.1	0.8	0.0	0.1	0.9	0.7	0.2	0.5	0.9	0.3	0.1	0.0	0.0	0.7	0.8	0.1	0.4	0.0	0.4	0.0	0.1	0.1	0.1	0.5	0.6	3.0	0.1	1.4	0.1	0.0	0.2	0.1	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.2	0.0	1.2	1.6	1.2	2.0	1.2	1.4	1.8	1.6	2.1	1.8	1.5	2.2	1.5	0.0	0.6	2.3	0.5	0.5	0.5	1.6	1.8	0.0	2.7	4.6	0.7	4.3	6.3	3.7	0.0	0.4	1.5	5.0	1.9	0.9	350.6	44.3	1.6	3.2	4.2	0.0	1.7	8.2	2.5	0.8	6.6	6.4	0.0	0.1	2.9	0.0	0.4	0.0	1.4	7.3	0.0	0.6	0.7	791.2	3.4	1.4	0.0	3.7	0.1	0.8	2.1	0.0	5.8	6.8	3.4	3.8	0.3	0.2	8.1	0.1	36.2	0.2	0.0	3.2	1.4	124.8	8.0	1.8	0.4	0.5	0.5	0.2	6.6	0.9
PPP2R2D	"B55D, B55delta, MDS026"	ENSG00000175470	"Protein phosphatase 2 regulatory subunit Bdelta"	Q66LE6	10	131901008-131959834	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 15.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA042122, HPA042770"	Approved		Approved	Cytosol		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA042122: AB_2677859, HPA042770: AB_2678155"	"unprognostic (7.75e-3)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.57e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.46e-2)"	"unprognostic (8.04e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.90e-2)"	1.5	3.0	4.5	1.2	5.4	0.0	1.4	7.0	5.8	2.1	3.8	2.8	2.1	1.6	2.0	1.6	1.6	1.6	3.3	4.9	4.1	1.8	1.6	2.3	2.4	4.1	4.1	3.6	15.9	3.2	2.3	1.9	4.1	1.8	1.9	2.8	3.3	1.9	2.8	2.7	2.4	1.3	3.6	1.8	2.1	1.3	4.6	1.7	2.2	2.9	1.5	2.3	1.9	4.9	4.4	3.8	2.4	1.8	3.3	2.6	3.4	1.5	3.1	2.9	3.1	3.1	3.6	1.8	1.0	1.8	1.8	7.9	3.2	0.7	3.1	4.5	4.2	3.0	3.7	1.8	1.1	3.2	3.4	0.9	6.7	3.2	4.5	4.6	2.0	2.6	3.9	0.8	3.2	2.1	1.5	7.3	1.5	1.5	3.4	2.0	1.6	0.5	2.3	0.6	1.9	2.6	1.9	1.6	1.8	2.5	1.4	2.4	2.8	1.6	0.7	2.3	8.1	2.8	1.6	2.3	1.4	1.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	5.4	7.0	5.8	4.9	4.1	4.1	4.1	4.1	3.6	4.6	4.9	26.8	19.2	14.3	22.2	20.0	37.3	37.4	6.4	20.5	55.0	25.8	23.6	36.3	14.3	10.2	9.2	10.4	10.6	36.1	27.6	19.6	9.8	12.7	21.5	24.8	19.0	10.7	18.7	43.0	17.7	13.6	21.8	19.9	32.3	6.3	33.1	13.2	23.2	14.1	52.2	37.5	18.2	8.2	12.0	17.6	6.4	17.4	23.3	12.4	26.2	10.5	28.3	18.6	29.7	38.1	16.8	18.0	20.7	20.3	39.1	20.0	29.6	5.7	32.6	26.3	29.2	23.2	14.3	20.1	18.8	34.0	11.8	24.4	39.5	19.1	39.6
PSAT1	PSA	ENSG00000135069	"Phosphoserine aminotransferase 1"	Q9Y617	9	78297125-78330093	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 175.0;liver: 267.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 115.5;Glandular and luminal cells: 145.9;Hepatocytes: 161.7;Proximal tubular cells: 304.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 15.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 15.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 1170.1;SK-MEL-30: 752.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014882, CAB040567, HPA042924"	Enhanced		Enhanced	Cytosol		NA	NA		2400000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"CAB014882: , CAB040567: , HPA042924: AB_2678223"	"unprognostic (8.26e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (4.05e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-7)"	"unprognostic (3.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.71e-1)"	7.8	65.8	123.3	7.3	124.6	2.0	5.1	130.5	175.0	5.1	92.8	5.9	5.4	4.3	61.6	33.2	34.7	1.7	2.7	122.4	126.5	136.7	267.9	5.1	9.3	130.2	122.4	5.6	129.1	9.7	7.6	3.0	129.9	10.0	5.5	6.2	19.2	4.0	0.6	57.2	4.5	3.3	133.6	6.0	19.4	10.4	120.3	30.0	30.3	0.5	12.4	7.3	11.2	161.6	222.8	146.0	121.1	215.6	35.1	41.2	284.7	184.3	130.4	91.8	170.6	38.2	41.9	143.2	79.8	416.9	82.9	215.3	209.1	203.6	136.4	141.2	73.9	49.2	60.8	293.3	322.0	277.6	84.6	131.1	1170.1	122.0	322.9	22.6	85.0	548.3	53.8	358.2	77.1	83.2	95.8	44.3	278.2	415.1	158.4	46.5	78.6	173.4	126.6	50.9	54.9	127.0	51.1	87.7	752.3	75.9	42.0	344.1	19.9	23.2	73.5	85.9	151.5	242.0	242.7	0.8	268.9	215.6	112.1	0.0	0.0	0.0	5.2	0.0	5.9	3.1	5.0	7.0	0.3	1.3	8.1	7.5	0.3	0.0	0.1	0.0	15.1	3.3	123.3	124.6	130.5	175.0	122.4	126.5	130.2	122.4	129.9	133.6	120.3	161.6	0.4	0.0	0.0	70.2	11.0	41.9	8.8	18.9	115.5	0.9	1.8	3.9	0.6	1.5	4.7	11.0	0.0	32.0	2.2	2.0	62.6	11.5	1.7	77.7	10.3	3.7	3.6	29.9	7.3	48.4	13.7	4.2	6.6	145.9	0.0	0.5	3.6	161.7	5.3	5.0	6.0	4.8	18.3	4.4	2.9	3.8	5.0	3.4	19.6	5.6	3.8	26.7	0.0	48.2	78.8	22.7	0.1	1.9	29.1	16.0	0.3	304.1	3.8	1.1	0.0	33.5	14.3	1.6	3.7	35.5	50.7	9.3	8.6	68.2	4.2	11.8
PTPRN2	"IA-2beta, ICAAR, KIAA0387, phogrin"	ENSG00000155093	"Protein tyrosine phosphatase receptor type N2"	Q92932	7	157539056-158587823	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Protein phosphatase, Receptor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;pancreas: 98.1"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 131.1;Excitatory neurons: 439.6;Inhibitory neurons: 433.4;Oligodendrocyte precursor cells: 138.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 23.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 23.6"	"Cell line enhanced"	"Detected in many"		"AF22: 45.5;HDLM-2: 42.0;MOLT-4: 22.1;NB-4: 43.0;SCLC-21H: 23.8;SH-SY5Y: 25.4;U-87 MG: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006900, HPA007255, HPA026656"	Enhanced		Approved	Vesicles		NA	NA		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912"	"unprognostic (2.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (9.37e-5)"	"unprognostic (7.12e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.16e-2)"	3.8	16.5	29.4	2.7	34.3	1.3	2.9	0.0	49.9	2.1	0.0	7.7	8.3	3.0	4.2	1.9	10.8	7.6	3.1	35.2	22.7	3.9	1.6	4.8	3.4	7.9	3.1	8.7	98.1	1.0	41.0	2.1	3.4	17.3	6.1	9.2	12.9	3.6	1.2	0.8	6.7	2.1	0.1	13.4	40.2	6.2	14.1	1.6	8.7	1.9	2.5	4.2	2.1	20.5	0.1	0.4	45.5	3.6	0.1	0.2	0.1	0.4	0.3	0.0	0.1	0.0	4.0	0.0	1.2	0.5	9.4	0.3	1.0	0.0	0.0	42.0	0.8	0.0	0.0	7.3	1.1	0.0	0.1	2.0	0.8	0.1	0.5	0.3	0.0	3.4	0.1	0.3	0.0	0.7	22.1	43.0	5.7	13.7	3.2	0.0	2.7	0.2	0.2	0.0	23.8	25.4	0.0	0.1	0.0	0.0	0.0	20.9	6.2	9.2	4.3	0.1	1.5	0.3	0.1	0.0	27.7	17.4	6.8	14.1	1.5	2.8	1.3	0.2	0.5	3.5	2.1	1.4	2.1	4.2	2.4	1.4	23.6	2.4	0.0	0.6	5.3	1.3	29.4	34.3	0.0	49.9	35.2	22.7	7.9	3.1	3.4	0.1	14.1	20.5	40.7	3.2	12.9	16.3	18.4	2.3	12.7	1.3	4.0	30.2	1.9	2.2	3.1	10.0	9.1	40.5	10.4	0.4	8.7	5.9	35.2	22.9	51.9	8.7	2.5	26.3	131.1	6.6	439.6	13.1	0.4	13.0	41.8	0.8	19.0	14.1	44.3	0.8	44.5	11.8	433.4	43.3	6.1	7.0	11.3	19.3	12.5	7.9	12.4	27.2	5.7	67.3	15.5	138.2	11.0	7.3	7.0	19.5	5.4	15.0	6.5	3.8	52.6	8.0	26.3	1.4	7.0	62.8	16.3	4.8	1.4	0.7	14.8	32.7	9.7	24.8
RAB26		ENSG00000167964	"RAB26, member RAS oncogene family"	Q9ULW5	16	2140803-2154165	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.9;choroid plexus: 43.0;liver: 45.9;pancreas: 42.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 36.1;Enteroendocrine cells: 99.4;Excitatory neurons: 52.0;Inhibitory neurons: 28.3;Intestinal goblet cells: 41.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 20.1;HeLa: 23.2;MCF7: 13.5;SCLC-21H: 27.2;SK-BR-3: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075624			Uncertain	"Vesicles,Plasma membrane,Centrosome"	"Intracellular and membrane"	No	No				"Cluster 22: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Vesicles, Plasma membrane"	Centrosome	"HPA075624: "	"unprognostic (1.01e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (7.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.92e-3)"	0.3	1.1	53.5	0.1	55.8	0.2	0.9	57.7	84.9	1.7	43.0	5.7	5.6	0.2	1.8	1.6	0.6	0.8	1.8	60.7	46.2	1.4	45.9	0.3	0.3	48.0	45.4	0.2	42.7	3.4	34.0	0.0	49.1	4.9	5.1	6.8	18.4	0.8	1.1	1.5	6.4	0.1	44.0	0.7	13.7	1.0	47.6	0.3	1.7	2.1	0.8	0.8	0.7	51.9	1.7	20.1	0.1	5.1	0.3	0.1	0.1	0.9	1.6	0.7	1.3	0.6	4.0	0.3	1.4	1.3	0.6	3.2	1.1	0.4	0.1	2.2	2.1	0.8	23.2	1.8	0.8	0.0	0.6	0.8	0.2	0.2	0.3	4.6	0.4	3.2	0.4	0.0	2.3	13.5	0.1	1.0	1.2	6.5	1.8	1.7	1.6	3.5	7.7	1.4	27.2	5.4	0.6	24.9	1.0	0.3	8.2	0.3	0.9	0.0	3.5	0.4	0.4	2.9	0.1	0.3	0.5	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	53.5	55.8	57.7	84.9	60.7	46.2	48.0	45.4	49.1	44.0	47.6	51.9	0.2	0.0	1.1	6.5	1.3	1.3	1.6	1.4	8.0	36.1	1.4	1.4	1.6	1.5	3.4	0.0	4.2	0.0	0.0	2.6	0.0	0.4	0.1	1.0	0.3	0.4	99.4	0.0	52.0	1.0	0.0	0.4	12.8	0.4	0.0	0.5	1.1	8.1	0.2	1.7	28.3	41.9	4.1	0.3	0.0	0.1	0.0	0.1	3.6	8.4	0.0	10.7	0.0	20.1	3.6	0.5	1.8	0.0	3.8	1.5	10.5	0.6	2.3	9.1	0.0	0.3	0.3	0.0	2.4	1.5	0.1	0.1	0.2	0.3	3.2	2.6
RASEF	"FLJ31614, RAB45"	ENSG00000165105	"RAS and EF-hand domain containing"	Q8IZ41	9	82979590-83063177	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 41.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 101.7;Gastric mucus-secreting cells: 356.8;Prostatic glandular cells: 106.4;Respiratory ciliated cells: 100.6;Urothelial cells: 107.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 53.2;RT4: 38.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021431, HPA078596"	Approved		Uncertain	Microtubules		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Microtubules		"HPA021431: AB_1856087, HPA078596: "	"unprognostic (1.22e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	1.1	1.6	16.2	2.8	15.4	3.6	17.6	21.2	21.9	2.9	18.0	15.2	6.3	2.7	10.2	7.1	6.3	12.6	1.1	13.9	9.2	5.3	2.4	8.2	1.5	10.0	6.3	1.5	23.1	5.3	3.9	3.4	9.8	15.2	15.2	5.1	15.3	3.8	1.9	3.8	8.6	1.1	1.0	1.5	41.0	4.0	9.8	3.4	25.9	0.0	3.5	13.8	2.3	24.7	14.0	15.5	1.8	1.5	0.3	0.5	5.6	1.0	0.2	1.6	3.9	8.7	16.9	2.3	13.7	0.4	11.0	16.3	0.3	0.4	1.9	1.4	17.3	1.9	11.9	2.2	0.2	1.7	1.6	0.3	6.7	7.6	0.2	2.1	0.1	2.4	2.5	16.8	0.2	27.2	2.3	1.8	10.5	53.2	6.1	2.5	4.8	6.0	18.0	38.5	5.6	8.3	2.8	26.8	1.1	6.7	22.9	2.0	2.6	2.6	14.6	2.1	1.7	11.3	10.1	1.4	5.8	1.0	3.0	6.5	2.0	1.9	3.7	1.4	3.5	3.9	3.5	2.9	1.1	5.3	3.8	3.3	9.8	3.6	1.6	3.8	2.9	0.7	16.2	15.4	21.2	21.9	13.9	9.2	10.0	6.3	9.8	1.0	9.8	24.7	0.7	76.9	101.7	0.3	1.1	0.8	5.4	7.9	4.0	1.1	61.3	21.1	0.6	42.9	59.7	9.2	4.2	5.5	0.5	61.8	7.9	35.4	0.6	39.7	7.9	4.5	3.6	0.8	1.0	37.4	10.3	5.7	356.8	88.2	22.1	0.4	0.7	1.7	0.8	0.0	0.6	85.7	48.8	0.0	0.4	2.1	0.3	4.2	1.8	4.7	1.6	0.1	0.0	0.0	0.2	46.2	40.0	0.0	1.5	106.4	10.4	8.3	100.6	1.3	0.0	0.7	2.8	0.5	4.8	28.2	0.9	7.5	3.1	1.2	35.7	107.7
RETREG3	"DKFZp686B1036, FAM134C, FLJ33806"	ENSG00000141699	"Reticulophagy regulator family member 3"	Q86VR2	17	42579513-42610623	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 29.8;Collecting duct cells: 31.3;Pancreatic endocrine cells: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016492	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA016492: AB_1853027"	"unprognostic (6.79e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (5.57e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.24e-1)"	"unprognostic (5.68e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.43e-2)"	16.2	21.7	17.3	13.2	16.6	6.9	16.9	16.4	18.9	23.0	18.7	19.0	14.2	18.5	21.3	29.2	16.8	10.9	16.2	17.0	17.4	19.5	33.4	17.4	19.5	16.9	18.0	19.6	39.9	18.9	20.4	20.9	17.7	25.5	16.8	31.4	23.2	14.0	22.4	33.9	20.7	15.1	16.8	30.1	22.8	38.7	19.1	20.6	16.3	16.4	21.6	19.4	23.1	15.0	12.0	36.6	15.8	25.8	39.6	21.9	22.5	16.9	22.7	19.6	22.9	17.5	25.3	26.3	23.1	27.5	20.1	45.9	20.5	25.3	18.9	28.2	19.3	10.7	22.2	31.0	27.2	18.6	26.5	33.6	34.2	21.5	21.8	21.7	21.3	19.0	22.3	25.4	15.7	20.7	27.5	26.9	10.0	22.5	9.0	14.7	24.2	27.2	22.5	38.2	28.2	19.3	18.1	14.6	26.1	28.9	41.5	14.2	27.2	21.0	12.8	21.1	16.2	43.4	55.3	22.7	19.3	11.6	16.2	54.9	16.2	36.4	44.5	19.2	39.1	23.7	36.5	42.9	15.1	24.8	35.1	40.4	13.8	28.2	24.1	15.0	57.0	36.4	17.3	16.6	16.4	18.9	17.0	17.4	16.9	18.0	17.7	16.8	19.1	15.0	16.7	25.6	29.8	0.0	8.8	0.0	0.0	0.0	0.0	0.0	21.7	18.3	0.0	0.0	6.2	31.3	0.0	22.4	24.7	0.0	7.9	16.4	0.0	14.5	16.7	7.4	0.0	0.0	0.0	25.4	16.0	7.4	0.0	20.0	7.6	26.8	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	7.2	0.0	0.0	0.0	0.0	33.8	0.0	0.0	8.8	0.0	0.0	13.4	5.1	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	20.4	8.1	17.3	0.0	0.0
RHOBTB3	KIAA0878	ENSG00000164292	"Rho related BTB domain containing 3"	O94955	5	95713522-95824383	"Predicted intracellular proteins"	Transport	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Leydig cells: 397.3;Peritubular cells: 314.8;Skeletal myocytes: 347.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 7.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 7.3;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 250.6;HaCaT: 332.7;SuSa: 315.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000265			Uncertain	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA000265: "	"unprognostic (1.68e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.39e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.28e-1)"	"unprognostic (6.00e-3)"	"unprognostic (9.29e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.56e-3)"	"unprognostic (7.01e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.23e-1)"	"unprognostic (8.21e-2)"	79.8	38.3	58.8	11.9	81.2	8.1	23.8	59.1	64.2	27.7	12.1	22.5	14.8	13.1	27.0	17.0	16.5	19.7	33.7	55.6	47.8	28.3	21.7	16.9	6.8	81.5	56.4	83.0	111.1	55.6	13.2	54.0	52.1	28.8	20.8	29.0	41.9	20.6	29.8	13.2	16.6	20.6	50.6	11.3	22.6	21.4	64.5	8.3	19.9	32.7	2.3	25.5	13.4	67.4	53.7	20.4	51.1	55.1	188.4	108.5	0.5	91.0	86.4	34.7	54.0	96.5	9.6	0.2	250.6	45.8	88.5	332.7	27.7	6.6	59.4	2.2	36.6	18.3	185.8	28.9	148.6	4.3	25.5	176.6	4.8	52.0	0.9	147.6	27.0	15.5	74.7	13.4	139.3	14.8	5.8	14.9	19.7	33.4	33.4	8.2	100.3	6.5	29.1	35.6	90.3	118.9	71.8	31.0	85.7	315.9	23.6	26.3	44.5	46.1	195.7	31.1	35.8	13.5	28.3	2.7	14.8	1.1	76.8	0.1	0.6	7.3	1.9	0.3	0.7	0.5	1.4	1.6	0.1	0.1	1.8	0.4	0.4	0.3	1.0	0.8	0.8	0.6	58.8	81.2	59.1	64.2	55.6	47.8	81.5	56.4	52.1	50.6	64.5	67.4	23.4	176.3	13.3	229.9	5.4	10.8	65.8	25.9	13.6	68.3	81.2	44.1	79.4	44.3	49.8	141.6	20.9	62.2	15.7	21.4	60.7	69.7	11.4	55.3	118.6	15.7	92.0	32.6	35.2	111.0	139.7	201.3	3.1	76.8	100.1	178.3	14.3	77.3	33.3	6.7	57.3	66.9	14.2	23.0	11.6	22.1	397.3	20.4	42.7	30.0	3.7	270.3	71.1	117.6	64.8	40.7	70.1	314.8	7.1	53.8	19.9	3.1	33.7	35.9	32.9	347.6	99.2	4.6	8.8	10.1	27.4	115.2	9.8	177.2	84.5	102.2
RNF214	DKFZp547C195	ENSG00000167257	"Ring finger protein 214"	Q8ND24	11	117232625-117286454	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 20.5"	"Group enriched"	"Detected in all"	5	"granulocytes: 6.4;T-cells: 20.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039332	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA039332: AB_10671874"	"unprognostic (7.36e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (2.06e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.28e-2)"	10.9	11.7	8.9	8.8	10.2	12.4	10.8	10.5	9.9	11.4	6.0	10.8	9.4	11.0	8.5	9.2	9.9	8.9	10.5	7.8	10.1	10.3	13.2	9.1	10.8	9.9	9.4	13.2	21.8	11.5	12.5	11.0	9.6	9.6	9.4	12.2	11.3	10.0	17.9	10.1	10.1	11.2	7.3	11.4	12.7	18.6	10.4	14.4	13.5	13.4	10.6	11.0	9.6	11.9	12.0	14.1	31.7	19.1	15.6	15.6	17.9	19.3	17.5	20.5	21.7	21.6	28.1	16.8	32.7	22.6	19.6	15.7	34.8	16.9	21.1	31.3	10.2	53.3	11.7	16.6	30.5	25.2	19.8	14.4	18.2	25.4	37.6	23.1	25.7	29.0	30.7	17.9	21.1	9.0	20.8	21.0	17.2	20.7	14.0	22.5	21.1	22.4	19.3	17.8	20.5	22.2	22.1	14.8	10.4	24.7	25.1	16.9	24.4	20.7	16.6	11.4	16.3	10.3	7.7	20.2	7.6	20.3	24.3	6.4	2.5	2.7	2.3	2.4	1.4	1.9	7.8	4.0	2.2	1.9	2.2	2.1	1.1	1.2	2.5	2.5	20.5	1.6	8.9	10.2	10.5	9.9	7.8	10.1	9.9	9.4	9.6	7.3	10.4	11.9	19.1	25.6	15.1	23.5	14.8	5.0	9.6	10.6	21.6	23.8	11.1	14.5	12.8	15.7	14.8	5.5	10.4	14.9	10.0	9.0	9.8	13.3	46.8	15.7	26.2	11.9	9.0	14.7	20.9	12.7	13.6	12.9	14.8	15.5	5.1	21.6	7.9	7.1	12.8	13.5	24.7	8.5	10.2	10.6	6.3	20.0	10.2	13.5	8.8	12.2	12.7	14.0	14.4	33.7	24.5	10.6	9.8	12.8	14.9	7.1	10.6	12.1	10.0	37.1	13.1	20.9	19.5	64.6	57.5	15.5	5.1	19.4	17.8	28.2	8.8	7.6
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.5;pancreas: 67.1;pituitary gland: 38.5"	"Cell type enriched"	"Detected in some"	5	"Enteroendocrine cells: 600.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2;renal cancer: 22.6"	"Group enriched"	"Detected in many"	4	"cerebellum: 23.6;hippocampal formation: 14.5;hypothalamus: 43.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;CACO-2: 6.4;HEL: 4.6;Hep G2: 3.6;SCLC-21H: 24.7"	"Region enriched"	"Detected in many"	16	"olfactory bulb: 82.0"	"Region enriched"	"Detected in some"	9	"olfactory bulb: 137.1"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Cytosol		"CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		3.7	3.5	1.7	3.4	1.2	0.2	3.3	23.6	2.9	0.1	0.1	16.9	12.4	0.0	0.0	0.2	0.1	0.9	11.7	14.5	43.5	1.4	4.1	0.8	0.1	1.7	2.3	0.3	67.1	0.1	38.5	3.3	6.1	2.0	19.2	1.0	2.5	0.1	0.0	0.6	11.5	1.2	1.4	0.0	18.9	0.6	0.9	0.4	1.9	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	24.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.2	23.6	2.9	14.5	43.5	1.7	2.3	6.1	1.4	0.9	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.0	0.6	0.5	107.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.1	0.0	0.0	2.2	600.1	0.0	0.2	0.4	0.2	0.3	9.2	0.0	0.0	0.9	3.3	0.5	0.1	0.0	1.8	14.3	4.1	0.0	0.0	0.2	0.6	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	4.8	3.7	0.0	0.0	3.7	1.1	3.1	0.0	0.0	13.1	0.0	9.1	0.2	1.1	0.0	0.0	0.0	0.1	0.5	2.2	0.3
SEC11C	"SEC11L3, SPC21, SPCS4C"	ENSG00000166562	"SEC11 homolog C, signal peptidase complex subunit"	Q9BY50	18	59139866-59158832	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ionocytes: 685.6;Muller glia cells: 544.7;Plasma cells: 1164.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 523.5;Karpas-707: 546.2;RPMI-8226: 1150.0;U-266/70: 587.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026816, HPA047533"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane"	"Golgi apparatus"	"HPA026816: AB_10602089, HPA047533: AB_2680078"	"unprognostic (1.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.13e-3)"	"unprognostic (4.48e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.83e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.15e-1)"	24.6	76.7	110.0	86.5	117.5	63.1	81.8	122.9	140.5	57.8	94.4	92.3	126.7	40.1	284.6	42.5	41.4	47.3	30.0	112.9	146.4	70.2	219.0	62.7	104.2	137.3	130.2	29.9	374.0	153.9	155.2	28.4	136.8	225.7	78.2	108.1	397.3	62.3	15.7	29.7	97.8	30.1	123.7	81.4	138.5	28.1	113.5	53.0	163.7	20.0	117.8	59.4	21.2	135.8	82.4	100.0	52.9	74.1	31.9	6.8	64.7	72.4	62.9	89.9	55.2	78.3	42.5	176.8	109.9	46.6	67.6	82.8	84.7	59.0	58.4	523.5	113.8	58.5	69.3	242.3	99.3	199.4	87.6	20.4	140.7	56.2	161.1	20.2	33.7	78.4	67.4	546.2	34.6	100.0	79.0	79.2	48.1	140.4	60.5	72.8	50.0	1150.0	67.5	76.1	223.2	90.5	43.1	162.5	252.8	29.9	76.0	148.5	24.7	98.5	45.4	36.5	86.9	587.3	434.4	176.0	99.4	131.8	124.5	76.4	70.7	57.9	146.1	97.6	187.6	197.8	150.4	142.5	78.8	127.9	77.7	105.4	12.2	108.3	108.8	299.6	223.7	222.1	110.0	117.5	122.9	140.5	112.9	146.4	137.3	130.2	136.8	123.7	113.5	135.8	64.8	28.9	120.7	19.2	295.9	32.6	49.3	92.4	12.5	63.6	120.0	128.3	59.3	144.4	102.5	60.7	50.1	70.8	148.7	76.3	88.0	164.4	45.4	58.7	34.2	60.3	339.3	43.8	12.2	263.1	109.1	29.2	60.6	147.1	47.5	21.5	56.4	224.7	112.9	50.5	13.3	223.1	685.6	37.1	56.9	18.8	12.5	63.9	256.1	10.3	46.4	544.7	96.8	17.1	31.2	148.9	78.4	23.0	1164.8	380.9	99.3	118.8	81.3	89.3	6.6	23.1	70.6	110.2	81.5	35.5	45.5	149.7	92.3	40.1	88.3	79.2
SFT2D1	"C6orf83, MGC19825, pRGR1"	ENSG00000198818	"SFT2 domain containing 1"	Q8WV19	6	166319728-166342576	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014677	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA014677: AB_2238986"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (7.47e-4)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (3.64e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (4.20e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.75e-2)"	40.8	43.9	55.0	35.6	61.7	35.8	45.9	62.3	76.2	35.4	54.0	52.1	39.2	26.5	68.2	36.6	33.8	34.4	30.5	54.5	59.0	51.0	24.5	37.0	50.9	64.0	59.0	31.9	51.1	36.1	17.3	48.9	65.3	47.5	50.1	12.9	70.7	28.0	22.2	24.7	39.0	24.8	62.9	41.9	50.7	26.9	57.2	41.7	46.3	27.5	47.9	40.4	29.4	72.4	47.1	39.9	41.9	86.3	76.1	65.9	56.4	70.7	69.6	56.8	85.5	80.2	103.3	43.9	55.7	68.8	90.2	59.7	62.5	67.0	88.3	58.8	88.4	53.0	35.4	133.4	65.9	134.9	106.5	61.1	78.9	65.5	58.3	81.8	31.3	73.1	96.1	46.8	90.3	68.5	42.1	241.5	40.2	154.5	36.2	28.6	45.0	105.4	141.6	46.1	8.0	34.3	45.6	87.8	73.0	48.1	46.4	252.3	28.6	33.4	60.4	87.4	79.7	40.7	32.3	50.6	70.4	84.8	85.5	141.1	90.7	126.3	62.1	98.6	38.7	88.1	47.3	52.3	103.4	72.5	50.3	51.7	166.0	58.9	107.3	204.9	79.4	92.7	55.0	61.7	62.3	76.2	54.5	59.0	64.0	59.0	65.3	62.9	57.2	72.4	45.6	41.7	66.5	25.1	103.4	86.5	127.8	262.4	59.2	10.0	136.0	103.6	25.0	51.5	143.9	108.5	0.0	153.0	154.2	109.3	90.1	154.5	70.3	52.0	49.9	55.8	28.8	63.3	15.6	126.8	259.4	81.5	61.2	73.9	149.0	31.3	65.3	30.6	211.6	15.2	13.6	162.5	168.9	178.5	178.4	25.2	85.1	143.5	99.6	21.5	198.3	31.7	111.2	16.6	71.5	155.4	146.5	47.4	108.5	239.2	115.5	140.4	96.0	9.1	85.5	69.5	64.0	159.0	93.4	72.9	102.9	131.2	74.9	63.2	131.4	194.0
SH3BP4		ENSG00000130147	"SH3 domain binding protein 4"	Q9P0V3	2	234952017-235055714	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 83.5"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.0;plasmacytoid DC: 3.1"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 3.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037533, HPA037534"	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 35: Glandular cells - Unknown function"			"HPA037533: AB_10672903, HPA037534: AB_2675528"	"unprognostic (2.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.38e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.30e-1)"	"prognostic favorable (2.07e-6)"	"unprognostic (2.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.17e-2)"	12.4	9.0	17.8	5.7	21.8	1.1	35.3	21.7	15.9	20.8	20.4	13.8	17.2	12.5	14.5	7.7	17.5	19.0	10.2	14.5	16.2	18.3	26.1	13.2	2.2	21.3	21.1	22.5	61.3	5.8	4.0	18.2	20.5	20.3	13.7	2.4	83.5	16.8	9.5	16.6	11.1	13.6	15.8	5.6	25.6	10.2	19.7	4.7	11.1	9.4	3.8	9.4	7.5	28.1	49.3	30.6	77.7	5.8	33.8	22.4	35.2	70.2	66.6	54.6	48.8	23.5	28.8	0.0	19.0	140.4	126.8	26.1	22.6	47.2	64.8	0.2	10.3	0.0	39.5	64.1	55.8	0.0	0.1	43.9	69.9	76.6	41.4	52.4	58.7	0.1	0.4	0.2	81.4	37.8	0.1	0.2	42.5	56.2	16.8	0.0	16.0	9.3	50.0	9.9	47.9	19.3	15.8	101.4	42.7	55.2	11.9	0.2	47.2	59.8	52.2	47.1	45.7	0.0	0.1	0.2	55.6	0.1	89.2	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.1	17.8	21.8	21.7	15.9	14.5	16.2	21.3	21.1	20.5	15.8	19.7	28.1	23.5	3.2	9.1	4.2	1.0	14.8	50.2	15.6	14.2	2.3	37.3	18.0	6.6	18.6	22.5	7.3	6.2	8.7	3.9	6.0	9.8	24.7	3.4	21.4	10.9	22.9	6.6	1.3	0.7	24.8	29.9	11.7	14.8	29.2	1.3	10.0	17.2	26.8	2.1	3.3	1.4	9.1	16.2	1.4	13.1	4.9	8.1	10.9	24.9	20.6	2.6	1.3	0.0	18.1	52.4	39.6	6.3	9.4	0.2	96.9	0.8	1.9	20.7	0.7	0.0	1.9	12.4	0.8	2.8	8.8	11.1	37.1	0.5	5.5	18.0	30.4
SHC2	"SCK, SHCB, SLI"	ENSG00000129946	"SHC adaptor protein 2"	P98077	19	416583-460996	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 109.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 44.8;Hepatic stellate cells: 45.3;Hepatocytes: 56.7;Horizontal cells: 48.8;Oligodendrocyte precursor cells: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.9;HHSteC: 5.6;SCLC-21H: 12.6;SH-SY5Y: 11.4"									HPA006136	Approved		Approved	Cytosol		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA006136: AB_1856827"	"unprognostic (2.54e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (8.53e-4)"	"unprognostic (4.45e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.86e-2)"	"unprognostic (4.43e-2)"	16.0	19.9	21.4	1.6	17.9	0.1	17.5	9.5	31.1	28.2	5.1	22.0	6.3	24.2	2.0	5.0	23.6	10.9	18.2	17.0	32.0	12.2	63.8	17.3	1.7	24.9	18.6	14.1	109.8	7.0	48.0	7.6	19.6	32.6	0.4	1.2	24.5	5.1	5.0	10.2	10.6	2.9	15.7	26.6	21.4	9.6	29.0	0.3	32.7	1.2	0.3	10.0	11.7	19.0	0.0	0.1	0.4	0.1	0.0	0.0	0.6	0.5	2.5	0.3	0.0	0.0	0.4	0.0	4.9	0.0	1.2	0.4	1.1	0.0	0.0	1.1	1.7	0.0	0.0	2.8	5.6	0.0	1.9	0.3	0.0	0.0	0.0	2.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	1.9	0.0	12.6	11.4	0.0	0.0	0.0	2.3	0.3	2.0	0.0	0.5	3.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	17.9	9.5	31.1	17.0	32.0	24.9	18.6	19.6	15.7	29.0	19.0	44.8	6.4	8.8	33.3	0.5	1.9	2.0	0.8	0.6	11.4	11.3	10.0	9.9	18.6	1.5	0.0	2.1	0.1	0.9	0.1	0.0	25.2	2.5	2.8	4.9	16.6	8.4	2.7	22.1	38.5	0.1	9.5	3.6	4.1	0.0	15.4	45.3	56.7	0.9	48.8	33.1	3.5	6.1	5.3	1.7	7.2	9.0	0.4	8.8	15.0	1.0	29.5	0.0	49.8	28.4	21.1	0.1	11.3	0.2	11.3	0.3	0.4	1.4	3.5	0.0	4.5	13.8	14.7	11.0	0.4	3.1	0.0	1.0	1.6	0.9	3.7
SHISAL2B	FAM159B	ENSG00000145642	"Shisa like 2B"	A6NKW6	5	64690442-64718190	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	9	"brain: 3.0;pancreas: 4.9;stomach 1: 2.8"	"Group enriched"	"Detected in some"	13	"Breast glandular cells: 1.8;Pancreatic endocrine cells: 1.0"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 3.9"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 9.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA011778	Enhanced					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA011778: AB_1848382"	"unprognostic (5.83e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.25e-1)"	"unprognostic (5.01e-2)"		"unprognostic (1.49e-1)"		"unprognostic (9.12e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.84e-2)"	"unprognostic (5.36e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.60e-1)"	"unprognostic (6.99e-2)"	0.2	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.4	0.2	0.1	4.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	9.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.6	0.0	3.0	1.4	0.2	0.4	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC25A22	"EIEE3, FLJ13044, GC1, NET44"	ENSG00000177542	"Solute carrier family 25 member 22"	Q9H936	11	790475-798281	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.1;pancreas: 83.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 143.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014662	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria	Nucleoplasm	"HPA014662: AB_10600808"	"unprognostic (1.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (8.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.61e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	15.8	13.6	49.1	11.0	59.8	7.5	11.2	17.9	83.1	9.0	0.0	10.0	12.9	9.6	2.1	15.2	10.4	4.1	7.7	74.2	7.9	15.1	40.2	15.1	10.1	24.5	11.1	12.7	83.4	4.0	48.7	5.0	25.4	13.9	3.0	16.1	14.4	4.3	2.0	14.2	12.2	3.7	2.4	13.9	13.5	19.1	19.1	6.3	9.4	0.5	6.2	10.3	10.3	40.2	56.2	35.7	20.4	18.6	8.3	14.8	19.4	26.3	21.3	28.0	17.7	34.9	37.1	16.8	19.2	21.6	31.9	48.8	22.4	31.1	6.3	31.9	41.4	15.4	18.2	21.9	35.8	24.7	25.0	14.9	18.6	21.4	22.6	8.8	13.0	19.3	31.8	25.3	12.7	33.9	26.3	23.5	44.8	33.9	53.7	30.9	11.2	38.9	16.8	9.2	100.3	45.3	15.0	35.9	18.7	3.1	17.4	12.5	13.0	32.1	21.5	14.8	25.0	22.1	14.3	21.5	37.8	22.2	19.3	0.0	1.6	2.5	3.7	3.3	2.2	1.3	2.3	3.9	1.8	1.0	1.3	2.3	0.9	2.0	3.4	0.5	1.3	1.6	49.1	59.8	17.9	83.1	74.2	7.9	24.5	11.1	25.4	2.4	19.1	40.2	5.7	6.4	8.6	7.8	8.4	12.6	8.7	9.5	9.1	143.2	9.1	7.5	2.5	8.6	5.0	9.2	33.3	7.1	8.8	3.9	3.9	22.0	12.4	9.5	9.0	7.0	13.1	2.5	11.8	19.3	10.3	5.1	12.8	11.2	2.5	7.2	3.3	17.6	4.3	43.7	10.0	7.6	2.0	2.8	4.6	7.7	4.7	4.1	3.6	3.7	6.6	16.0	13.4	2.5	1.4	14.1	7.8	4.9	13.7	23.8	13.0	7.1	5.8	32.0	0.0	2.8	6.7	1.8	10.4	7.4	13.4	3.1	8.2	13.7	5.9	8.8
SLC39A11	C17orf26	ENSG00000133195	"Solute carrier family 39 member 11"	Q8N1S5	17	72645949-73092712	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 205.3;Excitatory neurons: 107.7;Oligodendrocytes: 360.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 217.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021455			Approved	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA021455: AB_2670710"	"unprognostic (2.29e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.45e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.96e-3)"	"unprognostic (3.85e-2)"	12.6	7.8	14.0	10.8	27.8	21.2	17.4	22.5	17.2	14.9	9.5	24.0	20.3	5.5	15.7	15.5	9.1	11.0	4.9	14.1	17.9	13.4	39.4	10.9	8.8	25.7	23.7	3.4	29.3	4.7	2.9	8.7	24.0	7.7	24.1	2.3	30.3	8.0	4.5	14.2	22.8	7.3	16.9	7.9	48.2	6.8	23.9	5.5	36.1	3.5	12.4	12.5	9.3	35.3	20.5	36.8	4.3	17.2	30.7	24.8	24.4	21.6	19.0	9.7	13.0	13.7	90.7	25.4	21.5	22.1	15.4	17.2	6.2	10.9	14.8	27.6	12.8	23.8	9.9	16.3	18.3	25.4	217.5	21.2	20.3	20.1	11.6	10.6	10.1	13.1	12.6	31.0	12.4	28.9	16.3	55.1	3.5	62.4	15.6	10.9	16.3	21.5	16.0	20.9	10.2	13.8	11.6	84.7	12.7	16.8	58.4	34.9	8.5	19.0	17.7	16.3	13.4	24.9	12.2	17.9	30.8	50.6	11.1	19.3	39.9	26.0	16.7	40.4	10.9	16.7	12.5	12.5	37.9	9.8	8.8	12.1	6.6	22.6	33.1	26.8	17.1	18.1	14.0	27.8	22.5	17.2	14.1	17.9	25.7	23.7	24.0	16.9	23.9	35.3	4.9	0.0	6.3	205.3	7.6	4.5	5.3	5.6	10.2	2.6	13.7	5.5	2.3	4.3	8.6	3.7	0.0	5.6	6.9	15.8	0.0	9.4	18.5	5.6	3.6	4.0	8.4	9.9	107.7	14.1	17.4	4.7	29.0	9.5	29.9	7.9	3.6	30.1	26.3	5.0	32.1	79.0	10.2	21.0	5.6	66.7	4.1	14.4	10.6	64.6	19.6	4.1	8.2	22.6	360.3	9.1	20.5	3.4	15.1	6.0	24.8	11.5	7.8	1.6	13.1	2.6	7.1	2.0	2.9	10.3	4.4	4.9	5.4	4.4	18.3	7.5
SLC4A4	"hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5"	ENSG00000080493	"Solute carrier family 4 member 4"	Q9Y6R1	4	71062667-71572087	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 119.5;pancreas: 260.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 819.1;Cholangiocytes: 133.0;Distal enterocytes: 282.9;Ductal cells: 129.2;Proximal tubular cells: 211.0"	"Group enriched"	"Detected in many"	5	"glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 13.0;fHDF/TERT166: 6.1;HBF TERT88: 5.7;hTERT-RPE1: 6.0;RPTEC TERT1: 15.4;U-138 MG: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022493, HPA035628, HPA035629, HPA079220"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220: "	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (7.69e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (7.00e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.04e-1)"	5.1	0.7	30.0	2.2	43.6	0.5	1.0	47.0	32.5	11.5	0.0	41.1	54.3	0.4	0.3	1.2	0.9	29.4	6.2	21.5	37.9	119.5	21.7	6.9	0.2	38.6	28.0	0.8	260.3	17.2	5.8	2.7	24.8	34.7	41.2	5.1	2.5	1.1	2.2	0.1	14.6	1.7	38.2	0.8	18.6	0.5	38.5	3.5	22.0	3.5	0.0	4.5	0.4	33.2	0.0	3.5	1.0	0.0	0.0	0.0	0.1	13.0	1.9	2.2	1.6	0.0	0.1	0.0	0.1	6.1	0.5	0.0	0.2	0.0	5.7	0.0	1.7	0.9	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	6.0	0.0	0.7	0.0	0.5	1.2	0.0	4.8	0.2	0.1	0.2	0.0	0.0	0.0	0.9	15.4	4.1	0.9	0.1	0.0	0.0	0.2	1.3	0.0	0.0	0.0	7.7	0.7	5.5	0.6	0.0	0.0	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	30.0	43.6	47.0	32.5	21.5	37.9	38.6	28.0	24.8	38.2	38.5	33.2	1.5	3.2	37.1	819.1	2.2	0.0	4.3	3.2	0.6	3.2	0.9	0.3	24.0	133.0	31.1	25.8	0.0	0.3	7.2	282.9	15.6	129.2	11.5	2.8	0.5	1.3	8.5	4.0	51.4	24.2	0.1	4.9	33.1	5.8	1.3	0.6	3.9	35.8	0.2	0.0	93.4	65.6	2.0	0.6	0.2	1.5	0.0	2.3	1.8	34.7	1.0	3.9	1.0	29.1	3.7	16.2	60.8	0.0	1.7	40.8	31.8	211.0	10.4	1.5	6.6	1.0	6.2	0.1	1.0	5.5	0.0	0.3	6.8	2.4	68.1	12.3
SMAP1	"FLJ13159, SMAP-1"	ENSG00000112305	"Small ArfGAP 1"	Q8IYB5	6	70667776-70862011	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 325.7;Late spermatids: 281.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030574	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA030574: AB_10601589"	"unprognostic (1.55e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.73e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.22e-1)"	17.0	12.8	24.4	16.1	27.8	18.6	13.6	19.5	44.8	15.2	13.3	27.5	26.8	14.1	18.0	28.4	10.2	17.4	23.1	27.6	24.3	14.1	16.6	14.9	15.4	22.7	25.3	11.1	37.2	28.5	8.6	16.1	23.7	17.6	28.3	24.8	18.0	15.2	32.9	20.4	26.7	19.7	20.1	13.7	20.9	30.9	24.4	24.8	21.1	20.1	22.4	18.1	16.1	29.2	60.3	18.6	28.5	35.3	26.0	33.9	46.4	26.6	29.5	21.4	20.9	27.9	17.4	31.4	28.1	32.0	30.5	18.5	27.4	28.1	35.5	36.3	39.4	34.7	16.5	23.6	17.2	25.5	28.0	22.3	31.3	24.2	29.2	39.6	34.2	16.1	33.8	36.9	33.8	35.0	19.2	31.4	21.3	30.9	21.9	36.0	107.9	51.8	38.1	36.0	40.7	28.7	16.9	23.3	17.1	24.2	31.0	37.3	33.6	17.2	29.7	11.4	23.5	34.3	32.9	16.0	13.0	29.4	24.2	35.0	16.4	18.4	18.2	18.3	20.7	14.8	24.3	21.0	14.0	12.7	12.1	15.7	22.6	25.6	20.0	13.7	25.3	23.4	24.4	27.8	19.5	44.8	27.6	24.3	22.7	25.3	23.7	20.1	24.4	29.2	45.0	38.5	39.4	58.1	39.3	66.9	37.7	66.9	33.0	51.8	39.6	47.2	38.8	52.9	46.0	38.6	37.5	26.2	47.6	111.3	54.8	78.9	325.7	26.1	46.8	43.2	41.9	28.8	120.1	151.0	48.8	40.3	64.7	52.1	48.2	42.9	58.5	41.3	56.6	55.5	104.3	82.3	61.1	61.2	59.8	281.1	50.7	53.0	32.0	60.0	64.1	69.7	64.9	115.6	72.7	108.2	99.5	67.0	51.8	76.3	92.6	69.6	21.1	38.6	65.7	36.3	53.3	105.2	84.2	89.3	77.3	31.7	64.9	44.1	75.8	51.6
SMOX	"C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO"	ENSG00000088826	"Spermine oxidase"	Q9NWM0	20	4120980-4187747	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 61.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 48.4;Erythroid cells: 89.7;Macrophages: 73.3;Pancreatic endocrine cells: 131.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.0;myeloid DC: 2.4;neutrophil: 3.6;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;granulocytes: 3.6;monocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"A549: 119.6;Karpas-707: 201.7;RPTEC TERT1: 91.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047117, HPA060198"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nuclear membrane, Vesicles, Cytosol"	"HPA047117: AB_2679940, HPA060198: AB_2684220"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.33e-6)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (4.92e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (4.08e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.07e-1)"	8.5	4.4	50.9	4.4	61.3	32.2	5.3	54.5	60.9	17.7	32.8	5.6	10.6	10.8	7.1	8.5	7.4	15.1	6.8	46.3	51.7	20.5	8.5	4.9	4.8	56.6	54.4	12.5	32.5	25.2	13.2	6.2	53.7	12.2	1.2	2.9	12.1	7.9	4.3	11.9	8.1	4.0	53.0	6.4	20.1	5.8	55.5	4.3	6.8	2.8	2.6	8.2	12.4	54.1	11.0	119.6	8.3	6.3	5.5	8.2	14.6	15.6	29.8	11.1	7.4	49.5	29.6	0.0	5.1	14.4	18.0	21.6	6.8	7.5	4.8	0.0	3.5	21.5	4.1	50.6	35.0	4.1	8.3	31.3	13.1	23.1	9.8	13.4	19.8	16.7	4.8	201.7	6.7	3.3	8.1	12.1	10.2	10.7	16.3	7.3	10.3	29.1	91.4	8.3	1.6	7.2	28.9	3.4	54.1	4.2	0.3	5.1	24.0	12.7	12.0	2.3	12.2	9.1	1.7	0.1	10.6	5.4	9.8	0.0	1.0	0.2	0.0	0.4	0.0	0.1	0.2	0.2	2.4	0.0	0.0	0.0	3.6	0.3	0.1	1.1	0.0	16.0	50.9	61.3	54.5	60.9	46.3	51.7	56.6	54.4	53.7	53.0	55.5	54.1	4.4	0.0	0.5	38.5	3.8	12.6	12.0	14.4	6.8	0.5	6.9	4.6	1.7	12.8	6.3	11.0	0.0	0.4	0.2	1.4	0.0	48.4	4.0	9.2	15.8	11.2	6.0	89.7	1.6	30.5	0.8	11.3	6.6	18.7	5.7	10.4	13.6	2.3	20.6	0.0	3.5	3.0	6.1	3.1	10.2	7.7	14.6	73.3	8.8	5.6	22.6	25.4	1.0	9.0	6.2	131.3	1.5	13.5	7.4	13.1	4.0	3.8	1.2	1.4	0.0	2.7	10.2	19.1	7.8	2.1	10.5	0.3	2.1	1.9	3.7	12.6
SOX9	"CMD1, CMPD1, SRA1"	ENSG00000125398	"SRY-box transcription factor 9"	P48436	17	72121020-72126416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.7;salivary gland: 80.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.0;Basal squamous epithelial cells: 166.8;Breast glandular cells: 141.0;Cholangiocytes: 190.1;Gastric mucus-secreting cells: 144.8;Muller glia cells: 141.3;Squamous epithelial cells: 273.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 78.1;Hep G2: 97.0;OE19: 74.3;U-251 MG: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001758, CAB022456, CAB068240"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB022456: , CAB068240: AB_2665670, HPA001758: AB_1080067"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.32e-3)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.21e-2)"	3.1	2.2	54.7	4.4	50.4	0.1	28.0	42.3	58.5	7.4	46.8	17.1	19.7	2.9	0.9	13.7	7.5	13.0	15.8	50.6	49.3	12.7	3.5	3.1	1.1	73.7	72.2	0.3	38.4	0.1	10.3	0.3	48.8	24.8	17.8	15.0	80.1	10.9	2.7	23.3	15.1	1.2	56.9	0.2	40.5	30.7	51.4	0.5	20.2	1.2	4.4	1.9	6.4	49.0	31.1	19.2	38.9	78.1	3.9	1.1	0.1	4.8	4.2	8.2	4.4	27.0	40.8	0.0	2.9	1.1	43.8	31.3	0.0	18.6	7.5	0.0	2.5	0.0	4.2	97.0	0.3	0.0	0.1	0.7	1.6	9.5	9.0	47.0	0.0	0.0	0.0	0.1	11.7	0.4	0.0	0.1	1.5	74.3	29.1	0.0	31.4	0.4	35.2	2.0	1.9	1.9	4.0	4.7	0.1	21.0	16.7	0.2	0.0	15.8	42.0	8.5	66.5	0.0	0.0	0.1	11.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.7	50.4	42.3	58.5	50.6	49.3	73.7	72.2	48.8	56.9	51.4	49.0	1.1	12.8	5.6	160.0	1.9	55.4	88.2	28.9	166.8	3.0	141.0	108.2	13.6	190.1	21.1	36.8	0.0	0.3	2.8	52.1	7.9	55.3	5.1	18.4	0.9	3.2	59.7	0.0	3.1	46.7	0.0	26.0	144.8	21.7	4.5	1.9	0.0	3.4	0.2	0.0	1.5	99.0	24.4	0.0	3.4	14.5	4.4	2.3	12.4	9.4	1.0	141.3	0.0	4.5	11.1	40.8	39.1	0.4	2.8	81.1	17.7	61.0	36.4	6.8	6.6	59.9	14.5	10.2	3.1	273.5	17.8	0.1	2.8	0.1	103.8	77.2
SPATA2L	"C16orf76, MGC26885, tamo"	ENSG00000158792	"Spermatogenesis associated 2 like"	Q8IUW3	16	89696357-89701705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041182, HPA042453"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA041182: AB_2677352, HPA042453: AB_2678005"	"unprognostic (1.22e-1)"	"unprognostic (9.04e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.13e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.86e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.86e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.55e-1)"	6.7	5.1	5.7	2.3	6.6	5.0	4.9	4.8	8.7	3.9	5.2	6.2	5.9	6.1	0.7	5.8	6.2	2.2	4.9	8.0	4.9	10.3	13.6	7.1	1.5	4.9	3.8	5.4	14.2	2.2	16.7	1.8	3.1	5.9	0.8	0.6	5.7	1.3	1.3	7.7	7.1	1.4	2.6	6.0	6.9	4.9	4.2	1.7	7.0	0.3	0.8	3.8	3.5	6.3	7.4	5.8	2.0	9.6	1.5	1.6	10.7	4.9	2.3	2.3	1.5	11.1	6.2	2.5	6.6	1.6	3.1	12.5	1.8	2.8	0.5	2.5	19.9	1.7	2.2	15.3	5.1	1.3	5.0	1.6	3.5	3.6	1.1	2.6	2.6	2.9	7.7	1.7	1.6	34.0	4.3	8.0	5.4	7.6	7.5	9.4	1.0	7.4	3.4	2.6	11.0	7.0	5.3	5.4	6.5	0.9	14.0	5.7	6.7	2.3	8.5	0.4	2.3	4.2	2.8	2.3	6.9	4.1	4.4	2.8	4.0	5.3	5.5	6.5	3.9	3.7	3.9	4.2	4.4	4.1	3.5	3.9	13.7	2.1	4.9	4.6	3.7	4.1	5.7	6.6	4.8	8.7	8.0	4.9	4.9	3.8	3.1	2.6	4.2	6.3	5.9	3.2	0.5	2.3	10.8	15.7	18.7	7.7	5.2	9.5	11.0	6.6	0.4	7.2	3.1	11.0	0.0	8.7	18.4	27.8	1.9	13.7	7.4	7.6	3.2	6.3	23.8	0.0	13.6	13.8	5.7	6.4	9.2	9.3	4.5	2.1	6.1	5.7	7.4	3.3	7.1	7.6	14.2	6.1	13.2	1.5	2.8	9.1	8.8	2.8	4.3	6.6	8.2	2.5	1.3	12.7	21.8	2.2	8.6	12.7	32.3	10.3	1.5	8.0	0.0	9.3	7.0	2.7	2.5	2.6	19.9	24.9	10.5	4.7	9.3	11.7
SPATA45	"C1orf227, LOC149643"	ENSG00000185523	"Spermatogenesis associated 45"	Q537H7	1	212830141-212847649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"pancreas: 2.9;testis: 11.8"	"Group enriched"	"Detected in some"	24	"Early spermatids: 151.6;Late spermatids: 139.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-698: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049921	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	"Nuclear speckles, Cytosol"		"HPA049921: AB_2680953"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.05e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.39e-4)"	"unprognostic (1.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.64e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (9.50e-2)"	"unprognostic (2.67e-3)"	0.2	0.1	0.3	0.1	0.5	0.3	0.3	0.4	0.9	0.1	0.0	0.3	0.1	0.3	0.7	0.2	0.7	0.4	0.1	0.2	0.4	0.3	0.4	0.4	0.8	0.7	0.4	0.1	2.9	0.1	0.3	0.3	0.5	0.3	0.1	0.6	0.0	0.0	0.2	0.0	0.2	0.5	0.5	0.5	0.2	11.8	0.6	0.1	0.4	0.5	0.4	0.2	0.0	0.7	0.1	1.5	0.3	0.9	0.2	0.7	0.9	0.1	0.0	0.3	0.4	0.3	0.2	0.3	0.0	0.0	0.6	0.1	0.6	0.0	0.3	1.4	0.0	0.0	0.0	0.8	0.4	0.0	0.6	0.5	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.6	0.8	0.9	0.1	0.3	0.2	0.3	0.5	0.8	0.1	0.0	0.7	0.1	0.3	1.0	0.6	0.0	0.0	0.3	0.2	0.5	0.0	0.3	0.0	0.7	0.4	0.4	0.7	1.7	0.1	0.6	0.4	0.0	0.1	1.6	0.2	0.3	0.3	0.1	0.0	0.0	0.2	1.1	0.2	0.3	0.8	0.1	0.2	0.0	0.1	0.1	0.3	0.5	0.4	0.9	0.2	0.4	0.7	0.4	0.5	0.5	0.6	0.7	0.2	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	5.9	0.0	151.6	0.1	0.0	0.2	0.0	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.3	0.0	1.3	0.0	0.0	0.0	0.0	139.9	1.5	0.2	0.0	1.0	0.6	0.0	0.0	1.0	2.1	0.1	0.0	0.4	0.0	0.0	0.8	0.3	1.5	0.0	0.0	0.0	0.1	1.5	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SPIN3	TDRD27	ENSG00000204271	"Spindlin family member 3"	Q5JUX0	X	56818298-56995827	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 23.8;Inhibitory neurons: 23.3;Oligodendrocyte precursor cells: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.5"					"Low region specificity"	"Detected in all"			HPA000727	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA000727: AB_2196121"	"unprognostic (3.12e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.45e-3)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (1.20e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.85e-4)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.98e-2)"	"prognostic favorable (6.30e-4)"	4.5	6.1	7.4	3.1	7.2	0.3	5.4	7.7	7.8	7.0	4.3	4.3	2.9	6.0	4.7	3.8	6.0	3.2	3.2	7.2	7.6	5.4	6.4	3.1	4.4	6.0	6.1	6.4	8.7	2.9	8.6	2.5	6.2	5.8	4.0	8.4	5.6	4.1	3.0	3.2	5.6	4.2	5.5	4.9	5.5	3.1	8.0	1.8	4.7	1.6	4.2	5.1	5.2	6.6	4.5	6.6	3.6	0.0	6.9	5.9	2.8	3.4	2.0	2.1	2.9	3.5	5.6	0.0	2.4	3.3	7.3	4.9	5.7	2.2	3.2	0.0	1.4	0.6	20.5	2.7	3.7	0.0	4.6	5.3	4.7	2.7	4.2	4.0	1.6	0.0	2.9	8.6	4.4	3.0	0.0	3.6	7.3	2.6	5.8	0.0	3.0	1.8	3.3	5.3	7.3	5.1	4.2	3.7	4.1	5.7	9.8	1.1	1.2	4.4	6.3	7.4	2.1	3.6	2.5	0.0	4.2	0.0	3.4	1.5	0.4	0.8	0.1	0.6	0.8	1.1	1.7	0.6	0.7	0.3	1.9	0.5	0.0	2.2	0.1	0.1	0.5	1.0	7.4	7.2	7.7	7.8	7.2	7.6	6.0	6.1	6.2	5.5	8.0	6.6	2.9	0.0	3.7	11.8	3.7	0.3	4.0	1.8	2.8	2.0	5.1	4.6	1.1	2.8	2.8	7.3	0.0	2.6	0.5	0.7	1.9	4.1	0.0	3.0	4.7	2.3	0.0	0.4	23.8	3.0	2.1	3.2	2.6	2.3	1.3	4.7	2.2	1.6	0.9	1.7	23.3	0.8	2.0	1.0	1.2	0.0	4.1	0.9	1.8	7.5	1.5	0.9	1.0	25.1	10.0	3.6	0.3	2.6	2.5	1.8	1.1	2.9	1.1	3.0	6.6	1.4	2.2	0.0	0.3	1.4	0.4	0.4	1.1	5.8	1.5	2.2
SPR	SDR38C1	ENSG00000116096	"Sepiapterin reductase"	P35270	2	72887382-72892158	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 85.3;Exocrine glandular cells: 81.1;Proximal tubular cells: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 8.3;intermediate monocyte: 2.4;myeloid DC: 8.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 8.9;monocytes: 8.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039505	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA039505: AB_10795466"	"unprognostic (4.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.50e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.95e-1)"	25.9	50.8	26.0	7.6	27.2	0.6	20.0	27.2	61.4	14.5	39.6	36.4	23.4	13.4	36.9	19.7	26.3	11.9	44.4	26.8	30.0	44.2	99.8	15.9	3.2	27.9	31.5	12.2	63.5	38.4	10.9	6.8	29.8	26.2	32.5	3.1	31.2	16.7	43.9	9.1	22.0	11.5	27.9	9.6	42.1	7.3	28.5	2.4	20.5	25.4	5.1	25.2	13.7	28.0	47.5	130.9	0.6	20.0	51.2	18.5	31.8	21.4	31.8	16.0	15.0	84.0	48.0	34.5	25.4	26.1	80.6	43.9	58.1	35.1	13.3	10.0	43.7	51.7	30.8	87.4	19.1	8.2	13.6	16.7	38.7	17.6	19.7	32.7	42.6	25.4	54.0	6.8	21.4	100.5	3.3	31.1	10.9	139.9	118.7	0.0	82.8	20.3	85.8	73.4	8.0	14.6	39.6	89.7	31.0	16.9	40.4	9.9	52.8	17.4	42.2	30.5	38.7	7.2	16.9	2.3	25.0	17.6	31.0	0.0	8.3	0.7	0.3	2.4	0.3	0.0	0.1	0.1	8.9	0.0	0.1	0.3	0.0	0.0	0.9	0.9	0.0	2.4	26.0	27.2	27.2	61.4	26.8	30.0	27.9	31.5	29.8	27.9	28.5	28.0	13.8	12.8	7.3	0.3	1.1	8.4	23.0	14.8	20.5	0.7	22.2	16.5	46.2	38.6	10.8	42.3	0.0	18.1	0.4	85.3	21.5	56.9	0.3	12.5	4.2	16.7	11.4	6.6	0.7	81.1	10.6	13.9	26.0	6.7	4.5	8.4	17.2	62.9	42.1	1.7	0.4	39.6	12.2	6.0	7.4	1.5	9.3	9.7	14.2	1.9	20.8	13.8	0.0	0.0	0.3	43.3	50.4	5.7	1.4	33.9	71.0	91.6	11.2	0.7	6.6	8.3	8.6	0.4	10.2	17.8	6.5	4.4	1.9	8.7	57.8	15.6
SPSB4	SSB-4	ENSG00000175093	"SplA/ryanodine receptor domain and SOCS box containing 4"	Q96A44	3	141051347-141148611	"Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 2.9;pancreas: 7.0;pituitary gland: 3.0;testis: 2.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 23.6;Late spermatids: 11.7;Oligodendrocyte precursor cells: 41.7;Spermatocytes: 22.1"	"Group enriched"	"Detected in some"	5	"glioma: 4.6;testis cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.5;NTERA-2: 3.5;RH-30: 4.2;SH-SY5Y: 3.6;U-2 OS: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062793			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA062793: AB_2732689"	"unprognostic (5.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.72e-4)"	"unprognostic (7.49e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.46e-4)"	"unprognostic (9.80e-3)"	0.3	0.3	0.5	0.0	0.9	0.0	0.1	0.8	1.2	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.3	2.0	0.3	0.0	0.4	0.0	2.8	2.1	0.0	7.0	0.2	3.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	1.5	1.1	0.0	2.9	1.1	0.2	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	12.5	0.2	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.9	0.0	3.5	0.0	0.0	0.0	4.2	0.6	0.0	0.0	1.1	3.6	0.0	0.0	0.0	2.0	0.2	0.3	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.8	1.2	0.3	2.0	2.8	2.1	1.6	1.5	1.1	0.9	0.4	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.6	0.0	0.1	0.1	0.0	0.0	2.8	0.5	0.0	3.2	0.0	0.0	0.0	0.4	0.4	0.1	0.2	0.0	5.6	0.0	0.0	5.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.3	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.4	22.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
SST	SMST	ENSG00000157005	Somatostatin	P61278	3	187668912-187670394	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 449.5;intestine: 386.6;pancreas: 479.4;stomach 1: 418.0"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 1404.1;Intestinal goblet cells: 460.2"	"Cancer enriched"	"Detected in many"	4	"pancreatic cancer: 1039.3"	"Region enhanced"	"Detected in all"		"hypothalamus: 449.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 22.4;U-2 OS: 44.7;U-251 MG: 7.6;U-698: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000075, HPA019472, CAB034105"	Enhanced	Supported			"Secreted to blood"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360"		"unprognostic (2.44e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (5.12e-3)"	"unprognostic (1.54e-2)"			"unprognostic (4.69e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.45e-1)"	5.5	43.0	59.9	4.6	52.1	4.2	0.5	1.3	67.8	0.6	2.5	31.8	386.6	0.7	0.1	1.6	0.4	1.1	1.3	30.6	449.5	6.2	0.3	0.3	1.5	96.9	48.1	2.4	479.4	0.0	9.3	0.1	50.3	1.3	23.8	6.3	0.1	21.6	0.1	8.9	133.3	2.8	137.8	0.2	418.0	0.2	117.2	1.1	1.0	0.0	0.0	7.3	1.8	18.7	0.0	0.0	0.8	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.5	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	44.7	0.4	7.6	0.0	2.9	11.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.9	52.1	1.3	67.8	30.6	449.5	96.9	48.1	50.3	137.8	117.2	18.7	0.0	0.0	0.0	9.1	0.5	0.0	0.0	3.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	5.5	0.0	0.1	0.0	4.3	0.0	0.0	0.3	0.3	0.5	0.1	1404.1	0.0	1.7	0.0	0.2	0.7	0.0	4.2	0.0	0.0	0.0	0.0	0.3	0.0	146.2	460.2	215.7	0.0	0.0	0.1	0.0	0.0	0.0	9.4	3.6	0.0	0.0	3.0	9.1	0.0	0.6	0.0	0.0	0.0	11.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.9	13.8	0.2
STK39	"DCHT, SPAK"	ENSG00000198648	"Serine/threonine kinase 39"	Q9UEW8	2	167954020-168247595	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 159.9;Inhibitory neurons: 142.9;Oligodendrocyte precursor cells: 153.3;Oligodendrocytes: 359.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046022, HPA061803, HPA062802"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		80000	"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Vesicles, Cytosol"	"CAB046022: AB_2196960, HPA061803: AB_2684616, HPA062802: AB_2684870"	"prognostic favorable (3.96e-4)"	"unprognostic (2.97e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.36e-1)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (3.04e-2)"	"unprognostic (8.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.20e-3)"	19.4	6.7	20.1	14.0	25.8	5.1	8.4	25.3	25.1	12.0	52.9	26.3	32.0	7.3	14.5	36.3	6.4	18.1	15.8	16.0	18.6	9.0	1.9	7.6	22.2	28.8	25.8	6.6	25.6	13.7	8.2	2.3	31.9	28.7	32.4	27.8	67.9	11.5	2.7	6.3	18.6	11.7	20.8	8.6	31.8	48.5	25.6	29.1	6.9	7.6	23.5	24.8	9.5	37.0	19.1	10.9	40.9	12.9	28.1	37.5	4.0	45.0	33.8	29.6	27.8	0.2	59.9	51.1	12.2	30.5	25.5	46.6	26.7	34.4	37.1	16.2	16.4	21.2	11.8	42.9	52.3	30.5	2.1	29.1	52.8	35.1	36.5	38.5	21.2	41.3	0.5	0.0	67.0	11.4	51.6	13.0	30.3	41.0	24.3	72.1	16.0	4.8	27.9	47.6	65.7	27.0	15.7	2.6	21.8	20.3	8.0	25.9	20.2	36.6	11.1	26.5	32.2	0.1	0.0	41.5	29.7	28.5	25.1	0.0	0.3	0.0	1.1	0.2	0.6	0.2	0.9	1.6	0.5	0.5	0.2	0.8	0.0	1.0	0.1	0.1	1.8	0.2	20.1	25.8	25.3	25.1	16.0	18.6	28.8	25.8	31.9	20.8	25.6	37.0	6.1	3.2	14.0	64.6	6.4	3.8	34.4	6.5	5.7	14.8	5.5	6.5	26.2	18.6	15.2	5.5	16.7	0.1	30.0	47.7	21.5	10.9	29.4	11.9	11.6	5.6	22.8	5.7	159.9	23.1	0.1	9.2	28.1	18.9	0.0	5.8	2.9	0.4	3.5	20.2	142.9	17.3	14.2	6.7	6.7	16.2	10.2	6.7	17.8	64.6	5.5	28.9	12.3	153.3	359.4	36.0	20.1	11.3	9.5	74.8	14.5	7.9	17.5	30.0	6.6	7.7	18.2	25.4	8.1	7.5	4.4	0.3	19.4	15.8	22.4	50.6
STXBP6	"amisyn, HSPC156"	ENSG00000168952	"Syntaxin binding protein 6"	Q8NFX7	14	24809656-25050297	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 128.6;Inhibitory neurons: 180.6;Oligodendrocytes: 188.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 48.6;Daudi: 50.7;HBF TERT88: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003552, HPA074869"	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA003552: AB_10603343, HPA074869: "	"unprognostic (1.52e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.73e-3)"	"unprognostic (5.10e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-3)"	7.3	0.8	18.5	3.8	19.6	0.2	5.0	16.2	27.7	13.5	0.6	11.9	12.3	7.5	38.1	6.0	7.0	11.0	24.7	18.9	21.6	3.6	4.3	26.3	1.6	23.9	23.6	2.8	39.5	23.0	1.0	42.8	17.8	12.7	14.8	2.1	15.0	9.5	4.4	15.0	18.5	5.1	11.4	0.7	9.8	4.4	42.1	7.8	18.0	7.6	5.5	12.3	2.6	19.1	0.1	1.0	2.0	0.5	12.9	22.3	0.2	15.1	40.2	35.5	37.5	48.6	0.3	50.7	0.1	42.6	0.0	0.1	0.0	0.1	64.1	27.2	3.2	12.1	0.4	37.0	9.4	0.9	6.3	3.3	0.0	0.0	0.2	2.0	0.0	1.4	0.5	16.9	34.2	9.7	0.2	0.1	6.6	25.4	0.0	0.0	28.1	0.4	0.0	2.8	2.3	0.1	0.1	7.8	42.6	4.3	0.5	0.7	0.0	6.4	17.2	41.2	2.1	5.1	6.0	2.4	21.8	0.3	24.2	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.2	18.5	19.6	16.2	27.7	18.9	21.6	23.9	23.6	17.8	11.4	42.1	19.1	50.3	51.3	7.7	128.6	0.4	67.7	48.4	0.1	20.5	0.6	2.9	3.3	27.4	64.3	3.4	20.2	0.0	1.4	1.7	12.6	0.0	47.9	20.4	38.8	4.9	35.8	40.7	8.6	72.9	98.7	1.5	44.9	20.4	72.8	42.6	0.8	36.8	5.8	20.1	0.0	180.6	64.6	2.0	1.0	11.0	4.6	1.5	2.9	110.3	113.4	2.0	2.7	0.0	113.6	188.1	39.9	49.6	1.2	3.1	73.9	71.8	9.6	0.0	0.5	0.0	16.4	6.5	12.6	19.7	4.1	48.2	4.0	3.2	0.0	51.7	16.4
SYBU	"FLJ20366, GOLSYN, KIAA1472, OCSYN, SNPHL"	ENSG00000147642	Syntabulin	Q9NX95	8	109573978-109691791	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 140.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 200.5;Horizontal cells: 95.9;Inhibitory neurons: 129.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"memory B-cell: 6.4;naive B-cell: 3.2"	"Lineage enriched"	"Detected in single"	27	"B-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 24.4;PC-3: 25.7;SK-BR-3: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053057	Uncertain		Supported	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA053057: AB_2682028"	"unprognostic (4.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.27e-1)"	"prognostic favorable (7.74e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.89e-2)"	"unprognostic (4.27e-2)"	32.2	38.7	39.1	3.2	42.0	0.0	22.2	44.5	52.4	10.7	4.4	15.4	10.9	5.6	11.5	5.6	20.1	10.3	6.9	42.4	58.6	4.2	52.1	8.8	4.4	24.2	34.0	9.2	140.5	1.5	30.4	2.5	36.6	8.2	19.7	26.1	21.5	11.0	3.8	9.6	12.0	6.9	22.8	1.0	28.2	1.8	50.8	5.4	12.3	7.7	7.8	5.9	8.8	30.2	8.6	5.2	3.6	0.0	0.5	0.6	2.5	3.1	0.0	0.0	0.0	7.9	5.4	0.7	0.5	2.5	1.2	24.4	0.8	5.7	0.0	0.1	11.6	0.0	15.2	8.2	6.2	0.0	0.0	1.9	7.7	0.0	7.2	0.4	3.3	0.6	0.4	1.6	3.5	0.2	0.2	0.0	0.7	7.7	25.7	0.0	0.0	0.0	9.5	2.2	16.3	1.9	6.9	51.4	1.7	2.5	6.8	0.3	5.0	0.3	2.0	0.1	1.5	1.5	0.1	0.5	10.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	39.1	42.0	44.5	52.4	42.4	58.6	24.2	34.0	36.6	22.8	50.8	30.2	39.3	9.6	7.7	16.0	4.3	5.7	2.5	8.3	17.1	46.1	10.9	9.1	2.4	30.0	18.0	11.0	8.4	4.6	0.1	3.6	3.9	5.4	1.4	29.3	3.4	11.8	34.5	0.0	200.5	9.4	0.9	7.9	5.6	20.9	0.0	0.7	10.0	39.1	0.3	95.9	129.6	22.2	2.0	0.8	4.2	0.4	2.1	0.3	1.8	21.5	0.7	2.1	0.0	22.1	5.7	3.9	9.8	0.4	0.1	11.8	16.2	0.1	15.6	7.4	0.0	16.5	4.2	1.3	1.5	3.5	3.3	0.7	0.6	0.1	13.7	4.2
TBC1D24	"DFNA65, DFNB86, KIAA1171, TLDC6"	ENSG00000162065	"TBC1 domain family member 24"	Q9ULP9	16	2475051-2509560	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Deafness, Disease variant, Epilepsy, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 16.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 43.8;Inhibitory neurons: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 34.7"									"HPA044712, HPA068080"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane, Cell Junctions"		"HPA044712: AB_10795619, HPA068080: AB_2685948"	"prognostic unfavorable (3.22e-4)"	"unprognostic (5.23e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.37e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.66e-3)"	"unprognostic (2.02e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.61e-1)"	3.8	3.3	7.5	1.8	8.1	2.5	2.8	3.6	10.5	2.1	0.0	2.0	2.2	1.4	2.8	1.0	2.3	1.9	3.0	8.3	3.7	4.3	3.7	3.9	1.8	2.9	2.9	1.0	10.6	1.9	2.6	2.1	3.1	2.5	0.9	4.2	16.5	3.5	3.4	1.2	1.6	1.7	1.9	2.0	2.2	1.2	4.4	0.9	3.1	1.7	1.2	1.8	0.9	2.8	3.4	6.7	4.5	9.2	5.1	5.1	3.8	6.2	3.3	4.0	3.5	6.2	2.9	8.6	5.2	4.9	1.9	6.3	7.1	2.0	2.9	9.3	8.0	8.0	9.5	5.5	3.1	5.9	3.2	1.9	2.8	3.5	1.4	2.8	5.1	3.3	9.9	4.8	3.8	6.4	4.1	11.9	4.0	3.2	4.3	20.9	8.5	6.1	2.9	2.3	34.7	8.5	3.8	15.3	2.6	1.6	4.8	5.2	5.4	7.8	8.4	7.9	6.2	3.2	3.0	11.0	3.4	8.5	7.2	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	7.5	8.1	3.6	10.5	8.3	3.7	2.9	2.9	3.1	1.9	4.4	2.8	4.7	28.9	26.7	15.7	1.9	0.5	3.0	1.4	1.8	19.0	17.8	10.8	6.9	10.0	6.9	5.5	43.8	1.5	5.6	2.4	33.2	5.0	0.2	2.8	10.0	5.4	11.4	6.5	29.6	6.1	1.0	5.8	5.6	4.0	3.8	6.0	10.4	17.3	3.5	26.9	34.0	2.6	6.1	5.1	3.3	1.0	9.0	3.0	1.8	6.5	3.6	13.8	6.2	25.1	9.7	5.0	2.8	6.0	1.7	3.1	1.8	3.9	3.6	25.5	0.0	11.2	3.7	8.8	5.9	1.4	1.4	0.3	2.9	3.4	4.7	1.6
TBC1D30	KIAA0984	ENSG00000111490	"TBC1 domain family member 30"	Q9Y2I9	12	64759484-64881033	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.1;pancreas: 12.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 30.9;Inhibitory neurons: 42.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 25.9;OE19: 11.9;RPMI-8226: 12.6;RT4: 12.8;SCLC-21H: 26.5;SK-BR-3: 16.7;T-47d: 14.5"									"HPA039772, HPA040043"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Cytosol	"HPA039772: AB_10795409, HPA040043: AB_10795411"	"unprognostic (1.85e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (3.61e-5)"	"unprognostic (9.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.65e-5)"	"prognostic favorable (5.08e-4)"	"unprognostic (1.75e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.67e-3)"	"unprognostic (7.80e-3)"	1.5	1.1	2.0	1.0	2.7	0.3	2.3	4.9	10.1	3.0	1.4	1.4	1.8	1.4	1.8	0.6	1.5	1.8	0.6	5.3	1.7	2.2	1.2	2.3	0.4	6.8	1.8	0.9	12.0	2.4	6.4	0.6	6.9	3.0	1.5	2.2	6.8	2.7	0.3	0.8	1.6	0.9	2.0	1.9	3.9	1.9	2.0	0.3	1.5	0.3	0.3	3.3	1.3	3.8	5.1	1.0	0.5	0.3	0.1	0.6	0.7	0.0	0.0	0.1	0.0	4.3	1.8	0.1	0.9	0.1	0.3	0.1	5.3	0.2	0.0	0.0	3.8	0.3	1.4	0.1	0.0	4.0	0.8	0.3	0.1	0.0	0.0	0.6	3.8	1.2	0.0	2.0	0.3	25.9	0.0	0.6	1.1	11.9	5.2	0.2	0.1	12.6	0.9	12.8	26.5	1.8	1.4	16.7	0.3	0.3	14.5	1.4	4.2	0.0	0.9	0.9	2.5	0.0	0.0	0.1	0.1	0.4	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.0	2.7	4.9	10.1	5.3	1.7	6.8	1.8	6.9	2.0	2.0	3.8	5.1	0.0	6.3	4.9	0.6	0.9	4.6	0.9	0.0	9.3	7.2	3.8	0.6	5.7	4.5	3.7	8.4	0.7	1.5	2.5	9.8	3.9	14.2	2.2	0.8	6.5	0.0	0.0	30.9	4.9	0.3	0.7	3.6	4.2	8.9	0.8	1.8	0.3	1.6	0.0	42.8	6.4	6.1	4.0	6.2	1.9	0.3	3.0	5.4	12.2	1.2	2.6	0.0	1.5	2.0	2.7	4.9	0.0	0.6	9.1	3.9	2.3	1.8	0.6	0.0	0.6	1.0	3.7	3.0	0.3	1.4	0.1	0.8	0.4	4.4	8.7
TBL2	"DKFZP43N024, WBSCR13, WS-betaTRP"	ENSG00000106638	"Transducin beta like 2"	Q9Y4P3	7	73567537-73578791	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.2"	"Group enriched"	"Detected in all"	7	"Early spermatids: 398.2;Late spermatids: 515.4;Spermatocytes: 345.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007477, HPA051533"			Supported	Cytosol	"Secreted in male reproductive system"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA007477: AB_1080214, HPA051533: AB_2681523"	"unprognostic (9.04e-2)"	"unprognostic (6.61e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.24e-3)"	"unprognostic (7.50e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.88e-5)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.31e-1)"	4.9	9.1	1.7	5.3	1.8	1.6	4.2	2.8	5.4	4.6	2.7	4.7	5.4	4.5	8.3	5.4	4.3	2.7	4.0	1.9	1.7	4.2	5.9	5.5	1.9	1.7	1.6	4.8	16.4	5.6	3.2	4.4	1.8	4.4	5.5	4.0	11.0	4.3	2.9	4.9	4.3	4.6	1.6	3.1	6.4	44.2	1.7	2.3	4.9	1.5	3.2	3.6	4.5	1.8	22.1	27.5	8.7	12.6	19.9	18.2	10.2	26.9	18.4	9.3	17.1	40.9	22.0	18.4	5.4	21.7	19.5	15.9	18.2	9.5	19.4	6.8	10.8	6.6	11.8	26.3	28.5	13.3	22.4	11.4	15.0	28.7	22.1	16.7	10.2	2.4	26.0	12.6	14.7	20.2	13.2	10.7	8.7	23.8	18.1	8.6	14.6	38.8	10.5	16.0	8.4	14.3	25.8	65.8	16.9	10.1	17.2	5.7	18.7	17.1	8.8	17.1	25.7	25.8	18.0	20.0	23.3	15.3	21.3	16.8	11.1	4.9	6.3	7.3	5.9	3.0	5.0	5.2	13.6	4.1	5.9	3.7	1.4	8.8	7.4	10.2	6.5	8.1	1.7	1.8	2.8	5.4	1.9	1.7	1.7	1.6	1.8	1.6	1.7	1.8	8.6	25.6	9.3	3.3	8.1	4.6	14.5	17.3	4.0	10.8	10.8	6.3	4.7	11.5	13.5	5.5	8.4	45.2	6.5	12.7	1.9	26.1	398.2	11.3	14.9	12.6	9.5	6.3	4.1	30.1	54.6	17.3	7.7	11.6	14.0	13.9	10.0	14.7	27.4	3.3	4.5	16.8	6.1	9.4	3.8	515.4	23.6	17.5	7.2	4.7	17.3	8.1	10.3	4.5	4.1	22.6	13.7	26.7	19.9	17.1	14.6	5.1	9.8	13.4	6.6	13.8	15.1	345.8	27.9	7.8	3.7	43.4	5.0	17.0	15.8	9.0
TMEM125	MGC17299	ENSG00000179178	"Transmembrane protein 125"	Q96AQ2	1	43269983-43274002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 75.7;pancreas: 89.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 121.8;Alveolar cells type 2: 136.9;Distal enterocytes: 72.7;Proximal enterocytes: 164.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 26.8;BEWO: 21.8;CACO-2: 20.6;CAPAN-2: 48.3;OE19: 31.3;SK-BR-3: 41.2;T-47d: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015796			Approved	Midbody,Cytosol		Yes	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Midbody, Cytosol"		"HPA015796: AB_1858081"	"unprognostic (2.53e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.37e-3)"	"prognostic favorable (5.11e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.86e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.16e-2)"	0.3	0.7	17.4	3.2	32.2	0.2	11.5	27.6	29.9	16.4	12.8	21.2	35.4	1.6	18.3	10.9	15.5	11.3	0.9	17.0	20.7	16.4	1.1	75.7	0.3	31.5	28.5	1.4	89.6	22.2	31.0	4.4	29.0	22.0	21.0	0.1	31.8	7.1	0.0	12.9	27.5	0.8	22.6	0.3	27.4	1.5	26.8	0.4	44.9	0.0	2.5	2.9	3.4	42.8	26.8	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	20.6	48.3	0.1	1.2	0.0	0.0	11.7	0.0	7.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	12.1	0.1	0.1	1.1	31.3	0.0	0.0	0.0	0.7	0.4	8.5	12.4	0.1	0.0	41.2	0.0	3.6	33.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	17.4	32.2	27.6	29.9	17.0	20.7	31.5	28.5	29.0	22.6	26.8	42.8	0.2	121.8	136.9	0.0	0.9	0.0	2.3	18.0	0.6	0.0	30.4	15.2	0.5	42.9	56.0	16.5	0.0	33.5	0.1	72.7	17.6	39.1	3.7	20.1	1.4	0.6	21.7	0.0	0.2	38.5	2.2	0.6	45.3	13.1	1.3	4.9	0.0	0.0	2.4	0.0	0.2	63.0	34.6	0.0	0.2	7.9	0.3	0.6	0.0	0.0	0.6	1.7	1.0	0.0	55.3	22.7	40.1	1.2	0.6	12.2	164.2	33.9	43.8	0.0	0.0	0.0	2.3	1.4	0.3	2.1	0.4	7.3	1.0	0.1	38.6	9.1
TMEM187	"CXorf12, DXS9878E, ITBA1"	ENSG00000177854	"Transmembrane protein 187"	Q14656	X	153972754-153983194	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in single"			HPA038134	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 22: Non-specific - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Cytosol"		"HPA038134: AB_10669517"	"unprognostic (1.51e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (7.41e-2)"	"prognostic favorable (9.14e-8)"	"unprognostic (6.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.04e-2)"	6.9	9.1	5.5	4.8	6.5	2.7	6.5	6.3	6.5	6.7	8.9	6.2	5.0	5.8	7.0	5.1	7.4	4.2	6.2	5.5	6.0	5.6	8.3	4.8	7.7	6.8	6.3	7.1	12.4	5.6	6.8	3.6	6.3	6.7	3.2	2.7	10.7	6.2	6.4	8.5	6.8	4.4	6.7	7.0	6.4	3.9	6.1	5.4	5.0	3.2	4.6	5.9	5.6	8.0	11.9	13.1	2.9	11.6	12.1	10.0	1.8	4.7	2.9	1.4	4.7	2.8	20.7	1.8	27.5	5.2	7.7	11.3	3.9	7.4	1.1	15.8	6.4	3.2	8.3	4.8	10.4	1.9	3.5	12.8	12.1	4.0	7.6	7.4	4.2	7.4	2.9	15.0	6.7	14.7	6.8	2.6	2.1	14.2	18.4	6.5	2.0	20.1	9.2	3.9	4.4	4.1	8.2	6.9	5.8	3.2	11.9	4.0	7.3	2.4	2.6	10.1	2.9	10.9	7.7	2.5	6.9	7.7	1.7	31.5	15.2	19.6	21.5	11.7	21.8	14.6	25.9	23.1	11.4	18.8	31.6	19.5	14.1	17.0	11.4	30.6	29.3	17.7	5.5	6.5	6.3	6.5	5.5	6.0	6.8	6.3	6.3	6.7	6.1	8.0	6.7	0.0	6.3	3.9	4.7	2.8	6.1	11.7	5.2	4.8	9.4	9.8	5.2	12.8	5.1	7.3	6.2	13.3	8.5	5.9	1.9	10.1	0.3	9.4	5.4	7.0	2.4	4.0	1.5	8.7	10.8	6.8	3.6	7.9	3.8	9.0	7.9	16.1	12.4	1.7	1.8	8.2	12.2	7.0	3.3	0.6	14.6	7.1	10.6	0.0	7.0	14.6	5.2	0.5	3.7	9.9	3.8	14.3	3.6	5.9	12.0	8.7	6.5	6.0	6.6	7.8	5.5	1.7	9.4	4.3	4.7	9.9	6.9	14.7	8.1	3.8
TMEM258	"C11orf10, Kud, Kuduk"	ENSG00000134825	"Transmembrane protein 258"	P61165	11	61768501-61792802	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044602	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Plasma membrane"	"HPA044602: AB_10961423"	"unprognostic (6.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.99e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.48e-2)"	"prognostic favorable (4.37e-4)"	"unprognostic (1.34e-3)"	"unprognostic (7.39e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.58e-1)"	116.4	158.4	125.5	66.1	128.7	128.4	120.8	130.8	162.2	142.2	123.0	112.4	80.9	116.0	350.1	122.8	123.1	59.3	170.8	122.6	128.7	123.5	160.6	110.0	83.0	130.0	125.6	154.9	300.3	80.5	128.9	80.4	130.3	105.5	107.6	44.0	183.9	88.7	146.7	95.3	99.8	81.5	131.1	124.4	142.8	79.1	126.8	111.7	109.1	120.6	108.9	107.5	111.7	140.1	144.3	254.9	194.9	173.3	329.0	308.4	117.1	113.9	177.1	104.5	124.8	223.5	265.5	103.9	205.9	272.1	196.1	154.8	186.7	222.7	149.1	141.7	168.6	86.8	258.3	347.6	310.7	186.9	96.3	272.5	339.6	137.1	364.8	267.9	210.9	207.4	221.7	394.5	185.4	501.1	131.2	318.8	267.1	315.6	172.9	142.1	144.6	673.0	241.5	243.7	169.3	173.1	103.8	221.7	211.5	179.6	244.5	347.3	108.0	129.2	111.7	166.1	78.3	248.6	201.7	173.6	183.8	112.6	135.7	507.9	225.6	287.6	169.5	200.4	216.5	233.2	198.8	190.1	177.8	187.1	167.1	166.7	182.4	151.7	204.4	496.4	236.8	244.9	125.5	128.7	130.8	162.2	122.6	128.7	130.0	125.6	130.3	131.1	126.8	140.1	211.3	102.5	224.1	6.8	323.6	228.9	220.5	794.5	170.8	41.3	525.1	608.3	491.3	403.2	445.9	318.2	18.8	409.5	279.8	306.2	295.4	534.8	234.4	369.2	304.7	254.8	311.1	197.7	7.4	654.4	667.7	314.8	210.5	305.6	226.7	261.8	335.2	572.9	461.4	37.0	8.2	631.5	441.5	401.7	396.9	142.8	335.5	265.7	569.2	3.7	430.0	418.6	270.8	6.0	25.8	469.4	432.6	214.4	821.3	296.6	392.2	553.8	470.9	73.9	170.9	192.3	248.5	399.4	433.8	297.4	279.0	508.0	245.2	135.3	442.1	274.9
TNFSF13	"APRIL, CD256"	ENSG00000161955	"TNF superfamily member 13"	O75888	17	7558292-7561608	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 141.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 10.4;Basal squamous epithelial cells: 8.0;Erythroid cells: 5.9;Gastric mucus-secreting cells: 11.2;Macrophages: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 438.1;intermediate monocyte: 420.9"	"Group enriched"	"Detected in all"	12	"dendritic cells: 283.5;granulocytes: 158.9;monocytes: 438.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 43.6;RPMI-8226: 39.9;RPTEC TERT1: 110.6;U-937: 44.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004863	Uncertain				"Secreted to blood"	NA	NA	6770000	35000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"			"HPA004863: AB_1078187"	"unprognostic (2.46e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.42e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (1.30e-9)"	"unprognostic (4.69e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.38e-2)"	27.7	31.6	39.5	37.7	43.7	48.4	29.5	39.7	47.3	33.5	66.7	45.9	74.7	13.3	19.2	12.5	31.8	54.1	18.0	35.3	37.6	55.6	16.2	100.7	33.1	44.8	43.3	24.8	41.1	18.0	19.7	14.7	41.1	22.6	41.9	13.0	141.9	32.1	5.3	10.5	39.5	24.8	40.0	30.6	54.0	4.6	44.8	14.1	27.0	10.1	24.5	26.0	15.5	38.8	20.8	8.3	2.8	5.5	3.2	1.7	3.4	3.7	2.7	1.5	1.3	4.6	12.8	9.1	43.6	3.8	5.2	13.1	0.1	3.6	1.6	16.2	7.0	5.9	18.2	9.7	6.7	5.1	5.9	3.6	3.6	1.0	5.7	8.8	4.7	6.5	4.6	3.5	1.3	3.1	2.3	16.6	2.7	20.3	6.0	16.5	3.4	39.9	110.6	13.5	5.1	4.9	7.2	18.8	2.5	4.1	25.2	12.4	2.4	4.8	5.8	2.1	8.1	0.8	2.8	2.4	1.9	44.1	9.5	75.2	438.1	158.9	0.9	420.9	0.8	13.7	0.5	0.7	283.5	25.0	2.4	1.5	56.9	7.9	265.4	130.8	0.9	257.1	39.5	43.7	39.7	47.3	35.3	37.6	44.8	43.3	41.1	40.0	44.8	38.8	0.2	6.4	10.4	0.0	2.1	0.0	0.2	0.2	8.0	0.1	0.4	0.1	0.0	0.0	2.0	1.8	0.0	0.0	0.1	1.0	0.0	0.4	0.0	0.2	0.1	0.0	1.2	5.9	0.0	0.2	0.0	2.9	11.2	0.4	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	19.5	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.2	0.7	0.3	1.5	0.2	0.0	0.1	0.2	0.0	0.0	2.6	0.0	0.0	0.8	0.1	0.6	0.2
TPRN	"C9orf75, DFNB79, FLJ90254"	ENSG00000176058	Taperin	Q4KMQ1	9	137191617-137204193	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.4;pancreas: 91.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 177.7;Proximal enterocytes: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 61.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 23.6"	"HPA020899, HPA076667"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA020899: AB_1845835, HPA076667: "	"unprognostic (5.41e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (2.94e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.20e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.77e-2)"	"prognostic favorable (5.16e-9)"	"unprognostic (1.96e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.44e-2)"	3.7	5.1	24.3	4.4	37.8	2.7	4.8	29.9	33.1	5.2	15.1	25.4	22.0	4.7	0.9	20.5	5.1	3.2	10.7	23.5	23.7	19.1	24.3	8.1	2.4	33.1	32.4	6.4	91.4	2.5	6.0	3.3	28.2	8.0	6.9	1.7	11.8	3.4	6.2	15.6	26.0	1.5	20.8	5.0	29.3	9.3	31.9	2.0	5.5	3.1	1.5	7.8	6.9	56.4	10.2	11.4	3.8	17.0	5.2	5.5	30.1	7.0	4.3	7.0	3.9	38.5	12.1	18.6	10.1	3.6	9.2	30.4	7.9	3.9	0.9	11.9	11.1	8.7	17.5	25.5	7.9	13.5	10.8	4.7	7.5	6.2	4.3	4.6	4.5	8.2	16.1	6.4	2.1	61.9	8.9	29.0	13.5	55.5	14.8	26.3	9.1	28.4	15.9	21.0	24.4	8.9	10.8	49.6	13.0	2.9	57.8	21.0	5.0	12.7	6.0	20.1	15.1	5.3	11.0	9.7	9.1	12.1	7.2	0.0	0.8	0.0	0.3	0.8	0.1	0.3	0.3	0.5	0.6	0.3	0.1	0.3	0.0	0.8	0.4	0.6	0.6	0.2	24.3	37.8	29.9	33.1	23.5	23.7	33.1	32.4	28.2	20.8	31.9	56.4	4.6	19.2	5.5	6.2	3.5	1.8	1.3	2.6	2.2	19.3	13.2	9.5	7.6	15.7	2.6	16.5	6.2	5.4	8.4	177.7	7.9	8.0	3.1	7.6	4.1	2.9	9.0	7.4	3.3	45.4	1.3	3.0	15.3	9.6	1.3	8.7	3.9	19.5	3.6	11.8	3.8	46.0	6.1	2.8	1.6	5.3	3.4	5.2	5.4	1.0	2.8	12.4	1.0	2.5	30.4	15.3	39.7	4.5	1.9	3.3	95.9	20.0	2.3	7.3	6.6	3.2	4.5	2.7	4.4	5.8	2.8	1.9	4.5	10.3	36.7	1.7
TRBV6-7	"TCRBV13S8P, TCRBV6S7, TRBV67"	ENSG00000253188	"T cell receptor beta variable 6-7 (non-functional)"		7	142487863-142488295	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 1.6;lymphoid tissue: 1.3;pancreas: 1.6;testis: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.9"	"Not detected"	"Not detected"																	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"		"Cluster 58: T-cells - T-cell receptor"													"unprognostic (1.38e-1)"								0.0	0.0	0.7	0.0	0.5	0.2	0.0	0.5	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.3	0.7	0.5	0.0	1.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.3	1.6	1.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.7	0.0	0.0	1.9	0.3	0.3	0.0	0.0	0.0	0.7	0.1	0.7	0.5	0.5	0.9	1.1	0.5	0.7	0.5	0.7	0.4	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRBV7-1	"TCRBV6S7P, TCRBV7S1, TRBV71"	ENSG00000211707	"T cell receptor beta variable 7-1 (non-functional)"		7	142332182-142332701	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 8.1"	"Group enriched"	"Detected in some"	280	"Early spermatids: 75.2;Late spermatids: 36.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 2.0;naive CD4 T-cell: 1.8;T-reg: 2.8"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.8"	"Cell line enriched"	"Detected in single"	5	"SCLC-21H: 1.8"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"								"unprognostic (1.38e-1)"					"unprognostic (2.62e-2)"						"unprognostic (1.77e-1)"		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.6	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.0	2.8	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRHDE	"PAP-II, PGPEP2, TRH-DE"	ENSG00000072657	"Thyrotropin releasing hormone degrading enzyme"	Q9UKU6	12	72087266-72670758	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.6;pancreas: 10.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 216.9;Inhibitory neurons: 292.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 4.9;cerebellum: 4.4;cerebral cortex: 2.5;hippocampal formation: 7.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 30.3;BJ hTERT+: 29.1;EFO-21: 15.3;HBF TERT88: 10.3;hTERT-RPE1: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		7300000		"Cluster 22: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (3.56e-2)"	"unprognostic (4.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.44e-6)"	"unprognostic (1.77e-1)"	"unprognostic (6.37e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.14e-4)"	"unprognostic (2.40e-1)"	"prognostic favorable (1.53e-7)"	"unprognostic (2.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.94e-2)"	3.6	0.9	0.1	0.3	4.9	0.4	0.8	4.4	2.5	3.7	0.0	1.1	2.4	1.2	0.6	0.2	1.1	0.8	0.8	7.6	0.0	5.1	0.5	1.4	0.1	0.0	0.9	3.2	10.3	0.0	0.1	0.1	0.0	1.3	0.5	0.8	0.8	2.8	0.2	0.2	2.1	0.4	0.0	2.5	0.3	0.7	0.0	0.1	0.0	0.4	0.3	1.2	2.3	0.0	3.6	0.0	0.6	0.0	1.6	0.0	9.5	30.3	29.1	2.9	1.9	0.0	0.0	0.0	15.3	4.3	3.0	0.4	5.4	0.0	10.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	2.3	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	8.7	0.0	0.0	0.0	9.5	6.7	2.9	0.1	0.0	0.0	0.0	0.5	0.0	5.7	0.0	0.0	3.2	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	4.4	2.5	7.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.5	2.9	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.9	1.5	0.0	1.8	0.0	0.1	0.0	7.1	3.9	0.0	35.9	0.1	0.4	0.2	0.0	0.0	216.9	2.6	0.4	4.7	0.0	0.3	0.0	0.1	0.4	1.4	0.2	0.0	292.7	3.5	0.0	0.0	0.0	62.8	29.5	0.7	0.0	2.8	0.0	0.4	0.0	38.2	4.0	2.2	3.9	13.5	0.0	0.2	15.8	9.1	0.7	0.6	0.0	37.4	0.6	0.2	0.7	0.0	0.0	0.1	0.1	0.2	1.6	0.1
TRIM74	"MGC45440, TRIM50C"	ENSG00000155428	"Tripartite motif containing 74"	Q86UV6	7	72959485-72969466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 10.2;testis: 6.6"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 1.9;Respiratory ciliated cells: 2.1;Spermatocytes: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 3.8;Hep G2: 2.8"									HPA047843			Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA047843: AB_2680176"	"unprognostic (8.78e-3)"	"unprognostic (3.78e-4)"	"unprognostic (5.84e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.78e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.12e-3)"	0.9	1.6	1.2	0.6	1.4	1.0	1.2	2.5	1.6	1.8	0.8	0.8	1.3	1.2	1.2	0.5	2.5	0.5	0.7	1.3	1.4	1.7	2.6	0.7	1.2	1.5	1.3	1.8	2.5	0.5	1.7	0.1	1.3	1.9	0.3	0.6	0.7	0.5	0.5	0.9	1.3	0.4	1.2	1.2	10.2	6.6	1.2	0.6	1.5	0.2	0.3	0.8	1.2	1.8	0.0	0.1	0.7	0.7	0.2	0.0	0.0	0.4	0.0	0.1	0.2	1.0	0.7	0.5	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.4	3.8	0.6	0.0	2.8	0.1	1.3	1.6	0.3	0.2	0.0	0.2	0.5	0.0	0.9	0.5	2.2	0.0	1.1	0.4	1.9	0.0	0.0	0.8	0.9	0.3	0.4	1.1	0.4	0.3	0.3	0.4	0.0	0.8	0.1	0.0	0.6	1.4	0.1	0.5	0.2	0.0	1.7	1.4	0.3	0.5	0.7	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	1.4	2.5	1.6	1.3	1.4	1.5	1.3	1.3	1.2	1.2	1.8	0.0	0.0	0.5	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1
UBL3	"DKFZP434K151, FLJ32018, HCG-1, PNSC1"	ENSG00000122042	"Ubiquitin like 3"	O95164	13	29764371-29850617	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 350.5;Late spermatids: 316.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBF TERT88: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053772, HPA058781"	Uncertain		Approved	Centrosome		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 22: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Centrosome		"HPA053772: AB_2682258, HPA058781: AB_2683818"	"unprognostic (2.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.59e-1)"	"prognostic favorable (4.23e-4)"	"unprognostic (8.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.84e-1)"	23.3	20.7	39.6	17.8	49.6	22.2	29.3	58.0	47.1	38.3	25.9	28.6	27.7	42.4	25.6	42.9	27.1	31.5	20.5	38.5	52.3	35.1	41.7	36.9	19.3	51.5	54.8	30.7	55.8	30.0	17.1	22.6	49.0	22.5	27.7	47.2	29.2	22.7	29.7	24.1	29.0	30.7	53.8	25.2	72.8	22.4	47.3	21.5	40.4	35.5	19.0	19.5	23.6	61.3	12.5	7.8	23.9	14.5	33.0	31.7	25.3	101.2	59.2	42.5	34.0	18.6	27.7	10.9	22.3	101.3	19.7	12.2	11.0	15.1	121.0	17.3	13.5	11.5	9.9	15.0	10.4	17.0	14.8	18.8	48.2	22.4	14.3	36.7	15.5	12.9	5.8	7.7	18.1	84.5	12.8	14.3	14.3	29.3	11.1	14.5	30.8	12.5	28.2	14.7	27.8	13.9	14.3	49.0	106.8	50.6	26.4	28.6	13.4	54.7	13.6	30.3	13.8	17.7	7.4	8.2	19.4	14.4	37.0	10.4	11.2	10.0	10.7	11.4	5.0	2.9	13.5	10.5	10.9	4.1	7.6	9.5	11.2	6.9	13.0	5.1	34.7	9.1	39.6	49.6	58.0	47.1	38.5	52.3	51.5	54.8	49.0	53.8	47.3	61.3	60.7	192.3	46.2	58.4	47.0	77.0	99.6	30.6	57.5	166.8	47.3	29.6	35.6	70.1	63.3	36.8	77.2	17.2	55.2	81.8	92.0	36.7	350.5	113.7	66.4	44.0	60.6	8.6	77.2	37.3	87.9	73.0	154.5	103.6	14.5	16.4	35.0	58.0	39.1	95.9	95.1	58.8	42.7	60.0	92.1	316.1	34.8	69.4	97.8	91.8	56.6	174.9	38.1	97.0	214.1	60.9	34.8	33.1	58.3	65.9	45.1	50.8	80.4	67.9	19.7	91.0	49.6	72.5	24.5	55.2	80.0	29.6	56.8	76.5	43.8	104.0
VSTM5	"C11orf90, LOC387804"	ENSG00000214376	"V-set and transmembrane domain containing 5"	A8MXK1	11	93818232-93850618	"Predicted membrane proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7;placenta: 4.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 22.3;Excitatory neurons: 5.2;Inhibitory neurons: 9.2;Syncytiotrophoblasts: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.2;OE19: 3.7;PC-3: 5.4;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029525, HPA063591"	Uncertain		Uncertain	"Endoplasmic reticulum"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA029525: AB_10600789, HPA063591: AB_2732704"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-4)"	"unprognostic (2.45e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	0.2	0.2	2.2	0.1	1.9	0.0	0.4	1.0	3.4	1.1	0.1	1.1	0.1	0.4	1.2	0.1	0.2	0.4	0.1	1.8	3.7	0.8	0.0	0.1	0.0	3.1	2.0	0.1	0.5	0.1	0.6	4.4	3.3	0.5	1.7	0.5	0.4	0.4	0.0	0.1	0.7	0.7	1.4	0.0	1.9	0.2	3.3	0.0	0.1	0.0	0.1	0.2	0.1	2.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.5	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.4	0.0	0.0	0.1	0.0	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	1.0	3.4	1.8	3.7	3.1	2.0	3.3	1.4	3.3	2.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.9	0.5	0.5	0.3	0.0	0.1	0.0	0.0	22.3	0.1	1.1	0.0	0.4	0.0	0.3	0.2	0.1	0.0	0.0	5.2	3.0	0.7	0.3	1.5	0.7	0.0	0.1	0.0	0.0	1.5	0.0	9.2	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	1.1	2.1	0.4	0.0	0.1	0.5	1.5	0.0	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.1	5.9	0.0	0.0	1.6	0.1
WDR13		ENSG00000101940	"WD repeat domain 13"	Q9H1Z4	X	48590042-48608869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000913	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA000913: AB_1858795"	"unprognostic (5.03e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.65e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.54e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.32e-2)"	67.2	76.7	84.2	27.7	81.1	34.6	63.8	68.2	95.2	71.6	85.0	71.6	43.8	71.5	73.7	54.6	67.1	33.4	150.3	85.7	70.4	91.9	106.3	60.8	23.4	73.0	70.2	93.1	189.2	36.9	80.1	29.5	70.5	67.5	26.3	28.2	75.7	45.3	105.2	56.9	54.4	37.5	69.4	58.6	76.6	22.9	74.5	18.7	64.8	83.0	19.6	59.5	56.3	78.5	41.6	59.4	29.3	90.8	39.3	57.4	22.4	28.1	50.7	31.9	29.0	35.5	64.8	28.7	26.3	57.8	25.7	35.0	14.6	61.6	11.3	34.2	26.2	19.7	72.2	65.3	89.3	17.1	51.4	54.7	86.4	45.3	82.7	55.6	44.4	16.3	19.8	35.5	44.9	59.4	23.7	29.9	21.2	18.0	46.6	22.4	31.0	52.3	56.7	32.6	33.9	41.9	31.8	65.2	66.9	20.4	41.9	32.6	74.0	33.0	48.8	52.8	27.5	41.0	16.6	11.0	48.9	25.3	46.5	75.5	42.4	24.7	20.9	47.4	16.7	32.7	21.8	19.9	39.1	25.0	17.4	19.6	29.9	33.0	57.2	24.6	27.0	31.1	84.2	81.1	68.2	95.2	85.7	70.4	73.0	70.2	70.5	69.4	74.5	78.5	61.1	44.8	41.7	19.9	22.3	35.1	72.8	69.1	37.5	45.5	39.2	35.8	79.7	68.6	49.9	20.2	54.2	44.2	19.9	75.5	103.7	89.0	6.1	75.9	36.1	54.0	50.4	31.2	7.8	119.2	34.5	50.5	62.2	53.0	30.4	46.2	65.3	50.2	42.6	33.7	6.6	58.3	50.8	35.4	30.6	20.8	51.6	34.9	58.7	15.0	42.1	68.9	22.6	7.1	14.0	96.8	75.0	43.2	28.3	48.3	90.2	140.7	74.3	55.6	46.0	51.2	59.6	11.2	21.0	29.7	29.8	70.7	21.4	56.2	59.8	65.8
WDR25	"C14orf67, MGC4645"	ENSG00000176473	"WD repeat domain 25"	Q64LD2	14	100376418-100530303	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003113	Uncertain		Approved	Nucleoplasm	"Secreted to blood"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA003113: AB_2215263"	"unprognostic (5.31e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (7.36e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.62e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (3.89e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.51e-2)"	6.4	10.0	7.6	2.5	7.8	4.1	6.5	8.0	9.5	8.1	8.1	6.7	3.2	7.9	4.2	4.5	6.8	3.0	6.6	7.4	7.5	7.0	8.6	5.8	3.6	7.6	7.6	6.6	12.9	3.5	11.3	3.3	8.5	7.9	2.5	4.5	5.7	3.6	10.7	5.7	4.8	2.7	7.0	5.7	6.5	7.4	7.3	5.6	9.1	4.5	2.3	7.9	5.4	7.8	3.5	6.1	4.2	15.6	6.7	6.2	3.5	6.4	10.2	7.3	7.4	2.9	6.5	5.1	7.9	5.0	2.0	6.2	4.0	7.8	3.8	5.0	2.9	3.4	6.9	4.9	12.2	4.0	3.8	9.3	9.2	5.3	7.9	6.4	5.3	5.9	4.2	7.3	4.8	13.5	6.0	4.4	3.2	4.2	10.7	4.3	5.9	3.6	5.6	2.8	9.8	10.3	5.2	1.9	9.0	4.0	7.2	1.4	9.2	2.8	3.2	10.8	3.7	4.9	2.6	2.5	9.7	3.0	5.4	34.0	16.4	24.6	8.6	14.6	8.7	13.0	11.1	9.1	14.3	8.5	11.7	8.6	8.7	5.6	16.3	11.0	12.0	12.2	7.6	7.8	8.0	9.5	7.4	7.5	7.6	7.6	8.5	7.0	7.3	7.8	7.1	0.0	6.4	12.1	5.1	3.2	4.3	8.6	0.6	8.8	5.5	6.1	2.6	0.0	6.9	3.7	10.4	8.4	6.7	6.3	9.8	12.7	9.2	13.8	6.7	8.8	5.4	11.0	17.8	33.6	4.7	6.2	8.2	8.5	3.8	3.9	5.0	8.7	6.9	5.0	16.9	9.0	14.2	5.6	4.0	6.3	6.8	3.7	5.4	16.9	5.4	14.0	5.2	14.6	19.1	13.3	3.8	11.3	6.3	3.3	7.5	17.9	11.8	16.2	13.1	4.5	7.2	15.6	17.0	2.8	3.0	7.0	5.0	9.2	7.1	3.0
WDR91	"HSPC049, SORF-1"	ENSG00000105875	"WD repeat domain 91"	A4D1P6	7	135183839-135211534	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 32.2;THP-1: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024260	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA024260: AB_1844392"	"unprognostic (5.37e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.53e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	6.4	5.1	6.9	3.7	7.3	6.0	6.4	7.3	7.8	7.8	17.8	4.3	2.0	5.2	6.7	10.2	9.0	3.2	3.5	8.3	6.5	19.3	7.1	9.7	5.5	7.2	6.9	12.5	18.7	3.4	5.7	7.7	6.7	5.9	2.2	2.6	6.3	6.8	4.7	6.8	5.1	3.3	6.3	8.6	7.6	6.1	7.2	5.2	3.8	2.7	5.2	5.5	7.1	7.2	3.0	1.2	2.8	7.9	5.0	3.8	3.6	3.4	4.0	3.0	3.7	1.3	1.1	2.0	5.1	2.5	4.1	2.3	4.6	11.8	3.4	10.3	3.8	1.9	3.4	4.9	7.3	3.4	1.6	5.3	6.4	2.7	2.3	2.6	4.0	4.9	7.9	3.1	3.0	2.2	6.5	9.1	4.1	2.5	3.1	8.3	4.3	4.8	32.2	1.8	1.7	3.3	4.3	4.0	10.0	2.8	2.2	23.3	1.4	6.8	1.6	4.8	3.2	6.7	2.8	6.3	6.2	6.6	4.9	0.4	3.7	3.4	1.4	1.3	1.5	1.8	1.7	0.9	2.1	1.6	2.6	1.6	2.1	2.5	1.2	0.9	2.4	1.8	6.9	7.3	7.3	7.8	8.3	6.5	7.2	6.9	6.7	6.3	7.2	7.2	4.5	6.4	9.3	14.7	7.1	4.2	3.8	11.8	16.5	6.8	4.8	6.1	2.9	8.6	8.8	7.3	6.2	23.2	6.5	1.1	19.6	9.1	33.4	18.7	6.3	5.2	1.2	4.4	11.4	7.1	5.0	5.0	5.6	25.3	16.5	8.6	6.4	7.7	36.4	3.3	12.5	1.8	2.0	11.6	12.3	54.2	5.9	9.9	3.6	7.5	6.8	3.4	0.0	7.1	10.2	3.9	4.8	15.4	5.0	2.4	1.5	18.5	6.8	3.4	13.1	5.6	5.7	9.1	8.6	7.1	4.0	29.0	5.0	7.6	1.2	1.4
WWC1	"KIAA0869, KIBRA, PPP1R168"	ENSG00000113645	"WW and C2 domain containing 1"	Q8IX03	5	168291645-168472303	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 142.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 162.2;Cone photoreceptor cells: 91.8;Endometrial ciliated cells: 81.8;Glandular and luminal cells: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 120.2;RPTEC TERT1: 260.4;SK-BR-3: 136.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038016, HPA038017"	Approved		Approved	"Golgi apparatus"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"		"HPA038016: AB_10697091, HPA038017: AB_10669513"	"unprognostic (3.60e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.77e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.38e-2)"	"prognostic favorable (1.95e-8)"	"unprognostic (2.81e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-1)"	7.8	0.6	41.8	2.9	43.3	0.1	21.2	41.0	39.7	6.0	50.4	6.4	24.3	2.8	6.8	22.9	17.2	8.7	1.6	40.3	41.3	73.3	38.1	20.2	3.0	56.8	47.0	0.8	28.3	23.5	7.8	10.2	43.6	16.4	6.1	17.8	142.3	11.8	0.0	19.9	20.2	1.1	46.6	0.7	22.9	1.7	54.3	1.3	29.7	0.0	6.9	9.3	10.1	38.6	50.6	56.4	9.2	0.4	0.0	0.0	96.8	3.7	0.9	17.1	15.3	120.2	73.6	0.0	58.6	1.2	47.4	35.0	18.9	46.1	20.1	0.1	18.6	0.0	28.6	29.9	0.9	4.4	0.0	6.0	13.9	32.3	28.5	13.2	0.0	3.0	0.0	7.2	1.3	56.4	0.0	0.1	13.3	60.8	8.2	0.0	0.4	29.1	260.4	68.8	30.7	11.4	66.5	136.4	17.1	11.6	67.8	4.3	0.0	3.0	34.2	0.4	36.9	0.8	0.4	0.2	3.4	0.1	8.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	41.8	43.3	41.0	39.7	40.3	41.3	56.8	47.0	43.6	46.6	54.3	38.6	0.3	64.1	72.3	162.2	1.3	11.9	14.7	6.0	1.8	1.4	35.7	25.7	1.8	34.3	42.1	58.8	91.8	11.6	0.6	17.9	13.7	44.9	0.4	81.8	10.8	1.3	7.8	0.0	50.1	40.5	2.3	5.3	15.3	149.2	1.3	5.6	1.1	16.9	1.3	0.0	27.9	7.8	6.1	0.6	1.1	0.1	1.2	4.2	10.6	8.4	1.1	18.1	0.0	17.6	1.9	73.1	10.9	0.7	0.1	38.8	18.9	61.8	36.7	9.1	0.0	0.2	5.6	0.3	5.0	7.3	13.9	18.2	2.1	2.5	12.2	16.5
YARS1	"tyrRS, YARS, YRS, YTS"	ENSG00000134684	"Tyrosyl-tRNA synthetase 1"	P54577	1	32775237-32817380	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 17.5;Cytotrophoblasts: 41.8;Extravillous trophoblasts: 48.1;Hofbauer cells: 41.0;Syncytiotrophoblasts: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017936, HPA018950, HPA018954"	Enhanced		Enhanced	Cytosol		No	No		1400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915"	"unprognostic (4.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.38e-3)"	"prognostic unfavorable (6.97e-11)"	"unprognostic (5.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (3.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (6.57e-4)"	24.9	40.3	39.9	35.0	51.2	19.9	21.3	38.1	60.4	20.5	30.1	27.5	26.0	16.9	25.0	34.4	21.6	15.3	22.4	42.1	46.6	20.6	47.7	27.8	38.2	37.5	38.4	15.1	85.6	34.1	14.8	26.2	42.3	18.8	32.4	38.0	29.6	29.0	31.9	26.0	21.6	35.4	38.5	22.0	40.8	31.2	44.2	34.6	42.3	36.6	50.0	34.6	14.0	49.6	157.1	92.1	86.1	194.5	111.2	117.7	91.7	151.0	136.7	133.2	165.0	116.6	103.0	287.5	63.1	173.2	112.7	90.8	269.0	204.4	198.9	122.6	113.9	254.2	117.2	114.2	383.4	202.9	147.3	129.0	252.3	212.7	544.2	98.3	140.9	245.8	291.8	268.7	117.8	107.8	233.0	159.3	149.1	185.3	134.5	198.3	75.2	234.9	109.8	76.5	149.5	94.2	89.0	102.7	300.8	99.2	95.2	247.5	103.6	73.6	135.7	152.1	135.7	242.8	265.2	255.7	184.8	297.7	203.6	56.1	33.3	17.8	59.0	35.2	58.4	23.8	35.4	55.1	45.8	20.3	25.2	39.0	6.9	98.1	35.0	26.9	40.9	51.5	39.9	51.2	38.1	60.4	42.1	46.6	37.5	38.4	42.3	38.5	44.2	49.6	7.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	41.8	11.6	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	48.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	37.6	1.4	0.0	0.0	0.0
YIPF2	"FinGER2, MGC3262"	ENSG00000130733	"Yip1 domain family member 2"	Q9BWQ6	19	10922185-10928681	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 159.1;Syncytiotrophoblasts: 174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019902	Approved		Approved	"Golgi apparatus,Mitochondria"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus, Mitochondria"		"HPA019902: AB_1858925"	"unprognostic (1.27e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.92e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.00e-2)"	29.5	43.5	18.1	15.9	18.7	29.6	34.1	20.5	26.6	41.7	30.7	34.7	31.8	38.1	26.8	51.0	35.2	30.3	31.6	19.4	20.3	45.1	56.1	32.8	16.8	22.4	19.6	39.6	114.3	33.4	108.2	38.9	21.0	40.3	15.8	6.5	105.7	23.6	24.8	33.8	29.9	14.2	18.2	27.7	39.2	76.8	19.4	14.3	47.5	10.3	11.2	32.6	39.6	20.4	64.9	22.3	17.5	25.4	40.0	38.9	30.1	48.9	71.6	36.6	52.9	68.1	51.6	12.8	80.2	56.2	16.7	49.8	11.9	47.6	9.5	41.7	43.2	24.2	27.3	39.1	62.1	42.5	49.3	35.7	33.6	24.7	35.4	47.7	26.2	31.1	31.6	69.2	22.9	109.4	27.4	42.7	29.4	44.3	55.2	22.8	14.1	65.3	33.0	30.2	45.4	22.2	35.2	56.4	48.8	15.3	51.7	60.1	39.1	41.6	15.3	60.2	36.7	96.7	42.5	24.2	65.1	72.9	43.9	39.2	18.8	9.3	13.3	21.3	10.4	16.3	10.4	12.3	22.3	9.5	9.3	13.3	3.1	12.1	19.4	34.1	12.6	10.4	18.1	18.7	20.5	26.6	19.4	20.3	22.4	19.6	21.0	18.2	19.4	20.4	20.5	16.0	21.2	2.6	16.0	6.8	41.6	22.4	17.1	19.4	46.9	37.8	0.5	27.1	27.3	35.0	16.7	109.5	20.6	31.9	27.4	69.3	131.1	23.0	20.1	19.2	43.3	17.2	6.4	80.7	114.1	36.0	33.6	29.3	21.6	22.5	22.5	23.0	38.7	18.5	6.7	69.4	14.2	15.3	5.2	34.6	35.1	20.5	5.4	5.6	21.1	23.8	16.5	3.5	3.3	50.3	47.7	25.6	55.4	51.6	52.5	27.0	26.1	16.4	6.6	20.0	21.9	159.1	16.6	22.6	7.0	174.3	13.9	27.9	50.6	50.0
YIPF3	"C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1"	ENSG00000137207	"Yip1 domain family member 3"	Q9GZM5	6	43511832-43516985	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 494.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014859, HPA063699"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Nucleoplasm	"HPA014859: AB_1845729, HPA063699: AB_2685095"	"unprognostic (2.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	72.3	120.2	78.9	43.3	79.9	46.4	70.0	79.5	92.0	74.0	102.6	74.3	65.2	72.1	100.5	80.3	69.7	63.3	87.6	80.2	78.9	78.2	105.4	68.9	42.6	80.5	79.2	75.6	152.0	110.0	91.9	77.8	81.2	76.3	62.1	49.8	118.6	61.1	82.8	70.0	66.1	57.5	78.3	67.2	106.1	48.0	81.6	46.0	74.3	83.4	46.5	69.1	67.3	80.8	95.0	66.2	95.3	185.4	208.3	168.5	56.1	111.9	174.6	91.8	115.7	79.1	67.6	37.8	84.4	208.6	78.4	93.4	71.0	110.2	59.4	69.9	95.7	61.2	91.8	153.2	163.2	64.7	85.9	169.0	141.2	77.9	78.3	154.4	141.1	61.1	67.8	88.2	111.5	146.9	47.5	82.3	49.7	494.4	71.1	42.6	43.0	103.2	164.3	101.4	76.7	109.0	50.3	66.9	122.2	72.8	111.4	133.5	133.5	103.1	53.4	57.0	78.8	102.5	88.8	74.3	73.2	53.5	71.5	147.2	84.8	128.7	60.0	82.2	52.3	46.1	53.7	54.1	78.7	48.5	42.7	48.5	316.0	65.5	83.2	70.3	79.8	78.2	78.9	79.9	79.5	92.0	80.2	78.9	80.5	79.2	81.2	78.3	81.6	80.8	77.8	35.3	33.6	12.7	41.4	40.7	63.8	121.7	63.2	54.6	62.8	49.4	31.7	82.9	86.5	55.2	37.5	192.2	41.1	109.7	49.0	149.6	38.1	63.5	60.5	78.9	107.1	42.1	12.1	101.8	209.5	78.2	59.7	67.9	40.6	77.9	74.6	71.0	99.3	58.9	14.7	117.6	101.7	49.1	31.2	79.0	69.9	49.6	65.8	14.0	72.4	115.0	42.2	15.1	17.7	117.5	108.8	67.0	111.6	71.4	129.1	74.9	51.2	63.5	32.9	45.5	64.4	44.0	40.8	52.8	35.5	264.1	34.9	101.9	80.0	81.6
Z84492.1		ENSG00000272104	"Novel protein"		3	50350892-50367923	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 4.8;Karpas-707: 6.5"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"									"unprognostic (2.51e-1)"							"unprognostic (9.06e-2)"						1.7	0.5	2.4	0.9	2.2	1.1	1.7	1.9	3.7	1.5	1.0	2.8	4.6	0.8	4.0	1.2	1.6	0.8	0.3	1.5	3.2	2.5	0.4	0.5	4.5	1.8	1.6	3.0	3.5	1.2	0.7	0.2	1.7	2.7	1.1	0.4	4.3	1.0	0.6	4.4	4.7	0.5	1.4	2.6	3.6	1.3	2.4	1.2	3.2	0.1	1.8	0.6	0.0	1.7	1.6	0.0	0.0	1.0	1.1	0.0	0.3	1.7	1.1	0.3	1.3	0.0	1.0	0.9	1.5	0.0	0.1	0.9	0.0	0.6	0.9	1.8	0.4	0.0	1.3	0.0	0.4	0.0	4.8	0.0	0.8	0.6	0.0	0.2	0.0	2.4	0.3	6.5	0.0	0.6	1.8	0.0	0.6	1.6	0.0	0.6	0.3	2.6	0.3	0.0	1.2	3.0	0.0	1.2	0.2	0.3	1.1	0.0	0.0	0.3	0.1	0.0	0.5	1.6	2.5	1.1	0.0	0.4	0.0	4.8	0.1	3.6	5.8	0.3	8.4	8.3	10.5	8.6	0.1	9.3	14.2	8.2	0.5	10.4	0.7	1.6	15.4	3.0	2.4	2.2	1.9	3.7	1.5	3.2	1.8	1.6	1.7	1.4	2.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZFAND2A	AIRAP	ENSG00000178381	"Zinc finger AN1-type containing 2A"	Q8N6M9	7	1152071-1160759	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 490.1;Paneth cells: 310.4;Prostatic glandular cells: 255.2;Urothelial cells: 322.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 179.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019469	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA019469: AB_1859009"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.10e-3)"	"unprognostic (7.52e-2)"	"unprognostic (8.78e-2)"	"unprognostic (6.48e-2)"	"prognostic unfavorable (5.47e-7)"	"unprognostic (5.44e-3)"	"unprognostic (7.60e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.59e-2)"	27.0	26.0	57.7	10.6	58.9	80.5	24.1	62.8	98.9	18.1	52.7	26.4	17.8	20.7	14.7	21.5	18.8	18.1	18.5	63.0	61.3	30.8	81.1	32.5	15.4	58.7	60.4	20.9	33.8	16.4	22.4	21.1	60.8	23.2	18.1	15.1	19.6	12.1	13.2	20.3	19.9	14.4	60.3	24.3	32.5	26.9	59.3	13.4	27.0	7.9	11.8	25.2	21.7	66.2	44.7	50.6	12.8	29.3	28.6	20.3	20.3	40.1	32.6	40.1	30.6	35.7	35.4	14.5	15.8	33.5	63.3	59.8	10.2	10.6	40.5	11.9	21.1	9.8	22.7	179.8	54.4	29.2	19.3	19.1	34.2	32.9	58.3	28.2	14.0	32.8	56.0	33.0	29.6	69.6	8.3	32.8	51.8	105.8	69.3	25.3	2.4	23.0	16.5	19.0	18.6	19.0	14.3	39.1	50.5	26.7	40.1	58.5	18.2	29.6	23.2	34.3	54.7	40.0	51.2	27.3	29.1	32.5	64.3	71.6	25.8	34.2	31.3	24.7	28.8	32.3	28.1	33.0	18.7	34.5	26.9	23.4	31.8	33.2	25.3	34.6	39.5	30.0	57.7	58.9	62.8	98.9	63.0	61.3	58.7	60.4	60.8	60.3	59.3	66.2	65.4	32.1	17.2	4.2	40.6	22.6	490.1	27.6	46.7	15.6	39.8	34.7	17.9	22.8	17.4	7.3	16.7	18.9	49.1	211.8	23.5	21.6	9.7	46.3	33.4	40.7	126.9	17.2	5.6	39.5	46.6	50.8	54.0	83.8	116.4	9.7	20.3	50.3	40.6	11.8	5.8	207.9	18.3	29.2	119.6	12.6	13.4	121.1	32.0	1.0	31.6	23.7	21.6	2.5	7.4	65.7	310.4	18.0	89.7	255.2	29.3	34.1	13.1	25.6	0.0	16.6	40.5	47.1	39.0	64.8	27.7	65.9	156.4	13.3	123.6	322.2
ZNF444	"EZF2, FLJ11137, ZSCAN17"	ENSG00000167685	"Zinc finger protein 444"	Q8N0Y2	19	56132599-56160893	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 118.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056895, HPA065203"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Nucleoli	"HPA056895: AB_2683267, HPA065203: AB_2685431"	"unprognostic (1.58e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.87e-4)"	13.2	23.4	33.8	6.3	31.4	3.2	15.8	28.3	36.3	24.1	31.3	32.5	11.4	24.9	7.7	16.5	26.1	9.3	23.9	30.5	30.2	23.7	64.3	18.1	5.7	38.6	32.4	26.0	46.4	7.8	29.3	4.8	31.4	35.2	4.2	5.7	21.6	19.6	18.6	14.6	19.0	5.9	29.1	17.7	32.0	21.3	32.6	16.0	28.8	7.0	4.4	25.8	17.7	32.1	11.3	21.1	19.0	16.7	8.0	8.1	12.5	14.0	9.2	11.7	12.6	23.1	12.4	19.7	12.2	8.1	5.9	10.3	11.8	9.5	4.9	17.3	118.4	19.6	15.3	42.4	13.0	8.7	17.4	9.5	8.5	9.5	7.3	17.6	10.6	24.1	25.7	8.6	8.3	14.6	28.4	24.4	20.5	22.3	38.2	32.7	12.3	10.7	13.0	10.2	20.4	28.0	7.1	23.2	11.2	10.3	23.2	15.7	14.4	20.8	18.2	4.6	15.6	20.5	18.9	15.1	13.1	11.8	13.9	1.9	1.1	2.4	2.3	0.9	2.5	1.2	4.0	4.0	1.2	2.3	4.0	2.7	0.1	2.2	0.6	2.1	2.9	1.4	33.8	31.4	28.3	36.3	30.5	30.2	38.6	32.4	31.4	29.1	32.6	32.1	12.2	3.2	18.1	26.1	11.0	3.1	17.4	15.3	5.2	17.9	13.9	11.8	13.9	28.6	17.6	11.0	8.4	18.8	5.6	15.6	9.8	26.4	28.6	16.2	8.9	15.1	29.3	6.1	10.0	21.9	9.7	10.0	20.9	9.2	10.2	16.8	18.5	38.9	10.7	20.2	10.0	28.0	20.3	7.2	6.1	39.2	12.2	5.5	16.0	5.6	13.6	17.7	12.3	14.6	19.0	18.3	9.9	12.0	8.6	13.5	18.7	26.9	18.3	13.4	26.3	8.5	12.6	13.6	25.6	3.4	5.3	12.4	11.2	43.4	22.9	11.0
ZNF843	MGC46336	ENSG00000176723	"Zinc finger protein 843"	Q8N446	16	31432593-31443160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 4.6;Cardiomyocytes: 5.3;Prostatic glandular cells: 3.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.3;EFO-21: 1.8;HMC-1: 1.6"									"HPA030911, HPA030912, HPA077945"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nuclear speckles"	"HPA030911: AB_2673656, HPA030912: AB_10670434, HPA077945: "	"unprognostic (9.27e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.43e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.86e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.93e-3)"	"unprognostic (5.96e-3)"	"unprognostic (1.23e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.28e-5)"	"unprognostic (1.17e-1)"	0.6	0.5	1.5	0.3	1.2	0.3	0.6	2.5	1.3	1.0	0.0	0.4	0.2	1.0	0.7	0.4	1.1	0.7	1.7	1.6	1.9	0.6	0.4	0.3	0.3	1.1	1.4	3.0	2.1	0.9	1.5	0.4	0.9	0.6	0.1	1.1	1.5	0.8	2.2	0.9	0.3	0.5	1.1	0.4	0.4	0.5	1.8	0.2	1.0	0.8	0.2	0.5	0.6	0.9	0.1	0.3	0.2	1.2	2.3	0.6	0.0	0.2	0.2	0.0	0.1	0.1	0.3	0.0	1.8	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.6	0.2	1.6	1.2	0.3	0.0	0.1	0.8	0.0	0.2	0.2	0.2	0.6	0.8	0.1	0.4	0.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.2	0.8	0.0	0.2	0.1	0.1	0.0	0.1	0.4	1.0	0.2	0.2	0.7	0.1	0.4	0.2	0.2	0.7	0.1	0.2	0.1	0.4	0.7	1.7	0.1	0.2	0.1	1.0	1.5	1.2	2.5	1.3	1.6	1.9	1.1	1.4	0.9	1.1	1.8	0.9	0.5	0.0	0.5	2.9	0.3	0.8	4.6	0.1	0.0	2.2	0.9	1.3	5.3	0.0	0.7	0.0	2.1	0.3	0.1	0.3	0.0	0.3	0.2	0.4	2.0	1.0	1.2	0.0	1.4	0.2	0.1	1.4	0.0	0.4	1.3	1.4	1.8	0.3	0.6	0.0	1.7	0.0	0.0	0.3	2.1	0.0	1.5	0.9	0.0	0.0	0.1	1.4	2.1	1.0	1.3	0.1	0.1	1.5	0.1	3.6	0.0	0.4	0.0	1.9	0.0	2.8	1.3	0.4	0.7	0.1	1.4	0.3	1.2	0.8	0.1	1.9
ZNF98	"F7175, ZNF739"	ENSG00000197360	"Zinc finger protein 98"	A6NK75	19	22391019-22532485	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"ovary: 11.8;pancreas: 37.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.0;Distal tubular cells: 15.6;Early spermatids: 14.7;Granulosa cells: 12.9;Oligodendrocyte precursor cells: 10.6;Spermatocytes: 15.7;Spermatogonia: 21.1"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;GAMG: 5.4;NB-4: 4.8;RPMI-8226: 1.9;SuSa: 2.1;T-47d: 3.4;U-2197: 3.6"															NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"				"unprognostic (1.11e-1)"			"unprognostic (1.31e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.36e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.56e-1)"		"unprognostic (7.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.56e-2)"	1.0	0.6	1.8	0.2	5.6	0.2	3.8	0.6	10.1	3.3	0.0	0.2	0.1	1.2	5.7	0.2	2.1	0.4	0.6	2.7	4.0	2.0	0.0	0.2	0.4	1.6	1.9	11.8	37.2	3.9	0.3	0.5	1.6	0.8	0.1	0.6	0.8	0.6	0.0	0.1	0.1	1.3	0.2	0.2	0.3	7.6	1.4	0.0	4.7	0.2	0.0	0.5	0.2	5.8	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0	5.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	4.8	1.0	0.0	0.2	0.3	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	3.4	1.1	0.0	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	5.6	0.6	10.1	2.7	4.0	1.6	1.9	1.6	0.2	1.4	5.8	1.2	0.0	0.0	34.0	0.1	0.0	0.4	0.0	0.0	1.4	2.9	2.5	1.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	15.6	3.1	14.7	0.3	1.6	0.4	0.0	0.0	2.5	1.4	0.4	1.2	0.0	0.5	0.0	12.9	0.0	0.0	0.1	1.7	0.5	0.0	0.0	0.0	0.0	3.5	1.2	0.1	0.0	1.9	0.0	1.0	0.0	10.6	5.2	0.3	0.0	1.9	0.0	0.1	0.0	1.7	0.0	0.1	0.0	0.0	1.0	15.7	21.1	0.0	0.0	0.4	0.0	8.2	0.0	0.4
ZSCAN2	"FLJ20595, ZFP29, ZNF854"	ENSG00000176371	"Zinc finger and SCAN domain containing 2"	Q7Z7L9	15	84600986-84627796	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 18.0;Proximal tubular cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007296, HPA024331"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA007296: , HPA024331: AB_1859497"	"unprognostic (4.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (4.24e-1)"	"prognostic favorable (7.46e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.16e-5)"	7.6	5.8	3.0	4.2	3.9	8.7	7.2	4.8	3.6	6.7	2.3	4.5	3.1	6.4	2.3	2.3	4.0	3.5	6.0	3.2	4.1	7.5	8.8	3.0	4.1	3.2	3.3	6.0	16.6	4.1	4.1	2.1	3.8	5.2	2.9	6.2	6.8	3.0	8.2	2.6	4.4	3.3	2.8	5.9	8.1	11.8	3.7	10.1	4.1	3.1	3.1	4.6	3.5	4.8	2.2	13.4	9.0	14.6	5.7	3.5	8.5	2.5	6.2	5.3	6.4	10.4	5.2	4.9	6.9	3.5	9.8	5.6	6.9	5.0	4.6	10.4	13.0	6.2	8.4	22.0	4.9	3.9	4.4	5.6	4.9	7.0	6.6	7.0	15.5	24.0	8.4	3.9	5.6	6.7	16.8	9.6	16.9	4.5	7.9	16.8	5.6	9.2	5.3	16.7	13.5	23.1	7.6	4.1	11.7	14.5	9.1	9.8	10.8	6.3	12.4	3.2	3.3	6.3	9.5	16.8	4.3	8.7	3.7	6.4	5.8	5.0	5.7	6.4	2.8	3.9	5.2	4.3	6.6	3.5	3.8	4.3	3.1	5.6	8.4	5.9	7.8	3.9	3.0	3.9	4.8	3.6	3.2	4.1	3.2	3.3	3.8	2.8	3.7	4.8	9.1	0.0	2.0	1.6	3.9	0.9	1.2	2.6	2.2	3.1	3.5	3.2	2.5	4.3	1.7	7.3	2.1	1.6	2.5	1.3	5.9	6.9	18.0	5.7	3.3	3.0	3.0	3.0	1.6	8.6	5.1	2.3	4.6	6.9	1.3	8.0	1.1	7.5	3.6	0.0	1.6	3.2	4.1	2.8	2.3	12.3	0.9	2.9	1.8	1.0	5.5	2.3	2.1	4.0	2.5	9.9	4.2	1.5	11.1	2.6	1.9	22.6	1.8	3.1	6.6	2.3	3.9	7.1	8.2	0.9	0.4	1.4	3.7	3.6	2.6	1.5